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Abstract 
Palladium-catalysis is extremely important in fine chemical synthesis. This thesis looks at the 
development of new palladium-catalysed carbon–carbon bond formation reactions, with 
particular attention to forming new bonds to sp3 carbons. 
The opening chapter of this thesis gives an overview of current methods for palladium-
catalysed heterocyclisation, and the methods for incorporating further functionalisation into 
this process, then focuses on the optimisation and expansion of a new palladium-catalysed 
carboallylation reaction. The reaction mechanism was demonstrated via a deuterium-labelling 
study, confirming that the reaction proceeds through an isohypsic mechanism. 
Chapter 2 begins with a summary of palladium-catalysed isohypsic reactions, and the 
introduction of the isohypsic–redox sequence. New results are presented on the expansion of 
this isohypsic–redox sequence to include the oxyallylation–Heck-coupling, and work on the 
aminoallylation–Grubbs–Wacker oxidation. 
Chapter 3 commences with an introduction to MIDA boronates, describing their useful 
properties along with some uses, particularly in step-wise synthesis. The development of a 
new palladium-catalysed allylation of MIDA boronates is then detailed. Using MIDA boronates 
to form a new bond to an sp3 carbon for the first time, this was applicable to a range of allyl 
halides as well as a large number of MIDA boronates containing a range of functionality. 
Formation of a new sp3–sp3 carbon–carbon bond was explored, as well as an 
enantioselective allylation. The application of the allylation was demonstrated in the 
development of a new palladium-catalysed synthesis of Ibuprofen. 
Experimental procedures and data are summarised in Chapter 4. An appendix containing 
NMR spectra for new compounds is attached. 
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1 Pd-catalysed formation of heterocycles 
1.1 Introduction 
Palladium catalysis is widely used in formation of heterocycles.1, 2 It is particularly useful due 
to the wide range of reactivity available both during cyclisation and further functionalisation. 
This chapter describes some of the methods used to carry out both heterocyclisation and 
further functionalisation. After examining various different ways of initiating heterocyclisation, 
the development of a carboallylation reaction forming a new sp3–sp3 carbon–carbon bond is 
shown. 
1.1.1 C–X initiated heterocyclisation 
Aryl halides provide a widely available source to initiate heterocyclisation. Oxidative addition 
with a Pd(0) catalyst forms Pd(II) intermediate 1.2 (Scheme 1). After heterocyclisation has 
occurred, termination can occur via simple β-elimination, or the complex 1.3 can undergo 
further functionalisation giving access to a large selection of functionally diverse products. 
 
Scheme 1.1: Palladium-catalysed heterocyclisation 
The simplest method of termination is ß-hydride elimination. This involves an intramolecular 
Heck-type reaction to form the desired heterocycles, such as dihydrobenzofurans (Scheme 
1.2a).3, 4 While this is a simple process, it can result in the formation of complex structures 
such as 1.9, a key intermediate in the synthesis of maxonine (Scheme 1.2b). 
12 
 
 
 
Scheme 1.2: Heterocyclisation via intramolecular Heck-type reaction 
While β-hydride elimination may be more common, other groups can also be eliminated to 
reform an alkene. Lautens et al. showed this with an intramolecular Heck–β-oxygen 
elimination sequence (Scheme 1.3).5 This approach proved useful in the synthesis of a range 
of highly substituted heterocycles including tetrahydroquinolines 1.11 and 
dihydrobenzofurans 1.13. 
 
Scheme 1.3: Heterocyclisation followed by β-oxygen elimination 
While simple, ß-elimination does not add any extra functionality into the resulting product. If 
instead Pd(II) intermediate 1.2 (Scheme 1.1) is trapped in some way, a wide range of 
functionality can be introduced into the newly formed heterocycle. The use of widely available 
13 
 
organometallics such as boronic acids6-12 and stannanes as traps has been demonstrated by 
Grigg13  and Lamaty14, 15 (Scheme 1.4a, b). After heterocyclisation occurs, the resulting Pd(II) 
intermediate is trapped via a Suzuki or Stille coupling. Incorporation of CO during the trapping 
is also possible (Scheme 1.4c).16 Trapping via Sonogashira coupling has also been shown.17, 18 
 
 
 
Scheme 1.4: Heterocyclisation terminating with organometallic traps 
While the availability of organometallic traps makes them extremely useful, they are 
inherently atom-inefficient. A more efficient coupling is available by terminating by direct C–H 
activation.19-21 Fagnou and co-workers demonstrated the use of C–H activation to trap the 
Pd(II) intermediate with various sulfur containing heterocycles (Scheme 1.5).22 This resulted in 
the formation of a range of heterocycles including dihydrobenzofurans and indolinones 1.24. 
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Scheme 1.5: Heterocyclisation terminating by C–H activation 
A similar reaction was developed by Zhu et al. After formation of the cyclised Pd(II) 
intermediate, C–H activation was used to trap with 1,3,4-oxadiazoles. By using chiral ligand 
1.28, they were able to form a range of indolinones, achieving good yields and excellent ee 
(Scheme 1.6).23 
 
Scheme 1.6: Heterocyclisation terminating by C–H activation 
Instead of immediately trapping the Pd(II) intermediate, further transformations can also be 
carried out. Larock and co-workers showed that after heterocyclisation, 1.33 can undergo a 
1,4-shift to give 1.34 (Scheme 1.7).24  This intermediate can then undergo C–H activation 
followed by reductive elimination to form a second new ring. This allowed formation of a 
number of polycyclic compounds. 
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Scheme 1.7: Heterocyclisation followed by 1,4-shift and another cyclisation 
As well as the standard methods of termination, more exotic traps have also been shown to 
be effective. Lautens et al. reported a 100% atom-efficient carboiodination to form a range of 
heterocycles (Scheme 1.8).25, 26 This was one of the first examples of reductive elimination to 
form a C–halogen bond, and leaves an extremely useful functional handle in an otherwise 
difficult to access position. Other more unusual traps include cyanation,27, 28 isocyanides29 and 
trapping with a Buchwald-Hartwig-type aminocarbonylation.30 
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Scheme 1.8: Heterocyclisation terminated by reductive elimination to form C–I bond 
1.1.2 C–H activation 
As well as providing a method of termination, C–H activation can also provide another route 
for heterocyclisation itself.31 The lack of requirement for pre-activation of the reactive site 
allows for more atom- and step-efficient reactions. It is not without drawbacks, however – 
generally an external oxidant is required to complete the catalytic cycle. As with C–halogen 
initiated heterocyclisation, some of the earlier examples of C–H activation initiated 
heterocyclisation involve carbopalladation of an alkene, followed by β-hydride elimination.32 
Generally requiring electron-rich arenes, reactions of this type have been used by Stoltz33, 34 
and Oestreich35 to form heterocycles such as benzofurans and indolinones. Also proving 
useful in total synthesis, this type of heterocyclisation has been used as a key step in the 
synthesis of (±)-rhazinicine 1.44 (Scheme 1.9) and rhazinal 1.49 (Scheme 1.10) by Gaunt36 
and Trauner37 respectively. 
 
Scheme 1.9: Use of C–H activation initiated heterocyclisation in the synthesis of rhazinicine 
17 
 
 
Scheme 1.10: Use of C–H activation initiated heterocyclisation in the synthesis of rhazinal 
While all of the previous trapping methods make use of Pd(II), the less common Pd(IV) 
oxidation state can also be used. Oxidation to Pd(IV) can be achieved by use of a suitable 
oxidant, often a hypervalent iodine reagent. The C–H activation can occur before or after 
oxidation.38 
This type of trapping was used by Zhu and Li, using bisacetoxyiodobenzene as an oxidant. 
This allowed the introduction of O and N based nucleophiles during the formation of 
indolinones. These indolinones were generated from alkenes39 (Scheme 1.11) or alkynes40 
(Scheme 1.12). 
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Scheme 1.11: Heterocyclisation terminating with formation of C–Nu bond by Pd(IV) 
 
Scheme 1.12: Heterocyclisation terminating with formation of C–N bond by Pd(IV) 
As well as through the standard 0–II or a II–IV cycle, heterocyclisation can also occur via a 
radical process. Wang demonstrated this with a radical heterocyclisation/difluoromethylation 
process.41 In their proposed mechanism, PhSO2CF2I was reduced by Pd(0), affording Pd(I) 
and a difluoromethyl radical. Addition of this radical to the activated alkene of the acrylamide 
generated a further radical. This radical could be trapped by the aromatic ring, with C–H 
cleavage forming the indolinone (Scheme 1.13a). A similar reaction was reported by Li and 
co-workers, here, they instead used an electron-deficient alkyl bromide as a radical source 
(Scheme 1.13b).42 
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Scheme 1.13: Palladium-catalysed radical heterocyclisation 
A range of other groups have also been incorporated during heterocyclisation. By changing 
the order of events, Duan showed the addition of a selection of alkyl and fluoroalkyl halides 
(Scheme 1.14).43 First carrying out an oxidative addition with the alkyl halide, carbopalladation 
of the alkene took place. This Pd(II) intermediate could then undergo C–H activation and 
reductive elimination to form the indolinone. 
 
Scheme 1.14: Heterocyclisation using alkyl halides 
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1.1.3 Boron initiated heterocyclisation 
While far less common, other initiation methods such as use of arenediazonium salts44 and 
boronic acids45 have been described. Mikami reported an enantioselective synthesis of 
dihydrobenzofurans and sulfonamides from boronic acids (Scheme 1.15).46 Beginning with 
transmetallation of the boronic acid to give 1.65, carbopalladation gave heterocyclic 
intermediate 1.66. Finally, ß-hydride elimination gave 1.67. Molecular oxygen was used to re-
oxidise the palladium catalyst and complete the cycle. 
 
Scheme 1.15: Heterocyclisation initiated by boronic acids 
  
21 
 
1.1.4 Initial development of a carboallylation reaction 
While there are many different termination methods giving access to a range of functionality, 
there are very few examples involving formation of a new sp3–sp3 C–C bond. A recent goal of 
the pharmaceutical industry has been to increase the proportion of sp3 hybridised atoms in 
new drug candidates.47 This is due to research showing that drugs completing clinical trials 
have a higher proportion of sp3 hybridised atoms than those in the earlier stages of testing. 
For this reason, the ability to form a new sp3–sp3 C–C bond as part of the heterocyclisation-
functionalisation process would be highly desirable. 
Previous work in the France group led to the development of a palladium-catalysed 
heteroallylation reaction.48 As well as forming a new C–Nu bond, this reaction also forms a 
new sp3–sp3 C–C bond. The reaction was carried out on a range of alkenyl alcohols and 
amines under mild conditions, with no need for an inert atmosphere, forming the 
corresponding heterocycles, e.g. dihydrobenzofuran 1.69 (Scheme 1.16) and other 
heterocycles. As well as phenols, the methodology was also found to be applicable to 
cyclisation of benzyl alcohols, aliphatic alcohols, benzoic acid derivatives and tosyl amides. 
 
Scheme 1.16: Oxyallylation reaction to form dihydrobenzofurans 
The reaction was demonstrated to proceed through an isohypsic Pd(II) catalytic cycle 
(Scheme 1.17). The first step involved activation of the alkene followed by oxypalladation to 
give cyclised intermediate 1.70. The resulting Pd(II) intermediate 1.70 was then trapped by 
the allyl halide in a carbopalladation to form the new sp3–sp3 C–C bond in 1.71. The final step 
involved β-halide elimination to give the cyclised product 1.69. A deuterium labelling study 
was carried out and the results were consistent with this mechanism. 
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Scheme 1.17: Mechanism of oxyallylation reaction 
As part of a range of heterocycles formed, the oxyallylation reaction allowed formation of 
dihydrobenzofuran isomers 1.69 and 1.73 (Scheme 1.18a, b). It was proposed that the use of 
boronic acid 1.74 could lead to a similar reaction to form the structural isomer 1.75 (Scheme 
1.18c). As with the oxyallylation reaction, this palladium-catalysed heterocyclisation would 
result in the formation of a new sp3–sp3 C–C bond. 
 
Scheme 1.18: Ways to form 3 different dihydrobenzofuran isomers 
Initial studies showed formation of the desired dihydrobenzofuran 1.75, albeit as the minor 
component (Table 1.1, entry 1).49 The major side products were the result of direct coupling 
1.76 and the de-boronation product 1.77. Changing the electrophile from allyl bromide to allyl 
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chloride improved the rate of reaction and reduced de-boronation, but direct coupling was still 
the major product (entries 1, 2 and 3). A screen of different catalyst/ligand combinations 
identified Pd(hfacac)2 as the best catalyst system. Use of solid Na2CO3 instead of an aqueous 
solution improved conversion to the desired dihydrobenzofuran, but also increased formation 
of de-boronation product (entry 3 vs. entry 4). Organic bases proved ineffective, preferentially 
forming the direct coupling or de-boronation products (entry 5). After screening of several 
solvents, dimethoxyethane (DME) gave a good ratio of desired:direct coupling products, with 
no de-boronation product formed (entry 6). Finally, the boron source was investigated, with 
potassium trifluoroborate 1.78 providing increased conversion without loss of selectivity (entry 
7). 
Table 1.1: Initial development of the carboallylation reaction49 
 
Entry B X (equiv.) Base Solvent 1.74 1.75 1.76 1.77 
1 B(OH)2 Br (5) 2 M aq. 
Na2CO3 
Toluene 0 0.1 1 1.2 
2 B(OH)2 Cl (5) 2 M aq. 
Na2CO3 
Toluene 0.2 0.1 1 0.3 
3 B(OH)2 Cl (2) 2 M aq. 
Na2CO3 
Toluene 0.1 0.3 1 0.7 
4 B(OH)2 Cl (2) Na2CO3 Toluene 3.2 6.7 1 10 
5 B(OH)2 Cl (2) NEt3 Toluene 0.1 0.3 1 3.1 
6 B(OH)2 Cl (2) Na2CO3 DME 9.2 3.4 1 0 
7 BF3K Cl (2) Na2CO3 DME 0 3.5 1 0.2 
Product ratio determined by 1H NMR 
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1.2 Results 
1.2.1 Optimisation of carboallylation reaction 
While the initial optimisation had yielded some improvements in the carboallylation reaction, 
there were still some issues to overcome. Further optimisation was planned to improve the 
ratio between the dihydrobenzofuran and direct coupling products and to improve the yield of 
the reaction. 
Synthesis of trifluoroborate 
Before further optimisation could occur, synthesis of trifluoroborate 1.78 was required 
(Scheme 1.19). The synthesis began with the alkylation of 2-iodophenol with methallyl 
chloride. Stirring in DMF overnight at 70 °C with potassium carbonate gave alkylated aryl 
iodide 1.80 in a quantitative yield. Iodide 1.80 underwent lithium-halogen exchange upon 
treatment with nBuLi at –78 °C. Addition of triisopropylborate formed the corresponding 
boronic ester, which was hydrolysed on addition of HCl giving the desired boronic acid 1.74 in 
a 51% yield. Following a procedure developed by Lloyd-Jones et al,50 boronic acid 1.74 was 
converted to potassium trifluoroborate 1.78 in 95% yield using KF and ʟ-tartaric acid. This 
simple procedure avoids the formation of the HF traditionally generated during formation of 
trifluoroborates. 
 
Scheme 1.19: Synthesis of potassium trifluoroborate 1.78 
Initial attempts at optimisation 
With boronic acid 1.74 and potassium trifluoroborate 1.78 in hand, the carboallylation reaction 
was subjected to further optimisation in order to suppress formation of the undesired direct 
coupling 1.76 and de-boronation 1.77 side products (Scheme 1.20). As potassium 
trifluoroborate 1.78 had been shown to increase conversion compared to using boronic acid 
1.74 (Table 1.1), the previously optimised conditions were re-examined (Scheme 1.20). 
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Scheme 1.20: Product distribution of the carboallylation reaction 
Next, the presence of added water was examined (Table 1.2). Some water will be required in 
the reaction when using potassium trifluoroborate 1.78, as it must be hydrolysed to the 
boronic acid before reacting.51 As the solvent used was technical grade and used as 
received, it can be expected that it contained some adventitious water. However, adding extra 
water proved to have a negative effect on selectivity (Table 1.2, entry 1 vs. entry 2). This saw 
a reduction in the amount of the desired product 1.75, while there was increased conversion 
to the direct coupling product 1.76. 
Table 1.2: Effect of water on the carboallylation reaction 
 
Entry X (equiv. H2O) 1.78 1.76 1.75 1.77 
1 168 0 1 2.8 0.1 
2 0 1.4 1 4.9 0.45 
Product ratio determined by 1H NMR 
The choice of solvent was again found to be important (Table 1.3). Changing solvent from 
DME to toluene proved to have a negative effect on the selectivity (entry 1 vs. entry 2). Using 
toluene, the direct coupling product 1.76 was formed as the major product. 
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Table 1.3: Effect of solvent on the carboallylation reaction 
 
Entry Solvent 1.78 1.76 1.75 1.77 
1 DME 0 1 1.4 0.4 
2 Toluene 0 1 0.5 0.6 
 
Finally, the number of equivalents of allyl chloride was examined (Table 1.4). This was 
important to examine as allyl chloride is a key part of the formation of both the desired 
product and the direct coupling side product. If too much is added then formation of the side 
product will be faster; however, if too little is added, the formation of the desired product will 
occur too slowly for an efficient reaction. The previous optimisation had shown that 2 
equivalents of allyl chloride provided the best selectivity for the desired carboallylation 
product 1.75. Increasing the number of equivalents, it was found that using more than 2 
equivalents of allyl chloride had a negative effect on the ratio of desired products (entries 4–
7). Using between 1.2 and 2 equivalents also had a negative effect (entries 1–4). The results 
therefore showed that two equivalents of allyl chloride provided the best ratio of the desired 
product 1.75 to the two side products 1.76 and 1.77 (Figure 1.1). 
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Table 1.4: Effect of the number of equivalents of allyl chloride on the carboallylation reaction 
 
Entry x SM 1.76 1.75 1.77 
1 1.2 0 1 1.4 0.4 
2 1.5 0.25 1 3.6 0.3 
3 1.8 0.2 1 3.3 0.25 
4 2 1.4 1 4.9 0.45 
5 4 0.9 1 2.5 0.2 
6 8 0.6 1 1 0.15 
7 10 0.35 1 0.7 0.1 
 
 
Figure 1.1: Graph of allyl Cl equivs vs. desired product ratio 
Overall, the results of the optimisation study showed that using potassium trifluoroborate 1.78 
instead of boronic acid 1.74 did not change the previously optimal conditions (Scheme 1.20). 
As before, these were using Pd(hfacac)2, DME, 2 equivalents of allyl chloride, sodium 
carbonate and potassium trifluoroborate 1.78 with no added water (Scheme 1.21). 
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Scheme 1.21: Product distribution of carboallylation reaction 
While the potassium trifluoroborate 1.78 had proven to be the best boron source, it is also 
possible to form other trifluoroborate salts. Following the same procedure used to form the 
potassium trifluoroborate, the synthesis of the corresponding cesium and sodium 
trifluoroborates was attempted (Scheme 1.22). Synthesis of the cesium trifluoroborate 1.82 
was successful, proceeding in a 90% yield. Unfortunately, synthesis of the sodium 
trifluoroborate was unsuccessful, with none of the desired product being isolated. 
 
Scheme 1.22: Synthesis of other trifluoroborates 
The cesium trifluoroborate 1.82 was then submitted to the optimised reaction conditions 
(Scheme 1.23). Disappointingly, direct coupling product 1.76 was the major product formed, 
giving a 3:1 ratio between the direct coupling product and the carboallylation product 1.75. 
 
Scheme 1.23: Carboallylation of cesium trifluoroborate 1.82 
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1.2.2 Synthesis and reaction of other substrates 
To test the effect of substitution in the O-allyl chain, the unsubstituted potassium 
trifluoroborate 1.85 was formed. Starting with 2-iodophenol 1.79, an identical procedure was 
used as for the synthesis of potassium trifluoroborate 1.78 was followed (Scheme 1.24). 2-
Iodophenol was treated with allyl chloride and potassium carbonate in DMF at 70 °C 
overnight. After workup, this gave alkylated aryl iodide 1.83 in a quantitative yield. Aryl iodide 
1.83 was then treated with nBuLi at –78 °C. Addition of triisopropyl borane followed by 
hydrolysis of the resulting boronate ester gave boronic acid 1.84 in 46% yield. Finally, 
treatment of the boronic acid with potassium fluoride and ʟ-tartaric acid afforded potassium 
trifluoroborate 1.85 in 71% yield. 
 
Scheme 1.24: Synthesis of potassium trifluoroborate 1.85 
Submitting potassium trifluoroborate 1.85 to the optimised carboallylation conditions, none of 
the desired cyclised product was formed, with a complex mixture of products resulting instead 
(Scheme 1.25). Interestingly, no formation of benzofuran 1.87 was detected either. This 
would form as a result of β-hydride elimination and isomerisation after cyclisation had taken 
place. 
 
Scheme 1.25: Carboallylation reaction of potassium trifluoroborate 1.85 
Rotomer restriction with methyl substrate 
As both the desired 1.75 and direct coupling 1.76 products can form via an isohypsic process, 
the “reactive rotomer” effect52 can have an important effect (Scheme 1.26). After 
transmetallation to form Pd(II) intermediate 1.88, the proximity of the O-methallyl chain 
determines how easily direct coupling or cyclisation can occur. For cyclisation to occur, the O-
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methallyl chain must be in close proximity to the Pd(II). As it is less sterically favourable for 
the O-methallyl chain to be close to the Pd(II) (1.89), it will likely spend more time at a greater 
distance (1.88). This leaves the Pd(II) intermediate 1.88 more vulnerable to direct coupling. 
By replacing the hydrogen in the 3-position with another group, it is less favourable for the O-
methallyl chain to be oriented towards the 3-position. This should result in the equilibrium 
being pushed towards 1.89, therefore favouring cyclisation. 
 
Scheme 1.26: Reactive rotomer effect 
In order to test this theory, it was proposed to synthesise 1.94 (Scheme 1.27). While small, 
the addition of a methyl group in the 3-position should give some insight into whether the 
reactive rotomer hypothesis is correct. Starting with o-bromocresol 1.91, an identical 
procedure was used as for the synthesis of potassium trifluoroborate 1.78 was followed. o-
Bromocresol was treated with methallyl chloride and potassium carbonate in DMF at 70 °C 
overnight. After workup, this gave alkylated aryl bromide 1.92 in a quantitative yield. Aryl 
bromide 1.92 was then treated with nBuLi at –78 °C, followed by addition of triisopropyl 
borane. Hydrolysis of the resulting boronate ester gave boronic acid 1.93 in 66% yield. 
Finally, treatment of the boronic acid with potassium fluoride and ʟ-tartaric acid afforded 
potassium trifluoroborate 1.94 in 89% yield, 59% overall yield. 
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Scheme 1.27: Synthesis of potassium trifluoroborate 1.94 
Methyl substituted potassium trifluoroborate 1.94 was then subjected to the optimised 
carboallylation conditions (Scheme 1.28). Gratifyingly, only a trace of direct coupling product 
1.96 was observed, with only 5% of de-boronation product 1.97 observed. Unfortunately, 
despite complete consumption of starting material, only 46% of carboallylated product 1.95 
was formed. 
 
Scheme 1.28: Carboallylation of potassium trifluoroborate 1.94 
To rule out the possibility of decomposition during purification, the reaction was repeated and 
a known quantity of 1,3,5-trimethoxybenzene added to the crude reaction mixture. Analysis of 
the crude mixture by 1H NMR then allowed direct calculation of the yield. This analysis 
showed a 49% yield of the dihydrobenzofuran product, 6% yield of the de-boronation product 
and a 2% yield of the direct coupling product. No other significant peaks were identified. 
While addition of the methyl group in the 3-position successfully suppressed formation of the 
direct coupling product, the overall yield of the carboallylation reaction remains low. Despite 
full conversion and analysis of the product mixture, there is still some material unaccounted 
for. 
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1.2.3 Synthesis and reaction of BPin acrylamide 
Examples in literature and aim 
An interesting carboalkynylation reaction from Liu and co-workers was reported.18 This 
allowed the formation of a range of heterocycles, including dihydrobenzofurans. The reaction 
was proposed to follow a similar pathway to our carboallylation reaction. After formation of an 
aryl Pd(II) intermediate, carbopalladation formed the heterocycle. This Pd(II) intermediate 
was then trapped in a Sonogashira-type reaction. While Liu’s work proceeded through a 
standard 0–II cycle rather than the isohypsic process proposed for the carboallylation 
reaction, they also had competition between cyclisation and direct alkynylation (Scheme 
1.29). 
 
Scheme 1.29: Carboalkynylation reaction 
As in our experiments with the methyl-substituted potassium trifluoroborate, Liu found that 
increasing steric clash between the alkene side-chain and the 3-position favoured cyclisation. 
In their case, use of an N-methylated amide eliminated formation of the direct alkynylation 
product (Scheme 1.30). This allowed synthesis of 28 products in good to excellent yields 
(Scheme 1.31). 
 
Scheme 1.30: Products of carboalkynylation reaction 
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Scheme 1.31: Carboalkynylation reaction using acrylamides 1.103 
A very similar reaction was reported in 2016 by Guo.17 This carboalkynylation again made 
use of N-substituted acrylamides in the formation of indolinones (Scheme 1.32). 
 
Scheme 1.32: Carboalkynylation reaction using acrylamides 1.103 
With Liu’s results in mind, acrylamide 1.106 was proposed as a possible carboallylation 
precursor (Scheme 1.33). Use of the pinacol boronate ester as a boron source was proposed 
as the previous syntheses required use of strong base nBuLi. This would be unsuitable in this 
case due to the number potential sites for deprotonation. Use of the pinacol boronate ester 
avoids this by allowing installation via a palladium-catalysed Miyaura borylation. 
 
Scheme 1.33: Proposed carboallylation reaction of 1.106 
Synthesis of BPin acrylamide 
In order to synthesise the BPin acrylamide, the following synthetic route was proposed. 
Starting with a haloaniline 1.108, a palladium-catalysed Miyaura borylation would yield 
pinacol ester 1.110 (Scheme 1.34). This could then be subjected to an amide coupling using 
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methacryloyl chloride affording acrylamide 1.112. Finally, methylation with methyl iodide 
would then give methylated acrylamide 1.106. 
 
Scheme 1.34: Proposed synthesis of BPin acrylamide 1.106 
Following the planned route, Miyaura borylation was attempted using iodoaniline (Scheme 
1.35). Unfortunately, while the starting material was completely consumed, none of the 
desired pinacol ester was formed. The only product formed during the reaction was dianiline 
1.114. 
 
Scheme 1.35: Initial attempt at Miyaura borylation 
As iodoaniline was believed to be too reactive, the borylation was instead attempted using the 
less reactive bromoaniline (Scheme 1.36). This proved more successful, albeit with the 
desired pinacol ester being formed in just 14% yield – mainly due to low conversion. 
 
Scheme 1.36: Miyaura borylation using bromoaniline 
While the lower reactivity of bromoaniline helped prevent formation of dianiline 1.114, it had 
the undesired side effect of significantly reducing conversion. However, addition of a second 
portion of bis(pinacolato)diboron after 24 h greatly increased conversion, resulting in 
formation of pinacol ester 1.110 in 67% yield. 
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Scheme 1.37: Improved Miyaura borylation 
With pinacol ester 1.110 in hand, amidation was attempted (Scheme 1.38). The pinacol ester 
was treated with methacryloyl chloride and triethylamine in toluene at 0 °C. The reaction 
proceeded cleanly, giving acrylamide 1.112 in a 69% yield. Acrylamide 1.112 was then 
methylated using methyl iodide in the presence of potassium carbonate in DMF. This gave 
acrylamide 1.106 in 62% yield. 
 
Scheme 1.38: Synthesis of BPin acrylamide 1.106 
Reactions of BPin acrylamide and derivatives 
With the synthesis of acrylamide 1.106 successful, it was then subjected to the optimised 
carboallylation conditions (Scheme 1.39). Pleasingly, indolinone 1.107 was formed in a 47% 
yield, with only a trace of direct coupling product 1.116 detected. While the conversion to a 
single product was welcome, the overall yield was still only 47%, comparable to 1.95 
(Scheme 1.28). 
 
Scheme 1.39: Carboallylation of BPin acrylamide 1.106 
During the synthesis of dihydrobenzofurans, use of potassium trifluoroborates had produced 
the best results. It was therefore decided to form the potassium trifluoroborate analogue 
1.117 (Scheme 1.40). As before, this was carried out following the procedure developed by 
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Lloyd-Jones and co-workers.50 Disappointingly, the yield in this case was much poorer than 
expected. This was likely due to the difficulty in removing the pinacol byproduct. 
 
Scheme 1.40: Synthesis of potassium trifluoroborate 1.117 
The optimised conditions were then applied to potassium trifluoroborate 1.117. Indolinone 
1.107 was formed, but only in 21% yield. 
 
Scheme 1.41: Carboallylation of potassium trifluoroborate 1.117 
As the low yield in the previous cyclisation was thought to be caused by residual pinacol from 
the formation of the potassium trifluoroborate, a revised synthesis was attempted. This time, 
the crude mixture was washed repeatedly with Et2O to remove the pinacol byproduct. This 
gave two products, one of which was the previously isolated potassium trifluoroborate. The 
second product also appeared to be a fluoroborate, but was soluble in chlorinated solvents – 
an unusual property for potassium trifluoroborates. Further NMR and mass spectrometry 
analysis suggested the product could be difluoroborane 1.118 (Figure 1.2). 
 
Figure 1.2: Difluoroborane 1.118 
It was found that difluoroborane 1.118 could be formed in a quantitative yield from acrylamide 
1.106 under the Lloyd-Jones conditions.50 Stirring the reaction mixture for four hours rather 
than working up the reaction immediately afforded the difluoroborane 1.118 rather than the 
potassium trifluoroborate 1.117 (Scheme 1.42). Examples of similar difluoroboranes were 
found in the literature,53-55 often forming in a similar manner. 
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Scheme 1.42: Synthesis of 1.118 and 1.117 
Interestingly, when difluoroborane 1.118 was subjected to the carboallylation conditions, it 
could successfully be cyclised giving indolinone 1.107 in a moderate yield (Scheme 1.43). As 
with the other acrylamides, there was no formation of the direct coupling product. 
 
Scheme 1.43: Carboallylation of difluoroborane 1.118 
While the cyclisations of all three acrylamides were successful in forming the desired 
indolinone, the yields were disappointing. It was, however, unclear as to where the rest of the 
material was as the 1H NMR of the crude reaction mixture showed no other peaks. This 
suggests any loss of material occurs during the reaction rather than during purification. These 
observations are similar to the dihydrobenzofuran forming reactions carried out previously 
(Scheme 1.44). An investigation was therefore started to try and account for the missing 
mass. 
 
Scheme 1.44: Products resulting from the carboallylation reaction 
1.2.4 NMR study of the carboallylation reaction 
The carboallylation reaction to form dihydrobenzofuran 1.75 was chosen as the model 
reaction for this analysis due to the well characterised nature of the known side products, and 
the availability of the starting material. This reaction gave a moderate yield of the desired 
dihydrobenzofuran 1.75, as well as some of the direct coupling product 1.76 and a small 
amount of de-boronation product 1.77 (Scheme 1.44). 
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Due to the lack of other major peaks in the 1H NMR of the crude material, the first concern 
was that some of the material was being lost during purification. To find out if this was the 
case, a known quantity of 1,3,5-trimethoxybenzene was added to the crude material after 
workup as an internal standard. A 1H NMR was then taken of this mixture to work out the 
yield. This showed a similar yield suggesting that purification was not the problem (Scheme 
1.45). 
 
Scheme 1.45: Yields before and after purification 
The next concern was that material was being lost during workup. Changing the workup from 
filtering through a silica plug to an aqueous workup had little effect on the yield (Scheme 
1.46). The aqueous phase was concentrated in vacuo and analysed by 1H NMR, but only 
traces of the previously identified products were detected. As the reaction takes place under 
basic conditions the aqueous phase was acidified then extracted, but this did not yield any 
additional material.  
Finally, an internal standard was then added to the reaction mixture before workup and a 
small amount of this mixture analysed by 1H NMR. Examination of the carboallylation using 
methyl-substituted trifluroborate 1.94 by the different workup methods showed a similar yield 
suggesting that the material was not lost during any workup process. 
 
 
Scheme 1.46: Yields by different workup methods 
As loss of material during workup or purification had been ruled out, any loss of material must 
be occurring during the reaction itself. In an attempt to detect this, the reaction was followed 
by 1H NMR. The reaction was carried out under the standard conditions, with the addition of 
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1,3,5-trimethoxybenzene 1.119 as an internal standard. At each time point, a small aliquot of 
the reaction mixture was removed and concentrated in vacuo. This was then analysed by 1H 
NMR to determine the product distribution. The results showed a rapid consumption of the 
starting material 1.78, with some conversion to the intermediate boronic acid 1.74 (Figure 
1.3). The desired product was formed, alongside small amounts of the direct coupling and 
deboronation products. Even after the first time-point, there appeared to be material missing. 
Integration of the aromatic and alkene regions suggested that some of this missing material 
was insoluble, and that some contained aromatic protons but no alkene. 
 
 
Figure 1.3: Product distribution in the carboallylation reaction over time 
To try and analyse any insoluble material, the reaction was stopped after a short time and the 
mixture filtered, washing with acetone. The solid material was then collected and dissolved in 
various solvents for analysis by 1H NMR. The solid was completely or nearly insoluble in all 
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solvents used apart from D2O. 1H NMR analysis showed no significant peaks, suggesting it 
was likely leftover sodium carbonate. 
While the exact pathway for loss of material was not able to be determined, loss of material 
during purification or workup has been ruled out. Following the reaction by 1H NMR shows 
loss of material during the reaction, but no further products could be identified. Attempted 
analysis of solid material in the reaction mixture showed no organic peaks. 
1.2.5 Deuterium labelling study 
In order to provide a greater insight into the reaction mechanism, a deuterium labelling study 
was carried out. By replacing the allyl chloride with dideuteroallyl bromide, the product 
distribution should give a strong indication of the operative mechanism. It was proposed that 
there were three possible catalytic cycles. Mechanism A is the initially proposed isohypsic 
mechanism (Scheme 1.47).48 Beginning with transmetallation of boronic acid 1.74, Pd(II) 
intermediate 1.88 is formed. Carbopalladation then forms dihydrobenzofuran 1.120. A second 
carbopalladation with dideuteroallyl bromide forms 1.121 which can undergo a ß-halide 
elimination to give dihydrobenzofuran 1.122 as a single isomer deuterated at the terminal 
position. 
 
Scheme 1.47: Mechanism A  
Mechanism B begins with the oxidative addition of dideuteroallyl bromide to Pd(0) to form allyl 
Pd(II) species 1.123 (Scheme 1.48).56 Carbopalladation on the O-methallyl chain of boronic 
acid 1.74 forms intermediates 1.124a and 1.124b in a 1:1 mixture of the deuterated isomers. 
Transmetallation of the boronic acid gives rise to the cyclised intermediates 1.125a and 
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1.125b. Finally, reductive elimination gives dihydrobenzofuran product 1.126 in a 50:50 
mixture of deuterated isomers. 
 
Scheme 1.48: Mechanism B 
Mechanism C begins with direct oxidative addition of Pd(0) into the C–Br bond of 
dideuteroallyl bromide to form Pd(II) species 1.127 (Scheme 1.49).57 This results in the 
formation of the η1-palladium species instead of the η3-palladium species formed in 
Mechanism B. As with Mechanism B, carbopalladation on the O-methallyl chain of boronic 
acid 1.74 forms intermediate 1.128. Transmetallation of the boronic acid gives rise to the 
cyclised intermediate 1.129. Finally, reductive elimination gives dihydrobenzofuran product 
1.130 as a single isomer of the deuterated product. 
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Scheme 1.49: Mechanism C 
Examining the ratio of the deuterated dihydrobenzofuran product formed should give an 
insight into the operative mechanism. Mechanism A should give only product 1.122, 
Mechanism B a 50:50 ratio and Mechanism C only product 1.130 (Figure 1.4). 
 
Figure 1.4: Product distribution by Mechanism 
Before the mechanism could be tested, synthesis of dideuteroallyl bromide was required. This 
was done following a literature procedure (Scheme 1.50).58 Reduction of acrolyl chloride 
1.131 with lithium aluminium deuteride at 0 °C in Et2O gave dideuteroallyl alcohol 1.132 as a 
solution in Et2O. Treatment of dideuteroallyl alcohol 1.132 with phosphorous tribromide and 
pyridine in Et2O at 0 °C gave dideuteroallyl bromide 1.133. Distillation gave the desired 
dideuteroallyl bromide as a solution in diethyl ether. Dideuterioallyl bromide 1.133 was formed 
as a single deuterated isomer, with none of the other isomer formed by an SN2’ mechanism 
detected by 1H NMR. 
 
Scheme 1.50: Synthesis of dideuteroallyl bromide 1.133 
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With dideuteroallyl bromide 1.133 now available, the carboallylation reaction was carried out 
(Scheme 1.51). As predicted, dihydrobenzofuran was formed as a single deuterated isomer 
1.122, suggesting mechanism A is operative (Scheme 1.52). 
 
Scheme 1.51: Carboallylation using dideuteroallyl bromide 1.133 
 
Scheme 1.52: Mechanism of the carboallylation reaction 
Interestingly, direct coupling product 1.134a/b was formed as a 50:50 mixture of deuterated 
isomers. This suggests that mechanism B is responsible for its formation (Scheme 1.53). This 
is in contrast to earlier theories that both products shared a catalytic cycle, branching after 
transmetallation to form 1.88. With formation of the two products in fact involving different 
mechanisms, new options are opened up in controlling which is formed. 
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Scheme 1.53: Mechanism for formation of the direct coupling product 
As the direct coupling product 1.77 is formed through a Pd(0) mechanism, use of a Pd(0) 
catalyst should yield only this product, with no dihydrobenzofuran product 1.75 being formed. 
Swapping Pd(hfacac)2 for Pd2dba3 showed that this was indeed the case (Scheme 1.54). 1H 
NMR analysis of the crude mixture showed complete conversion to direct coupling product 
1.76 in a 54% yield, with no dihydrobenzofuran detected. 
 
Scheme 1.54: Sole formation of the direct coupling product using Pd(0) 
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1.2.6 Further optimisation attempts 
As the direct coupling product 1.77 is formed by a Pd(0) mechanism, it was proposed that an 
oxidant could remove any Pd(0) present therefore suppressing formation of 1.77. To this end, 
a range of oxidants were screened in the carboallylation reaction (Table 1.5). Initially, 
standard Pd(0) reoxidants were screened. Benzoquinone proved ineffective, forming only the 
direct coupling product (entry 1). Use of an oxygen atmosphere, either with (entry 2) or 
without (entry 3) a copper co-oxidant, mainly saw conversion to the de-boronated product. 
Silver(I) acetate also saw the de-boronated product formed primarily (entry 5). Use of DDQ 
saw low conversion, with oxidation of the boronic acid to the alcohol being the major product 
(entry 4). Use of oxone resulted in the desired dihydrobenzofuran 1.75 being the major 
product, but significant amounts of the direct coupling product were also formed (entry 6). 
Table 1.5: Carboallylation reaction with various oxidant additives 
 
Entry Oxidant Equivalents 1.75 1.76 1.77 Notes 
1 Benzoquinone 1 0 1 0  
2 O2 atm. -   1  
3 O2 atm. + 
CuCl2 
1   1  
4 DDQ 1    Boronic acid and 
alcohol only 
5 AgOAc 1   1  
6 Oxone 1 2 1   
 
Due to the rapid oxidative addition of allyl chloride to any Pd(0) present, an extremely quick 
oxidant was required. A search of the literature revealed that oxidation of Pd(0) by benzyl 
chloride occurs extremely rapidly.59 It induces fast electron transfers forming the 
corresponding Pd(II) chloride species as well as dibenzyl. As this seemed ideal for our 
purposes, the carboallylation reaction was carried out using 2 equivalents of benzyl chloride 
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(Table 1.6, entry 2). Unfortunately, the ratio of carboallylation to direct coupling products was 
worse than with no oxidant present (entry 1). Increasing the number of equivalents of benzyl 
chloride to 5 saw an improvement in the ratio, but still slightly worse than with no oxidant 
(entry 3). The use of 10 equivalents of benzyl chloride saw a further increase in the 
selectivity, this time giving a better ratio than the base reaction (entry 4). Conversion was, 
however, slightly lower with the benzyl chloride present. Use of benzyl chloride as a solvent 
proved to inhibit the desired reaction (entry 5). In this case, the major product was that of 
direct coupling. This is thought to be due to solubility issues hindering the carboallylation 
reaction. 
Table 1.6: Carboallylation with benzyl chloride as oxidant 
 
Entry Oxidant Equivalents 1.75 1.76 
1 None - 3.3 1 
2 Benzyl Cl 2 2.4 1 
3 Benzyl Cl 5 3.2 1 
4 Benzyl Cl 10 3.7 1 
5 Benzyl Cl Solvent 0 1 
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1.2.7 Conclusions 
After extensive attempts at optimisation, the optimal carboallylation conditions were shown to 
be using Pd(hfacac)2, 2 equivalents of allyl chloride, Na2CO3, DME as a solvent at 50 °C with 
no added water (Scheme 1.55). Attempts to improve the overall yield of the reaction proved 
unsuccessful, with mass recovery studies suggesting that material is lost over the course of 
the reaction. 
 
Scheme 1.55: Carboallylation reaction of potassium trifluoroborate 1.78 
While the direct coupling product was not completely suppressed in the carboallylation 
reaction of 1.78, its formation could be decreased by using substrates with restricted rotation. 
Both methyl substituted potassium trifluoroborate 1.94 and BPin acrylamide 1.106 were 
successfully cyclised without any formation of the corresponding direct coupling product 
(Scheme 1.56). 
 
 
Scheme 1.56: Carboallylation reaction of other substrates 
A deuterium labelling study was carried out using dideuteroallyl bromide. This gave crucial 
insights into the mechanisms of both the carboallylation product and the direct coupling 
product. The carboallylation product was confirmed to form via an isohypsic Pd(II) 
mechanism. Surprisingly, the direct coupling did not use this method, instead forming via a 0–
II cycle. The different mechanisms used to form each product could lead to a method for 
controlling completely which product is formed. This was partially demonstrated with the 
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ability to form direct coupling product 1.77 as the sole product by using a Pd(0) catalyst 
(Scheme 1.57). 
 
Scheme 1.57: Sole formation of direct coupling product using Pd(0) 
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2 Expansion of the Isohypsic–Redox Sequence 
2.1 Introduction 
Most palladium-catalysed reactions proceed through a 0–II cycle. Other processes have 
emerged more recently involving Pd(IV), particularly during C–H activation.38 There is also a 
small class of reactions where the oxidation state of the palladium is unchanged throughout 
the catalytic cycle. These are known as isohypsic reactions, and are also known to occur for 
rhodium,60 ruthenium,61 cobalt62 and gold.63 Some examples of palladium-catalysed isohypsic 
reactions were shown in Chapter 1, with the heteroallylation reaction and the carboallylation 
reaction (section 1.1.4). Probably the most famous example of a palladium-catalysed 
isohypsic reaction is the Overman rearrangement. Involving a [3,3]-sigmatropic 
rearrangement, this leads to formation of a new carbon–nitrogen bond. Initially reported as a 
thermal rearrangement, requiring the use of mercury salts,64, 65 the palladium-catalysed 
version was reported needing lower temperatures and shorter reaction times (Scheme 2.1).66, 
67
 Eventually, an asymmetric version was developed, making use of COP-Cl 2.3 as the 
catalyst (Scheme 2.1).68 
 
Scheme 2.1: The Overman rearrangement 
Extensive studies by Overman et al. revealed the operative isohypsic mechanism (Scheme 
2.2).69 Beginning with coordination of the palladium(II) catalyst to the alkene, 2.5 is formed. 
This species can then undergo nucleophilic attack by the imine, resulting in aminopalladation 
of the alkene to form cyclised intermediate 2.6. Finally, β-oxygen elimination gives rise to the 
product alkene 2.7 as well as releasing the palladium(II) catalyst. As there is no change in the 
palladium oxidation state, remaining in the 2+ state for the entire catalytic cycle, the Overman 
rearrangement is indeed isohypsic. 
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Scheme 2.2: Mechanism of the Overman rearrangement 
While rhodium-catalysed conjugate addition to enones is well established,70 the palladium-
catalysed analogue has emerged as a cheaper alternative.71, 72 Often making use of boronic 
acids, they can be tolerant of air and moisture. These Michael-type additions can often take 
place with high diastereoselectivity (Scheme 2.3).73 Lee and co-workers showed how the 1,4-
conjugate addition of boroxine 2.9 to enone 2.8 could occur in high yields with excellent 
diastereoselectivity. 
 
Scheme 2.3: Michael-type addition of boroxines 
In a follow-up paper, Lee et al. outlined their proposed mechanism for the transformation 
(Scheme 2.4).74 Beginning with transmetallation of the arylboroxine, palladium(II) intermediate 
2.11 is formed. Migratory insertion into the alkene 2.8 then takes place, occurring on the 
opposite face from the bulky alkyl group in the γ-position affording palladium(II) intermediates 
2.12 and 2.13. Subsequent protonolysis will yield the desired conjugate addition product 2.14 
as well as regenerating the palladium(II) catalyst. 
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Scheme 2.4: Mechanism of Michael-type addition of boroxines 
2.1.1 Isohypsic–Redox Concept 
By exploiting the differences in mechanism between palladium-catalysed isohypsic and redox 
processes, orthogonal reactivity can be accessed (Figure 2.1). During the isohypsic reaction, 
some functionality will be inert to the Pd(II) catalyst. When desired, the oxidation state of the 
metal can be changed, allowing the manipulation of this functionality in a traditional 
palladium-catalysed redox reaction. 
 
Figure 2.1: Isohypsic–Redox sequence 
This combined isohypsic–redox sequence can have a number of advantages. Traditionally, a 
major limitation of transition-metal catalysis has been the “one reaction–one bond” nature. 
The ability to form more than one new bond in a single process can allow greatly enhanced 
molecular complexity. The “plug and play” nature due to the number of known palladium-
catalysed isohypsic and redox processes opens up a wide range of product diversity. Finally, 
by using only a single metal to catalyse two processes, the entire sequence is made more 
efficient and more economical. 
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2.1.2 Previous work on Isohypsic–Redox Sequence 
Previous work in the France group saw the development of an Isohypsic–Redox Sequence 
(Scheme 2.5).75 By carrying out the an initial isohypsic oxyallylation reaction using phenol 
2.15, benzofuran 2.16 was formed. This contains an aryl bromide, which remains unaffected 
by the Pd(II) catalyst using in the oxyallylation. By reducing the catalyst to Pd(0), a range of 
traditional palladium-catalysed redox cross-couplings were able to be carried out. This led to 
the development of a novel palladium-catalysed process, combining the isohypsic 
heteroallylation reaction with redox reactions including Suzuki–Miyaura, Buchwald–Hartwig 
and Sonogashira couplings. 
 
Scheme 2.5: Previously developed isohypsic–redox sequences 
2.1.3 Aims 
The previously discussed work on the isohypsic–redox sequence has mainly focused on 
functionalisation at the aryl bromide site (Scheme 2.5). The aim of this work is to expand 
further functionalisation to the alkene site. This would allow incorporation of reactions such as 
the Heck-coupling (Scheme 2.6). 
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Scheme 2.6: Proposed oxyallylation–Heck-coupling sequence 
2.2 Results 
2.2.1 Heck reaction 
Synthesis of substrate 
In order to test the oxyallylation–Heck-coupling, it was first required to synthesise alkene 2.21 
(Scheme 2.7). Following a known procedure,48 starting from 2’-bromoacetophenone 2.23, a 
Wittig reaction was carried out using methyl triphenylphosphonium bromide and potassium 
tert-butoxide in THF. This formed alkene 2.24 in 87% yield. Treatment with n-butyllithium to 
give lithium–halogen exchange, followed by addition of CO2 formed acid 2.20 in 65% yield. 
Finally, the oxyallylation reaction was performed on acid 2.20 to give alkene 2.21 in 69% 
yield. 
 
 
Scheme 2.7: Synthesis of 2.21 
Optimisation of oxyallylation-Heck sequence 
The Heck reaction was initially attempted on isolated 2.21 with bromobenzene (Scheme 2.8). 
Using palladium acetate with tri-o-tolylphosphine as a ligand, triethylamine was used both as 
a base and to help the initial reduction from Pd(II) to Pd(0). Unfortunately, the reaction proved 
unsuccessful, giving none of the desired product 2.25. 
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Scheme 2.8: Initial attempt at Heck-coupling 
In order to improve the reactivity, bromobenzene was replaced with 4-iodonitrobenzene 
(Scheme 2.9). Stirring overnight at 50 °C gave some of the desired alkene 2.26, but 
significant amount of starting material 2.21 still remained. Stirring for an additional 24 hours at 
an increased temperature of 80 °C resulted in complete conversion to the desired product. 
 
Scheme 2.9: Heck-coupling using 4-iodonitrobenzene 
With the Heck reaction providing an initial hit, the combined oxyallylation–Heck procedure 
was tested (Scheme 2.10). After the oxyallylation under standard conditions was complete, 
the volatile components were removed in vacuo. Tri-o-tolylphosphine, acetonitrile and 
triethylamine were added, followed by 4-iodonitrobenzene. After stirring overnight at 80 °C, 
the desired Heck product 2.26 was formed in 40% yield along with 4% of the other Heck 
product 2.27 and 18% of the isomerised products 2.28. 
 
Scheme 2.10: Oxyallylation–Heck-coupling sequence 
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With the combined oxyallylation–Heck reaction proving successful, a small ligand screen was 
carried out (Table 2.1). Changing from tri-o-tolylphosphine to the Buchwald ligand 
DavePhos76, 77 saw a decrease in yield from 40% to 34% mainly due to increased 
isomerisation when using DavePhos (entries 1 and 2). Use of SPhos saw no change, with 
2.26 formed in 40% yield (entry 3). To try and increase the rate of the Heck coupling, the 
concentration of the second step was increased, but this had no real effect on the yield (entry 
4). Use of toluene for both steps, along with an increased temperature in the 2nd step saw no 
formation of any Heck products, with intermediate 2.21 the only product (entry 5). 
Table 2.1: Optimisation of oxyallylation–Heck-coupling sequence 
 
Entry Ligand Solvent Concentration 2.26 2.27 2.28 
1 P(o-tol)3 MeCN 0.1 M 40% 4% 18% 
2 DavePhos MeCN 0.1 M 34% 4% 26% 
3 SPhos MeCN 0.1 M 40% 5% 19% 
4 SPhos MeCN 0.25 M 39% 6% 18% 
5 SPhos toluene 
(110 °C) 
0.1 M 0% 0% 0% 
56 
 
 
 
Changing from 4-iodonitrobenzene to 4-bromonitrobenzene did not improve the yield, with the 
desired Heck product 2.26 still formed in 40% yield (Scheme 2.11). However, the formation of 
both the isomerised product 2.28 and the other Heck product 2.27 were decreased, forming 
in 7% and 2% yields respectively. 
 
Scheme 2.11: Oxyallylation–Heck-coupling using 4-bromonitrobenzene 
Aryl halide screening 
Screening was undertaken on a selection of aryl bromides (Figure 2.2). These aryl bromides 
were chosen as they are part of a GSK reagent set. These are designed to include more 
challenging, but biologically relevant, functional groups. 
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Figure 2.2: Aryl bromides screened 
While a lot of the aryl bromides did not undergo Heck-coupling, several did (Figure 2.3). 
These contained a range of functional groups such as free amines, alcohols, acids and 
sulfonamides. Addition of a known quantity 1,3,5-trimethoxybenzene allowed calculation of 
the yield of the combined oxyallylation–Heck reaction by 1H NMR. This showed that for these 
substrates, the Heck-coupling had proceeded in low to moderate yield. 
 
Figure 2.3: Successfully formed products in the oxyallylation–Heck-coupling 
Further purification was carried out on 2.29, 2.31 and 2.33. This allowed isolation as a 
mixture of the desired Heck-coupling 2.35, the branched Heck product 2.36 and the 
isomerised product 2.37 (Table 2.2). The selectivity for the linear Heck product was high in 
most cases, though the coupling of 5-bromo-1,3-dimethyluracil did lead to formation of a 
larger amount of the branched product (entry 2). A similar amount of isomerisation was seen 
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using 4-bromobenzenesulfonamide as with 4-bromonitrobenzene (entry 3). More 
isomerisation was seen using 5-bromo-1,3-dimethyluracil and 4-bromo-2-fluorobenzyl alcohol 
(entries 1 and 2). 
Table 2.2: Product distribution in the oxyallylation–Heck-coupling 
 
Entry ArBr Product 2.35 2.36 2.37 
1 Br
OH
F
 
 
33% 2% 11% 
2 
 
O
O
N
N
O
O
 
36% 10% 11% 
3 
 
 
44% 4% 8% 
 
While the Heck-coupling generally proceeded with good selectivity between the linear and 
branched products, isomerisation of the alkene after Heck-coupling is still an issue. This is 
likely caused by the re-addition and elimination of palladium hydride species after the Heck-
coupling has taken place. Overman and co-workers have shown that the addition of silver 
salts can suppress this type of isomerisation during Heck-couplings (Scheme 2.12).78 Initial 
attempts at the cyclisation of tertiary anilide 2.38 resulted in a 1:1 mixture of the desired 3-
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spiro-2-oxindole 2.39 and its alkene regioisomer 2.40. After screening a range of inorganic 
salts, it was found that the addition of 1 equivalent of silver nitrate allowed the formation of 
the desired 2.39 and its regioisomer 2.40 in a 70% yield and a 26:1 ratio. With this 
information in mind, addition of silver salts could be used during our Heck-couplings to reduce 
alkene isomerisation – the main side product formed. In some cases, this should give a 
significant boost to the overall yield. 
 
Scheme 2.12: Use of silver salts to suppress isomerisation in Heck-couplings 
2.2.2 Grubbs–Wacker reaction 
Following the successful development of the oxyallylation–Wacker oxidation in the France 
group (Scheme 2.13a), work was begun on the oxyallylation–Grubbs–Wacker oxidation as an 
isohypsic–redox sequence.75 This resulted in the development of conditions for the formation 
of aldehyde 2.44 in 33% yield, with ketone 2.43 formed in 19% yield (Scheme 2.13b). When 
these conditions were applied to 2.45, aldehyde 2.47 was formed in 24%, with a yield not 
obtained for ketone 2.48 (Scheme 2.13c). In an attempt to improve the yield and 
aldehyde/ketone ratios, further optimisation was planned. 
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Scheme 2.13: Previous work on the aminoallylation–Wacker and –Grubbs–Wacker sequence 
Substrate synthesis 
The first step was the synthesis of pyrrole 2.45 following a known procedure (Scheme 2.14).79 
Base-promoted allylation of methyl pyrrole-2-carboxylate 2.49 afforded N-allyl pyrrole 2.50 in 
a quantitative yield. Ester hydrolysis to the acid 2.51 allowed formation of the tosylamide 2.45 
in 81% yield using tosyl isocyanate. 
 
Scheme 2.14: Synthesis of tosylamide 2.45 
Tests with dodecene 
Before testing of the Grubbs–Wacker on pyrrole 2.45, testing was carried out on dodecene 
2.52 (Table 2.3). To try and simulate the conditions that would be present in the combined 
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oxyallylation-Grubbs–Wacker reaction, the oxidation of dodecene was carried out using 
Pd(hfacac)2 with addition of benzonitrile. Instead of oxidation, this resulted in isomerisation of 
the alkene, with no oxidised products formed (entry 1). Pre-stirring the catalyst and 
benzonitrile for 10 minutes before addition of dodecene made no difference, with 
isomerisation again the only product (entry 2). Use of the pre-formed catalyst PdCl2(PhCN)2 
gave a 1:2 aldehyde:ketone ratio (entry 3). When dried solvents were used, the 
aldehyde:ketone ratio was increased to 3:1 (entry 4). 
Table 2.3: Grubbs–Wacker oxidation of dodecene 
 
Entry Catalyst 2.52 2.53 2.54 2.55 
1 Pd(hfacac)2/PhCN 0 0 0 1 
2 Pd(hfacac)2/PhCN 0 0 0 1 
3 PdCl2(PhCN)2 0 1 2 0 
4* PdCl2(PhCN)2 0 3 1 0 
*Using dried solvents 
Optimisation with pyrrole substrate 
With these results in mind, attention was turned to the combined reaction using pyrrole 
substrate 2.45 (Table 2.4). After carrying out the aminoallylation, the volatile components 
were removed in vacuo. After addition of benzonitrile, silver nitrite, copper chloride and dry 
tert-butanol/acetonitrile, the reaction mixture was stirred under an oxygen atmosphere at 
room temperature. This resulted in low conversion of the intermediate to the oxidised 
products, with aldehyde 2.47 formed in 10% yield, with the amount of ketone formed unable 
to be determined (entry 1). Isomerisation of the alkene intermediate formed during the 
aminoallylation was also seen in significant amounts. As water has a negative effect on the 
aldehyde/ketone selectivity in the Grubbs–Wacker reaction, attempts were made to eliminate 
it. Addition of molecular sieves during the second step had a negative effect on conversion, 
with only a small amount of aldehyde formed (entry 2). As complete removal of the water 
present in the aminoallylation is difficult, this was attempted in the absence of water. 
62 
 
However, this resulted in greatly reduced conversion in the aminoallylation step, rendering 
this avenue fruitless (entry 3). 
Table 2.4: Attempted optimisation of aminoallylation–Grubbs–Wacker 
 
Entry Change 2.47 
1 - 10% 
2 Molecular sieves in step 2 <5% 
3 No water in step 1 0%, <20% conversion in 1st 
step 
 
Carrying out the aminoallylation step using tert-butanol and nitromethane had a negative 
effect on conversion (Scheme 2.15). Whether carried out at the standard concentration of 
0.25 M, or the lower concentration normally used for the Grubbs–Wacker step, only a small 
amount of the cyclised intermediate 2.46 was formed, leading to no formation of aldehyde 
2.47 in a detectable quantity. 
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Scheme 2.15: Aminoallylation using tBuOH/MeNO2 as solvent 
Previous studies had shown that the presence of an inorganic base such as KH2PO4 greatly 
improved the conversion in the aminoallylation. Unfortunately, the presence of any base also 
shuts down the Grubbs–Wacker reaction.75 To solve this, the aminoallylation was attempted 
using the solid-supported base Amberlite IR-45 (Scheme 2.16). Due to the base being 
supported on a resin removal should be easy, allowing the Grubbs–Wacker to proceed 
uninhibited. However, conversion to the cyclised product 2.46 was only 50%, showing no 
improvement over the base free reaction. 
 
Scheme 2.16: Aminoallylation using solid-supported base 
Previous tests on dodecene had shown isomerisation occurring when using Pd(hfacac)2 and 
benzonitrile as the catalyst system. To check if this was the issue again, the second step of 
the aminoallylation–Grubbs–Wacker was spiked with one equivalent of dodecene (Scheme 
2.17). As well as the normal isomerisation of the pyrrole alkene giving 2.56, this also resulted 
in isomerisation of the dodecene to form 2.55. This suggests that the active Pd(PhCN)2 
catalyst is not being formed properly. 
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Scheme 2.17: Spiking second step with dodecene 
In an attempt to form the active Pd(PhCN)2 catalyst, benzonitrile was added to the reaction 
mixture after the aminoallylation was complete (Scheme 2.18). This mixture was then 
refluxed for 2 hours. The Grubbs–Wacker step was then carried out as normal, with the 
removal of volatiles before addition of the new reagents. While the amount of isomerisation 
was reduced, the conversion was also reduced. This meant only a small amount of aldehyde 
2.47 was formed, with <5% yield. 
 
Scheme 2.18: Attempts to form active catalyst 
As the hfacac ligands could be hindering formation of the active Grubbs–Wacker catalyst, the 
aminoallylation was attempted using alternative catalysts (Table 2.5). Using the pre-formed 
PdCl2(PhCN)2 catalyst, conversion was extremely low, with a 9:1 ratio between the starting 
pyrrole 2.45 and the cyclised product 2.46 (entry 1). Use of palladium chloride was more 
successful, giving a 1.8:1 ratio (entry 2). Increasing the concentration from 0.25 M to 0.5 M 
had a negative effect, reducing conversion to just 25% (entry 3). Lowering the concentration 
to 0.1 M improved conversion slightly, but the starting material was still the major product, 
with a 1.4:1 ratio (entry 4). Still below 50% conversion, this was not good enough to form a 
reasonable amount of the oxidised products in the Grubbs–Wacker step. 
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Table 2.5: Screening of aminoallyation with different catalysts 
 
Entry Catalyst Concentration 2.45:2.46 
1 PdCl2(PhCN)2 0.25 M 9:1 
2 PdCl2 0.25 M 1.8:1 
3 PdCl2 0.5 M 3:1 
4 PdCl2 0.1 M 1.4:1 
 
2.2.3 Conclusions 
The isohypsic–redox sequence has been successfully expanded to include the Heck-
coupling. This resulted in the oxyallylation–Heck-coupling of acid 2.20 with a range of 
functionally diverse aryl bromides (Scheme 2.19). Some further optimisation is required to 
suppress isomerisation of the alkene, but this could possibly be achieved through the addition 
of silver salts, such as silver nitrate, to the Heck-coupling. Overall, the development of this 
sequence opens up another point of functionalisation after the heteroallylation reaction and 
adds another tool to the isohypsic–redox sequence. 
 
Scheme 2.19: Oxyallylation–Heck-coupling sequence 
While further optimisation of the aminoallylation–Grubbs–Wacker sequence was 
unsuccessful, crucial insights were gained (Scheme 2.20). One of the main issues was 
caused by isomerisation of the alkene to form 2.56 instead of oxidation. Competition 
experiments with dodecene showed that this is likely due to improper formation of the active 
Pd(PhCN)2 catalyst. Further work to ensure efficient formation of this catalyst could help 
66 
 
suppress alkene isomerisation, boosting the yield of the oxidised products 2.47 and 2.48. 
While silver nitrite is present in this reaction, addition of other silver salts could assist in the 
suppression of this isomerisation. 
 
Scheme 2.20: Aminoallylation–Grubbs–Wacker sequence 
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3 Allylation of MIDA boronates 
3.1 Introduction 
3.1.1 Background of MIDA boronates 
While the utility of boronic acids can hardly be understated, there are still issues surrounding 
their use in organic synthesis. As has been seen in Chapter 1, they can be prone to undergo 
undesired side reactions such as protodeboronation, oxidation and polymerisation. 
Protodeboronation, for example, often occurs in highly acidic or basic aqueous conditions, 
particularly when ortho-substituted or electron-poor aryl boronic acids are used (Scheme 3.1). 
Unfortunately, these are precisely the type of conditions used in Suzuki-Miyaura cross-
coupling reactions. Some types of boronic acid, e.g. alkyl boronic acids and 2-heteroaromatic 
boronic acids, are prone to decomposition on storage under air, often to the corresponding 
alcohol.80 
 
Scheme 3.1: Protodeboronation of boronic acids 
Some alternatives to boronic acids have been developed. As seen in Chapter 1, potassium 
trifluoroborates provide a more stable alternative to boronic acids. Due to the strong B–F 
bonds and the tetrahedral complex, the undesired side reactions that affect boronic acids are 
less common. When used in cross-coupling reactions, potassium trifluoroborates provide a 
slow release of the active boronic acid under aqueous conditions. Some of the drawbacks of 
potassium trifluoroborates are their low solubility in apolar and chlorinated solvents. They are 
also generally unstable to column chromatography. 
A more recently developed alternative to boronic acids are MIDA boronates.81 Formation of a 
dative B–N bond gives a tetrahedral space around boron. As well as the two five-membered 
rings protecting the boron atom, it has a filled p-orbital, increasing the stability of the boronate 
ester. This stability means that MIDA boronates are both air and water stable, tolerating 
neutral or acidic aqueous solutions. MIDA boronates are stable to anhydrous cross-coupling 
conditions, even when carried out at elevated temperatures. While not tolerant of strong 
nucleophiles, MIDA boronates are tolerant of other harsh conditions such as triflic acid or 
Jones reagent.82 When exposed to aqueous base, MIDA boronates undergo slow release of 
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the active boronic acids (Scheme 3.2). The speed of this release can be tuned by the 
temperature and by the base used. As the boronic acid is released slowly over the course of 
a reaction, it can be used as soon as it is formed. This prevents the boronic acid building-up 
in the reaction and undergoing the undesired side reactions. 
 
Scheme 3.2: Hydrolysis of MIDA boronates to release boronic acid 
Unlike potassium trifluoroborates, MIDA boronates have good solubility in a range of organic 
solvents. They are also stable to column chromatography, displaying useful properties. By 
exploiting the solubility of MIDA boronates, they can be purified using “catch and release” 
chromatography. When run in 1.5% MeOH/Et2O, the MIDA boronate will remain stationary, 
while most other organic molecules will elute quickly (Figure 3.1, left). Simply changing the 
eluent to THF results in rapid elution of the MIDA boronate (Figure 3.1, right). 
 
Figure 3.1: TLC of MIDA boronates in 1.5% MeOH/Et2O (left) and THF (right) 83 
Synthesis of MIDA boronates 
A range of methods have been developed for the synthesis of MIDA boronates. This allows 
formation of MIDA boronates containing a range of different functionalities – if one method 
fails, another is likely to succeed. Probably the simplest method is the condensation of a 
boronic acid with MIDA. Initially requiring the use of Dean–Stark conditions and DMSO as co-
solvent, this can now often be performed simply by heating the boronic acid in the presence 
of MIDA in DMF (Scheme 3.3).84 
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Scheme 3.3: Synthesis of MIDA boronate 3.8 
Other methods do not require an existing boronic acid. Bromoboration of an alkyne with 
tribromoborane gives the corresponding dibromoborane (Scheme 3.4).85 Trapping of this 
dibromoborane with MIDA in the presence of 2,6-lutidine affords the alkenyl MIDA boronate 
3.10. 
 
Scheme 3.4: Synthesis of MIDA boronate 3.10 
Organotrimethylsilanes can also be converted into MIDA boronates (Scheme 3.5).86 After 
undergoing transmetalltion with tribromoborane, the resulting dibromoborane can be trapped 
by the disodium salt of MIDA. This approach has been use in the synthesis of vinyl MIDA 
boronate 3.12, where other methods had been unsuccessful. 
 
Scheme 3.5: Synthesis of MIDA boronate 3.12 
Once formed, vinyl MIDA boronate 3.12 can also be used in the synthesis of a range of other 
alkenyl MIDA boronates (Scheme 3.6).86 By carrying out cross-metathesis, a wide range of 
alkenyl MIDA boronates can be synthesised. This mild approach tolerates a range of 
functionality and forms the E alkene isomer exclusively. 
 
Scheme 3.6: Synthesis of MIDA boronates via cross-metathesis 
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Use as a boronic acid protecting group 
As a result of their stability in the absence of aqueous base, MIDA boronates can effectively 
be used as protecting groups for boronic acids. They can allow a wide range of cross-
coupling reactions to take place while leaving the boronic acid completely untouched. Burke 
has particularly demonstrated this using bifunctional MIDA boronate 3.10 (Scheme 3.7).85 
Suzuki–Miyaura, Stille and Heck couplings were all carried out without any effect on the 
MIDA boronate. Further functionalisation was provided by Sonagashira and Negishi couplings 
and a Miyaura borylation, all yielding a highly useful bifunctionalised molecule. 
 
Scheme 3.7: Cross-coupling reactions carried out in the presence of MIDA boronates 
Reactions of MIDA boronates 
The ability of MIDA boronates to supress side reactions of boronic acids was demonstrated 
by Burke in the cross-coupling of furanylboronic acid 3.5 with the particularly deactivated 2,4-
dimethoxychlorobenzene 3.15 (Scheme 3.8).80 By using the furanyl MIDA boronate 3.4, the 
yield was improved from 68% to 99%. This is mainly due to the slow release of boronic acid 
over the course of the reaction preventing build-up of significant amounts of boronic acid. As 
the boronic acid is not forming in large amounts, the amount lost to any side reactions is 
greatly decreased. 
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Scheme 3.8: Difference in yield using MIDA boronate and boronic acid 
One of the most difficult substrates for cross-coupling reactions is the 2-pyridyl group. This is 
mainly due to the extreme sensitivity of the 2-pyridyl–boron bond to protodeboronation. 
Having isolated the 2-pyridyl MIDA boronate and found it to be air-stable, Burke developed 
conditions to allow its efficient cross-coupling  (Scheme 3.9).87 By making use of a highly 
active pre-formed catalyst, XPhosPdcycle, the oxidative addition is ensured to take place 
quickly, increasing the amount of Pd(II) available for transmetallation. This helps reduce the 
amount of time the free 2-pyridyl boronic acid spends in solution. Addition of copper acetate 
along with diethanolamine led to formation of a Cu(DEA)2 species. This could then undergo a 
pre-transmetallation with the 2-pyridyl boronic acid, allowing a faster transmetallation to 
palladium. Finally, the use of the stable MIDA boronate allowed a slow release of the reactive 
2-pyridyl boronic acid. As only a small amount of the free boronic acid was present at any one 
time, the potential for protodeboronation was greatly decreased. Altogether, these measures 
allowed the cross-coupling of 2-pyridyl MIDA boronate with over 20 different halides in 
moderate to excellent yields. 
 
Scheme 3.9: Cross-coupling of 2-pyridyl MIDA boronates 
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3.1.2 Step-wise/synthesis machine potential 
Due to the stability of MIDA boronates to anhydrous cross-coupling and the ability to control 
the release of the active boronic acid, they can be extremely useful in step-wise synthesis. 
This ability to carry out iterative cross-coupling has proven particularly useful in the synthesis 
of complex polyene frameworks.85 Beginning with alkenyl MIDA boronate 3.10, installation of 
the pinacol boronic ester formed bifunctional alkene 3.20 (Scheme 3.10). Selective cross-
coupling with (E)-1-chloro-2-iodoethylene gave diene 3.21 in 54% yield. Coupling of 3.21 with 
(E)-1-butenylboronic acid 3.22 afforded the all-trans trieneyl MIDA boronate 3.23 in 88% 
yield. Finally, full hydrolysis of the MIDA boronate, followed by cross-coupling with vinyl iodide 
3.24 gave the fluorescent probe β-parinaric acid 3.25 in an 86% yield. 
 
Scheme 3.10: Step-wise synthesis of β-parinaric acid using MIDA boronates 
Watson et al. reported a tandem chemoselective Suzuki–Miyaura cross-coupling made 
possible by careful control of the boron species (Scheme 3.11).88 Careful control of the 
amount of water and base present allowed conversion of the MIDA boronate into the pinacol 
borane to only occur after initial chemoselective cross-coupling of the boronate ester 3.26 
and aryl bromide 3.8. Once hydrolysis and conversion of the MIDA boronate 3.28 into the 
pinacol borane 3.29 had occurred, this allowed a second cross-coupling to form triaryl 
species 3.30. 
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Scheme 3.11: Chemoselective cross-coupling using controlled hydrolysis of MIDA boronates 
In 2015, Burke demonstrated the use of MIDA boronates in step-wise synthesis by forming a 
range of complex natural and bio-active molecules.83 Synthesis of protected ratanhiaphenol III 
3.35, a PTP1B inhibitor, began with vinyl MIDA boronate 3.31 (Scheme 3.12). After full 
hydrolysis of the MIDA boronate, the resulting boronic acid was coupled with the MIDA 
boronate containing aryl halide 3.32. Due to the anhydrous conditions used, the new MIDA 
boronate was completely untouched during the reaction. Hydrolysis of the resulting MIDA 
boronate 3.33 allowed cross-coupling with another aryl halide 3.34 giving the protected 
ratanhiaphenol III 3.35 in a 75% overall yield. 
 
Scheme 3.12: Step-wise synthesis of 3.35 
By using the ability to control the release of boronic acid, the stability to anhydrous cross-
coupling, and the “catch and release” column chromatography properties, Burke designed a 
deprotection-coupling-purification cycle (Figure 3.2, top). This process could be automated, 
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with a machine built that was capable of synthesising complex molecules from 14 different 
classes of small molecule (Figure 3.2, bottom). 
 
 
Figure 3.2: Use of MIDA boronates in the synthesis machine83 
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3.2 Results 
3.2.1 Development of MIDA allylation reaction 
While the previous examples are wide-ranging, there is one clear omission. None of these 
reactions form a new bond to an sp3 carbon. This is something that Burke himself has 
described as “particularly critical to realizing this potential”.82 By developing a reaction that 
takes the utility of MIDA boronates and combines it with formation of new bonds to sp3 
carbons, we could develop an extremely useful process. There are many bio-active or drug 
molecules which contain this aryl–sp3 carbon functionality that could not be accessed using 
existing aryl MIDA boronate chemistry (Scheme 3.13). 
 
Scheme 3.13: Compounds containing aryl–sp3 C–C bonds 
Initial optimisation 
The proposed reaction would take a MIDA boronate 3.36 and couple it with an allyl halide in 
the presence of a palladium catalyst (Scheme 3.14). This should generate the corresponding 
allylaryl species 3.37 containing a new bond to an sp3 carbon. 
 
Scheme 3.14: Proposed allylation of MIDA boronates 
The obvious starting point was with phenyl MIDA boronate 3.38. This was synthesised by 
stirring phenyl boronic acid 3.1 with MIDA in DMF at 85 °C (Scheme 3.15). After aqueous 
workup, phenyl MIDA boronate was separated from any residual phenyl boronic acid by 
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stirring the solid in Et2O. After stirring for an hour, the pure MIDA boronate 3.38 was collected 
by filtration resulting in a 72% yield. 
 
Scheme 3.15: Synthesis of MIDA boronate 3.38 
With phenyl MIDA boronate in hand, the allylation was attempted using Burke’s standard 
conditions (Scheme 3.16). While allyl benzene 3.39 was being formed, it was found to be 
evaporating during concentration. 
 
Scheme 3.16: Allylation of 3.38 
To avoid this problem, a heavier MIDA boronate was chosen. As allyl naphthalene should 
have a high enough boiling point, naphthyl MIDA boronate was synthesised (Scheme 3.17). 
Using the same procedure used in the synthesis of phenyl MIDA boronate, naphthyl MIDA 
boronate 3.41 was formed in a 93% yield. 
 
Scheme 3.17: Synthesis of MIDA boronate 3.41 
The allylation conditions were then applied to naphthyl MIDA boronate 3.41 (Scheme 3.18). 
Pleasingly, this resulted in the formation of allyl naphthalene 3.42 in a 79% isolated yield. 
 
Scheme 3.18: Allylation of 3.41 
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With the allylation working successfully, the reaction conditions were examined to see which 
parameters were required. In Burke’s work, the reactions were carried out under an argon 
atmosphere. When the allylation was instead carried out under air, there was found to be little 
difference in yield (92% vs. 88%) (Scheme 3.19). For operational ease, it was decided to 
carry out future reactions under air. 
 
Scheme 3.19: Allylation under air and argon 
Next, the amount of base required in the reaction was examined. Not surprisingly, decreasing 
the amount of base present had a negative effect on the yield (Table 3.1). This is likely due to 
the importance of the base in both hydrolysing the MIDA boronate and facilitating the 
allylation reaction. 
Table 3.1: Effect of number of equivalents of base on allylation 
 
Entry Equivalents of Base Yield of 3.42 
1 2 35% 
2 4 72% 
3 7.5 88% 
 
In Burke’s reactions, he made use of phosphine ligand SPhos. Carrying out the allylation 
reaction using SPhos showed a small reduction in yield, but the ligand was still tolerated 
(Scheme 3.20). This is positive as it leaves open the possibility of using a chiral phosphine 
ligand to carry out an enantioselective allylation. 
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Scheme 3.20: Use of ligand in the allylation 
Finally, the effect of the allyl halide used was examined. Both the previously used allyl 
chloride and allyl bromide were found to be effective, with both achieving allylation in an 88% 
yield (Scheme 3.21). 
 
Scheme 3.21: Effect of allyl halide source in the allylation 
3.2.2 Deuterium labelling study 
In order to determine the mechanism of the allylation, a deuterium labelling study was carried 
out using dideuterioallyl bromide. As with the carboallylation reaction and the direct coupling 
side product (see section 1.2.5), there are three potential pathways that the allylation reaction 
could go through. Examination of the ratio of the deuterated product isomers should 
determine which pathway is operative. 
Using the previously optimised conditions, the allylation reaction was carried out using 
dideuteroallyl bromide (Scheme 3.22). The allylation was successful giving a 1:1 mixture of 
deuterated isomers, in an 83% overall yield. 
 
Scheme 3.22: Allylation using dideuteroallyl bromide 
Having carried out the deuterium labelling study, an operative mechanism could be proposed 
consistent with the results. Beginning with Pd(0), oxidative addition of the allyl halide forms π-
allyl Pd(II) species 1.123 (Scheme 3.23). Transmetallation of the boronic acid gives Pd(II) 
species 3.45a/b. This can then undergo reductive elimination to give the allylated products 
3.43 and 3.44. 
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Scheme 3.23: Proposed mechanism of the allylation 
As the reaction proceeds through a 0–II cycle, addition of a Pd(0) catalyst could help improve 
the yield. When a Pd(II) catalyst such as palladium acetate is used, it must first be reduced to 
Pd(0). A common way for this to occur is through the double transmetallation/reductive 
elimination of boronic acids. As the MIDA boronate is the limiting reagent in our allylation 
reaction, any boronic acid that is consumed during this process will have a negative effect on 
the yield. Indeed, during further investigations, some of the binaphthyl product of this process 
was detected by 1H NMR. 
Replacement of palladium acetate with Pd(0) catalyst Pd2dba3 had the desired effect 
(Scheme 3.24). In this case, the allylation was successfully carried out in a 91% yield – a 
modest improvement on the 88% yield achieved when using palladium acetate. With the 
mechanism of the reaction confirmed, and the optimised conditions for the allylation found, 
attention was turned to the scope of the allylation reaction. 
 
Scheme 3.24: Allylation using a Pd(0) catalyst 
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3.2.3 Examination of substrate scope 
Allyl halide scope 
First, the use of different allyl halides was examined. Use of 1-methallyl chloride was 
successful (Scheme 3.25). The reaction proceeded in a 68% yield, giving a 1:1.6 ratio of the 
two possible product isomers. This is consistent with the reaction mechanism with reductive 
elimination being slightly favoured on the less hindered side. 
 
Scheme 3.25: Allylation with 1-methallyl chloride 
Prenyl chloride was also a viable substrate for the allylation reaction, giving a 77% yield 
(Scheme 3.26). Unsurprisingly, the ratio was even higher at 1:3, reflecting the increased 
steric bulk of the extra methyl group. 
 
Scheme 3.26: Allylation with prenyl chloride 
Use of cinnamyl chloride was also successful (Scheme 3.27). Here, the allylation occurred in 
an 83% yield. Due to the size of the phenyl group giving complete selectivity during the 
reductive elimination, only the terminal product isomer was formed. 
 
Scheme 3.27: Allylation with cinnamyl chloride 
Finally, the use of 2-methallyl bromide was also shown to be viable (Scheme 3.28). In this 
case, the symmetry of the π-allyl complex means only a single product isomer is possible. 
This was formed in an 81% yield. 
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Scheme 3.28: Allylation with 2-methallyl bromide 
MIDA boronate scope 
Having examined the scope of allyl halides, attention was then turned to the MIDA boronate 
scope. The wide range of commercially available MIDA boronates meant that a range of 
functionality could be examined. 
First, a range of aryl halide containing MIDA boronates were examined (Scheme 3.29). These 
are potentially challenging due to the potential for oxidative addition into the aryl halide bond. 
This could lead to undesired side reactions such as cross-coupling between the aryl halide 
and MIDA boronate, and possible polymerisation if this process continued. Pleasingly, this 
was not an issue and none of these possible side products were detected. Even in the case 
containing an aryl iodine, usually excellent for carrying out oxidative addition, only the desired 
allylated product was formed in a 91% yield. The lack of reaction at the aryl halide sites is 
thought to be due to the extremely rapid oxidative addition of the allyl halide to any Pd(0) 
present. As an excess of allyl bromide is used in these reactions, there is never a sufficient 
enough concentration of Pd(0) exposed to the aryl halide leaving no possibility for oxidative 
addition to occur. Another advantage of these reactions is that the aryl halide, while 
unreactive during the allylation reaction, provides a useful functional handle that could be 
used to carry out further transformations. 
 
Scheme 3.29: Allylation with aryl halide containing MIDA boronates 
The allylation reaction is also successful when applied to MIDA boronates with electron 
withdrawing groups present (Scheme 3.30). Both nitro and cyano groups were tolerated, 
achieving 92% and 88% yields respectively. While aryl MIDA boronates have been the focus 
so far, the allylation of vinyl MIDA boronate to form 3.58 also occurs in an excellent yield. 
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Scheme 3.30: Allylation of different MIDA boronates 
The next MIDA boronate examined was 4-hydroxyphenyl MIDA boronate 3.59. Using the 
standard allylation conditions, the product was not the expected 4-hydroxyallylbenzene 3.60, 
but the doubly allylated 3.61 (Table 3.2, entry 1). This is likely due to the strong base used in 
the reaction. Deprotonation of the phenol will assist in the alkylation by allyl bromide. By using 
the weak base potassium phosphate monobasic, this deprotonation should be prevented. 
This was indeed the case, with none of the doubly allylated product being detected (entry 2). 
Unfortunately, as the base is also required for hydrolysis of the MIDA boronate, conversion 
was greatly reduced with only 15% of the desired 4-hydroxyallylbenzene 3.60 being formed. 
When a slightly stronger base, sodium hydrogen carbonate, was used, the conversion was 
improved giving the desired product in 28% yield while still supressing formation of the 
undesired doubly allylated product (entry 3). 
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Table 3.2: Effect of base on allylation of 3.59 
 
Entry Base 3.60 3.61 
1 K3PO4 0% Major product 
2 KH2PO4 15% Not observed 
3 NaHCO3 28% Not observed 
 
Attention was then turned to heterocyclic MIDA boronates. Allylation of N-Boc pyrrole MIDA 
boronate 3.62 proceeded well under the standard conditions. The desired N-Boc 2-
allylpyrrole 3.63 was formed in a 67% yield (Scheme 3.31). 
 
Scheme 3.31: Allylation of 3.62 
The allylation of furanyl MIDA boronate 3.4 proved more challenging. Under the standard 
conditions, only 31% of the desired allylfuran 3.64 was formed (Scheme 3.32). Examination 
of the crude material showed that a significant amount of de-boronation to form furan was 
occurring. To slow the hydrolysis of the MIDA boronate, and therefore reduce the amount of 
boronic acid building up in the reaction, the temperature was reduced. This did improve the 
conversion to the desired allylfuran 3.64, increasing the yield to 45%. 
 
Scheme 3.32: Allylation of 3.4 
  
84 
 
3.2.4 Attempts at sp3 allylation 
With the allylation reaction being successfully applied to a range of MIDA boronates and allyl 
halides, so far, the bonds formed have been sp2–sp3 C–C bonds. If the methodology could be 
expanded to allow formation of sp3–sp3 C–C bonds, it would open up new areas of synthetic 
utility. 
Initial attempts 
The standard allylation conditions were applied to phenylethyl MIDA boronate 3.65. 
Unfortunately, none of the desired phenylpentene 3.66 was formed (Scheme 3.33). Use of 
different palladium catalysts, Pd(dppf)Cl2 and Pd(PPh3)4, also proved ineffective, with only 
hydrolysis of the MIDA boronate occurring. 
 
Scheme 3.33: Attempted sp3–sp3 allylation 
To diagnose the problem, the literature was searched for examples using phenylethyl MIDA 
boronate. A cross-coupling developed by Yudin89 was found (Scheme 3.34). In their case, 
bromobenzene was coupled with phenylethyl MIDA boronate using Pd(dppf)Cl2. While the 
solvent and base used are different, the conditions are reasonably similar. 
 
Scheme 3.34: Cross-coupling of sp3 MIDA boronate 3.65 with bromobenzene 
Yudin’s conditions were then applied to the allylation (Scheme 3.35). None of the desired 
product was detected, instead the major products detected were unreacted boronic acid 3.68 
and the alcohol 3.69 resulting from oxidation of the boronic acid. 
 
Scheme 3.35: Attempted allylation using Yudin conditions 
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To check that there were no issues with the MIDA boronate, or any of the other reagents 
being used, the literature reaction reported by Yudin was carried out (Scheme 3.36). The 
reaction was successful, and diphenylethane 3.67 was formed in 66% yield. 
 
Scheme 3.36: Confirmation that control reaction works 
Competition reaction 
To determine where in the catalytic cycle the reaction was failing, a series of competition 
reactions were carried out. The first point of potential failure was during oxidative addition. If 
this step does not happen, none of the other steps in the cycle can. To test this, naphthyl 
MIDA boronate 3.41 was added to the reaction (Scheme 3.37). If the allylnaphthylene product 
is formed, then the oxidative addition must be happening. This was indeed the case, with 
allylnaphthalene 3.42 being formed in 56% yield. The problem, therefore, is not with the 
oxidative addition stage. 
 
Scheme 3.37: Competition reaction between sp3 and sp2 MIDA boronate 
The next competition reaction saw the addition of both allyl bromide and bromobenzene 
(Scheme 3.38). In this case, neither the allylated product or diphenylethane were formed. 
Instead, the major product was unreacted boronic acid 3.68. This is not unexpected given 
that the oxidative addition of allyl bromide was found to be much faster than that of aryl 
halides. It also suggests that the problem may be occurring at the transmetallation or 
reductive elimination stages, as the boronic acid is clearly formed but is not being used to 
form the desired product. 
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Scheme 3.38: Competition reaction between allyl bromide and bromobenzene 
In an attempt to help the transmetallation and reductive elimination, more forcing reaction 
conditions were attempted. Changing the solvent to dioxane allowed testing of higher 
temperatures. Running the reaction at 120 °C saw no improvement – the only products were 
still unreacted boronic acid 3.68 and the corresponding alcohol 3.69 (Scheme 3.39). 
 
Scheme 3.39: Attempted allylation at increased temperature 
Next, the concentration was varied. Due to the biphasic nature of the reaction, this was done 
both by keeping the THF:H2O ratio constant and by keeping the amount of H2O constant. 
Increasing the concentration from 0.1 M to 0.5 M, both with and without a constant THF:H2O 
ratio, saw little change (Table 3.3, entries 2 and 3). The major product was again the boronic 
acid and corresponding alcohol. Further increasing the concentration to 1 M did provoke a 
change (entries 4 and 5). In these cases, styrene was now also formed in appreciable 
amounts. This could be as a result of β-hydride elimination after the transmetallation has 
occurred. 
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Table 3.3: Effect of concentration of allylation 
 
Entry Concentration THF:H2O ratio Products 
1 0.1 M 5:1 3.68/3.69 
2 0.5 M 5:1 3.68/3.69 
3 0.5 M 2.5:1 3.68/3.69 
4 1 M 5:1* 3.68/3.69+Styrene 
5 1 M 1:2 3.68/3.69+Styrene 
*aqueous layer saturated with K2CO3 
If β-hydride elimination is the cause of the styrene formation, use of ligands could help 
prevent it and encourage formation of the desired allylated product. Screening of a range of 
ligands was therefore undertaken (Table 3.4). The first ligands examined were phosphine 
ligands. Using either BrettPhos or SPhos saw no improvement, with styrene still being formed 
(entries 2 and 3). Interestingly, use of SPhos at 0.1 M also saw formation of styrene, 
something that was not observed in the ligand-free reaction at this concentration (entry 4). 
Table 3.4: Effect of ligand on allylation 
 
Entry Concentration Ligand Products 
1 1 M - 3.68/Styrene, 10:1 
2 1 M BrettPhos 3.68/Styrene, 20:1 
3 1 M SPhos 3.68/Styrene, 7:1 
4 0.1 M SPhos 3.68/Styrene, 4:1 
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Use of other catalyst/ligand systems was then examined (Table 3.5). Pd(quinox)Cl2 was 
ineffective, with styrene again being formed alongside the unreacted boronic acid (entry 1). 
Pyridinyl oxazoline ligand 3.70 and amino alcohol 3.71 were used in combination with 
palladium acetate. Again, styrene was formed in these reactions (entries 2 and 3). 
Table 3.5: Effect of ligand on allylation 
 
Entry Concentration Catalyst/Ligand Products 
1 1 M Pd(quinox)Cl2 3.68 + trace 
Styrene 
2 1 M Pd(OAc)2/3.70 3.68/Styrene, 10:1 
3 1 M Pd(OAc)2/3.71 3.68/ Styrene, 20:1 
 
As no catalyst/ligand combination seems to have any effect on the formation of styrene, the 
palladium-free reaction was run (Scheme 3.40). Interestingly, styrene 3.72 was also formed 
during this reaction. This suggests that styrene formation is at least not solely caused by β-
hydride elimination after transmetallation, but by the increased concentration. In this case, it 
is maybe due to elimination of the alcohol formed by oxidation of the boronic acid. 
 
Scheme 3.40: Formation of styrene in palladium-free allylation 
Tests using boronic acid 
To remove the requirements for MIDA boronate hydrolysis, it was decided to try the allylation 
reaction directly on the boronic acid. To this end, the MIDA boronate was fully hydrolysed to 
the boronic acid using Burke’s “fast hydrolysis” conditions.83 This was unsuccessful, instead 
yielding the corresponding alcohol 3.69 (Scheme 3.41). 
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Scheme 3.41: Fast hydrolysis of MIDA boronate 3.65 
As the fast hydrolysis conditions led to formation of the alcohol, the “slow hydrolysis” 
conditions were applied instead (Scheme 3.42). This time, some of the boronic acid 3.68 was 
formed successfully. Unfortunately, it decomposed to the alcohol upon standing in an NMR 
tube. 
 
Scheme 3.42: Slow hydrolysis of MIDA boronate 3.65 
To try and prevent formation of the alcohol, oxygen was excluded from the reaction (Scheme 
3.43). Again, using the “fast hydrolysis” conditions, the MIDA boronate was converted to the 
boronic acid. With the reaction carried out under an argon atmosphere, care was taken to 
avoid introduction of oxygen during the workup. After separation, the boronic acid 3.68 was 
partially concentrated under a flow of argon, and used as a solution in THF. 
 
Scheme 3.43: Hydrolysis of MIDA boronate 3.65 under argon atm. 
To ensure the sp3–sp2 reaction was still working with the boronic acid, a control reaction was 
carried out using bromobenzene (Scheme 3.44). This was successful, with diphenylethane 
3.67 being formed in a 71% yield. 
 
Scheme 3.44: Control reaction with boronic acid 
These conditions were then applied using allyl bromide (Scheme 3.45). Once again, the 
allylation did not occur. Analysis of the reaction mixture showed mainly unreacted boronic 
acid 3.68, along with a small amount of alcohol 3.69. 
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Scheme 3.45: Attempted allylation using boronic acid 3.68 
Other sp3 substrates 
As the allylation of phenylethyl MIDA boronate had not been possible, attention was turned to 
other potential sp3–sp3 C–C bond forming targets. Allylation was next attempted on the 
commercially available cyclohexyl MIDA boronate 3.73 (Scheme 3.46). Under Yudin’s 
conditions, none of the desired product was detected, with mainly cyclohexyl boronic acid 
3.74 remaining. Under the standard allylation conditions, the boronic acid 3.74 was again the 
main product. A trace amount of an unidentified allylated product was detected by 1H NMR, 
but it was not possible to isolate this species for further identification. 
 
Scheme 3.46: Attempted allylation of cyclohexyl MIDA boronate 
The next candidate was octyl MIDA boronate 3.76. This was synthesised from octyl boronic 
acid 3.75 in a 70% yield using the standard conditions (Scheme 3.47). 
 
Scheme 3.47: Synthesis of octyl MIDA boronate 
With the MIDA boronate 3.76 in hand, it was submitted to the allylation conditions (Scheme 
3.48). This resulted in a complex mixture of products, with no clear sign of the desired alkene 
product by 1H NMR. Further analysis by mass spectrometry found no evidence that the 
desired alkene had been formed. 
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Scheme 3.48: Attempted allylation of octyl MIDA boronate 
3.2.5 Attempts at enantioselective allylation 
Returning to sp2–sp3 couplings, investigations were carried out into whether an 
enantioselective version of the allylation reaction could be developed. By making use of a 
chiral ligand, it may be possible to control the selectivity during reductive elimination, leading 
to formation of a single enantiomer. 
In order to test this, 3-bromocyclohex-1-ene 3.77 was chosen as the allyl halide partner. After 
submission to the allylation conditions, the allylated product 3.78 was formed in 25% yield 
(Scheme 3.49). The lower yield could be due to the use of a more sterically bulky allyl halide. 
 
Scheme 3.49: Allylation using 3-bromocyclohex-1-ene 
Next, the reaction was carried out using different phosphine ligands (Scheme 3.50). As 
SPhos had previously been shown to be tolerated by the allylation reaction, it was tested first. 
While there had been little effect on the yield when using allyl bromide, here, the yield 
dropped to just 6%. This was due to greatly reduced conversion. The next ligand tested was 
chiral phosphine ligand (S)-PPhos. The yield in this case was 5%. While the yield was 
disappointing, the product was analysed by chiral HPLC to see whether any enantioselectivity 
had been conferred by the ligand. Unfortunately, the analysis showed that the allylated 
product 3.78 was racemic. This could be due to the bulkiness of both the allyl bromide and 
the ligand inhibiting the reaction. The allylation could then occur via any unligated palladium 
present explaining why there was no enantioselectivity during the product formation. 
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Scheme 3.50: Attempted enantioselective allylation 
3.2.6 Synthesis of Ibuprofen 
Aim 
To show the utility of the allylation reaction on a more complex system, a synthesis of 
Ibuprofen 3.81 was designed, featuring an allylation of a MIDA boronate as a key step 
(Scheme 3.51). Beginning with 4-bromophenyl MIDA boronate 3.8, a palladium-catalysed 
enolate arylation would give MIDA boronate 3.79. This would undergo allylation with 2-
methallyl bromide to give the allylated ester 3.80. Finally, a palladium-catalysed 
hydrogenation and deprotection would give Ibuprofen 3.81. As well as using the allylation 
reaction as the key step, this process could potentially be carried out using a single palladium 
catalyst for all 3 steps. 
 
Scheme 3.51: Proposed synthesis of Ibuprofen 
Enolate arylation 
A search of the literature revealed a palladium-catalysed enolate arylation developed by 
Buchwald (Scheme 3.52).90 Using palladium acetate with DavePhos as a ligand, he was able 
to carry out the enolate arylation on a range of aryl bromides. The choice of LiHMDS as a 
base proved key to avoiding formation of the diarylated ester, or the product of Claisen 
condensation. 
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Scheme 3.52: Enolate arylations carried out by Buchwald 
While in Buchwald’s case, the tert-butyl ester 3.84 was used, we attempted to see if the 
benzyl ester could also be used. If this was possible, it should allow both the planned 
hydrogenation and deprotection to occur at the same time. Benzyl propionate 3.87 was 
formed in a 93% yield by stirring benzyl alcohol and propionyl chloride neat (Scheme 3.53). 
 
Scheme 3.53: Synthesis of benzyl propionate 
Before testing on the MIDA boronate, the enolate arylation was carried out on bromobenzene 
(Table 3.6). Rather than the desired α-aryl ester, the product was instead the result of Claisen 
condensation 3.88. In an attempt to suppress formation of the Claisen condensation product, 
the ester addition was carried out at –20 °C instead but again, the Claisen condensation 
product was formed. To try and speed the reaction of the bromobenzene with the enolate, 
addition was carried out at room temperature. This was also unsuccessful, leading only to 
formation of the Claisen condensation product 3.88. 
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Table 3.6: Attempted enolate arylation using benzyl propionate 
 
Entry Enolate formation temp. Result 
1 –10 °C Full conversion to 3.88 
2 –20 °C Full conversion to 3.88 
3  RT Full conversion to 3.88 
 
As the enolate arylation with the benzyl ester was proving fruitless, use of the tert-butyl ester 
3.82 was planned instead. Using the same conditions as those used in the formation of 
benzyl propionate, tert-butyl propionate 3.82 was formed (Scheme 3.54). In this case 
however, the reaction did not go to completion, and the volatility of the product made 
purification difficult. 
 
Scheme 3.54: Synthesis of tert-butyl propionate 
Alternative conditions were therefore sought. Reaction of tert-butyl alcohol with propionic 
anhydride at 105 °C proved the best conditions (Scheme 3.55). Careful washing of the 
reaction mixture with 1 M aq. NaOH allowed the collection of tert-butyl propionate 3.82 in 
87% yield. 
 
Scheme 3.55: Synthesis of tert-butyl propionate 
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With tert-butyl propionate available, the reaction was again tested on bromobenzene 
(Scheme 3.56). This time, the enolate arylation was successful, giving the α-aryl ester 3.91 in 
21% yield. 
 
Scheme 3.56: Enolate arylation using tert-butyl propionate and bromobenzene 
The enolate arylation was next attempted on 4-bromophenyl MIDA boronate 3.8 (Scheme 
3.57). In this case, none of the desired α-aryl ester was formed, with decomposition of the 
MIDA boronate instead. This could be due to the low solubility of the MIDA boronate in 
toluene. 
 
Scheme 3.57: Attempted enolate arylation of MIDA boronate 3.8 
To address the solubility of the MIDA boronate 3.8, the enolate arylation was tested using 
alternative solvents (Scheme 3.58). Using dioxane, the enolate formation had to be carried 
out at room temperature due to the relatively high melting point of dioxane. This led only to 
formation of the Claisen condensation product 3.92. Next, THF was tested. This allowed 
formation of the enolate at –10 °C, but once again, the only product was that of Claisen 
condensation 3.92. 
 
Scheme 3.58: Attempted enolate arylation using different solvents 
As none of the single solvents tested seemed viable for both suppressing the formation of the 
Claisen condensation product and providing the required solubility for the MIDA boronate, 
solvent mixtures were examined (Table 3.7). A 1:1 mixture of toluene and dioxane lead to 
decomposition of the MIDA boronate 3.8 and formation of the Claisen condensation product 
3.92 (entry 2). Swapping dioxane for THF prevented complete decomposition of the MIDA 
boronate, only resulting in hydrolysis to the boronic acid. The Claisen condensation product 
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3.92 was also formed (entry 3). Use of dimethoxyethane also led to hydrolysis of the MIDA 
boronate and formation of the Claisen condensation product (entry 4). It appears that while 
the Claisen condensation product 3.92 does not immediately form when using mixed solvent 
systems, the unreactiveness of the MIDA boronate leads to its formation over time. 
Table 3.7: Effect of different solvents on enolate arylation 
 
Entry Solvent Resulta 
1 Toluene Decomposition 
2 Toluene:Dioxane, 1:1 Claisen + decomposition 
3 Toluene:THF, 1:1 Claisen + boronic acid 
4 DME Claisen + boronic acid 
a). Full conversion of 3.82 and 3.8 
Revised step order 
As the enolate arylation of the MIDA boronate 3.8 was proving unsuccessful, it was decided 
to reverse the order of the first two steps. First, the MIDA boronate would be allylated using 2-
methallyl bromide. The allylated product would then undergo enolate arylation to afford the α-
aryl ester. This should avoid the solubility issues faced during the enolate arylation, and avoid 
the need for an alternative solvent leading to formation of the Claisen condensation product 
3.92. 
As there was potential to use a single palladium catalyst for all steps, the allylation of 4-
bromophenyl MIDA boronate 3.8 was undertaken using palladium acetate and DavePhos 
(Scheme 3.59). This worked well, giving the allylated product 3.93 in an excellent yield. 
 
Scheme 3.59: Allylation of MIDA boronate 3.8 
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The allylated aryl bromide 3.93 was then submitted to the enolate arylation conditions 
(Scheme 3.60). Pleasingly, this resulted in formation of the desired α-aryl ester 3.94 in 53% 
yield. None of the Claisen condensation product 3.92 was formed, and only a trace amount of 
the diarylated product was detected. 
 
Scheme 3.60: Enolate arylation of 3.93 
With both steps now working, the combined reaction was attempted using a single palladium 
source. As the allylation requires water, which is likely to be a problem in the enolate 
arylation, this must first be removed. Before fully combining the reactions, it was decided to 
carry out the usual aqueous workup then submit the crude material to the enolate arylation 
conditions without further purification (Scheme 3.61). This resulted in formation of a trace 
amount of the α-aryl ester 3.94, however the main product was the allylated intermediate 
3.93. 
 
Scheme 3.61: Combined allylation and enolate arylation 
Due to the requirement for water in the first step, it is difficult to ensure the second step is 
completely dry. As even a small amount of residual water will severely hinder the enolate 
arylation, an alternative was sought in order to return to the initial step order. 
Enolate arylation by Negishi coupling 
Examination of the literature revealed an interesting Negishi coupling.91 After formation of a 
zinc enolate 3.95 from tert-butyl 2-bromopropionate, this could be coupled with an aryl halide 
giving the corresponding α-aryl ester 3.96 (Scheme 3.62). The use of THF as a solvent could 
help avoid the solubility issues experienced previously, while the lack of a strong base could 
help avoid decomposition of the MIDA boronate. 
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Scheme 3.62: Negishi coupling using zinc enolate 3.95 
Formation of the zinc enolate was carried out by the slow addition of tert-butyl 2-
bromopropionate 3.97 to zinc metal in THF (Scheme 3.63). This resulted in a highly 
exothermic reaction. After cooling to room temperature, the freshly prepared zinc enolate 
3.95 was used directly as a solution in THF. 
 
Scheme 3.63: Formation of zinc enolate 
The zinc enolate 3.95 was then used in the Negishi coupling with 4-bromophenyl MIDA 
boronate 3.8 (Scheme 3.64). Pleasingly, this resulted in formation of the desired α-aryl ester 
3.98, albeit only in small amounts. As well as unreacted starting material, a large amount of 
decomposed material was also produced. 
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Scheme 3.64: Attempted Negishi coupling using MIDA boronate 3.8 
Increasing the number of equivalents of zinc enolate from 1.2 to 2 achieved full conversion of 
the 4-bromophenyl MIDA boronate 3.8 (Scheme 3.65). The main result of this, however, was 
increased decomposition with the desired α-aryl ester 3.98 being formed in just 9% yield. 
 
Scheme 3.65: Negishi coupling with increased equivalents of zinc enolate 
To see whether it was the MIDA boronate that was the problem, the Negishi coupling was 
tested using bromobenzene (Scheme 3.66). This resulted in formation of the α-aryl ester 3.91 
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in 26% yield. While an improvement on the examples using the MIDA boronate, this was still 
lower than expected. 
 
Scheme 3.66: Negishi coupling using bromobenzene 
An investigation into the use of ligands revealed that phosphine ligand QPhos is highly active 
in these types of transformation.92 By increasing the rate of the reaction, decomposition of the 
MIDA boronate could be limited or completely prevented. The Negishi coupling was repeated, 
using QPhos 3.99 as a ligand (Scheme 3.67). The coupling was successful, giving the 
desired α-aryl ester. During workup, the tert-butyl ester was inadvertently hydrolysed, giving 
the free acid 3.100 in a 43% yield. 
 
Scheme 3.67: Negishi coupling using QPhos as ligand 
Repeating the reaction, this time with a modified workup, once again resulted in formation of 
the desired α-aryl ester 3.98 (Scheme 3.68). This time the tert-butyl ester remained intact, 
giving the desired product in a 90% yield. Care had to be taken with the reaction time – after 
1.5–2 hours, the reaction was usually complete. If left much longer than this, decomposition 
of the MIDA boronate would start to occur. However, if the reaction was stopped too early, 
the mixture of the two MIDA boronates 3.8 and 3.98 proved impossible to separate. 
 
Scheme 3.68: Negishi coupling with alternative workup 
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Allylation of Ibuprofen MIDA 
With the successful formation of the α-aryl ester MIDA boronate 3.98, the next step was to 
carry out the allylation. Using the standard conditions and 2-methallyl bromide, formation of 
allylated ester 3.101 was achieved in 73% yield (Scheme 3.69). 
 
Scheme 3.69: Allylation of MIDA boronate 3.98 
Hydrogenation/deprotection 
With both the enolate arylation and the allylation carried out successfully, attention was now 
turned to the final hydrogenation and deprotection steps. Initially, transfer hydrogenation was 
explored. Using zinc and acetic acid as a hydrogen source,93 along with zinc and a palladium 
catalyst, a small amount of the hydrogenated product 3.102 was formed (Scheme 3.70). 
Using palladium acetate and DavePhos, no conversion was seen. However, using palladium 
chloride, a 7:1 ratio between the alkene 3.51 and alkane 3.102 was observed. 
 
Scheme 3.70: Attempted hydrogenation of 3.51 
Due to the low conversion when using acetic acid, a different procedure was attempted, using 
formic acid as a hydrogen source (Scheme 3.71).94 In this case, none of the hydrogenated 
product was obtained, with the alkene being recovered intact. 
 
Scheme 3.71: Attempted hydrogenation of 3.51 
As transfer hydrogenation was proving problematic, hydrogenation using molecular hydrogen 
and a homogenous palladium catalyst was attempted (Scheme 3.72). Carrying out the 
reaction in trifluoroethanol, using palladium acetate with DavePhos as a catalyst system, full 
conversion was achieved to the hydrogenated product 3.102. 
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Scheme 3.72: Hydrogenation of 3.51 
Attempting to combine the allylation and hydrogenation, the allylation reaction was carried out 
on naphthyl MIDA boronate 3.41 (Scheme 3.73). The reaction mixture was then concentrated 
in vacuo before addition of trifluoroethanol and H2 atmosphere. Disappointingly, none of the 
hydrogenated product was formed, with only the intermediate alkene 3.51 present after 24 
hours. 
 
Scheme 3.73: Combined allylation and hydrogenation 
In an attempt to help harmonise the conditions, hydrogenation was attempted under the 
allylation conditions at room temperature, simply with addition of a H2 atmosphere. Again, 
testing on methallylnaphthalene 3.51, the hydrogenation was successful, with full conversion 
to the alkane achieved (Scheme 3.74). 
 
Scheme 3.74: Hydrogenation under allylation conditions 
The hydrogenation was then attempted on the α-aryl ester 3.101 (Scheme 3.75). After 16 
hours, the H2 atmosphere was removed and HCl added. After stirring for a further 16 hours, 
Ibuprofen 3.81 was formed in 67% yield. 
 
Scheme 3.75: Hydrogenation and ester hydrolysis to give Ibuprofen 3.81 
With the synthesis of Ibuprofen 3.81 successfully achieved, attempts were made again to 
combine the allylation and hydrogenation steps in order to minimise the number of operations 
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involved (Scheme 3.76). Using the standard allylation conditions, followed by addition of a H2 
atmosphere, hydrogenation was unsuccessful, with the alkene 3.51 remaining present. 
 
Scheme 3.76: Combined allylation and hydrogenation 
As the presence of leftover allyl halide, or MIDA formed after hydrolysis of the MIDA boronate 
could be inhibiting the hydrogenation, these were submitted as additives (Table 3.8). Neither 
of these were found to inhibit the hydrogenation, which gave full conversion to the alkane 
3.102 in both cases. 
Table 3.8: Effect of allyl bromide or MIDA on hydrogenation 
 
Entry Additive Result 
1 Allyl bromide Full conversion to 3.102 
2 MIDA Full conversion to 3.102 
 
As the presence of leftover allyl halide, or MIDA was not inhibiting the hydrogenation, there 
could be an issue with the catalyst system being used. A change of catalyst from palladium 
acetate/DavePhos to Pd2dba3 saw no change, with the allylation successfully carried out, but 
no hydrogenation (Table 3.9, entry 1). Addition of HCl during the hydrogenation step did 
result in some hydrogenation taking place, but resulted in a complex mixture of products 
(entry 2). Use of DavePhos as a ligand during the allylation step, and HCl during the 
hydrogenation saw no conversion to the hydrogenated product, with the alkene remaining 
(entry 3). Perhaps unsurprisingly, addition of Pd/C to the hydrogenation step resulted in 
complete conversion to the hydrogenated product (entry 4). 
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Table 3.9: Effect of ligands and additives on hydrogenation after allylation 
 
Entry Ligand Additive Result 
1 - - 3.51 
2 - HCl Complex mixture 
3 DavePhos HCl 3.51 
4 - Pd/C (5 mol%) 3.102 
 
As the hydrogenation had proceeded to completion using Pd/C, the allylation was attempted 
using this as the catalyst (Scheme 3.77). This proved successful, giving the desired allylated 
product 3.42 in an excellent 90% yield. 
 
Scheme 3.77: Allylation using Pd/C as catalyst 
Having shown that Pd/C could be used to carry out both the allylation and hydrogenation, this 
was then applied to the combined reaction (Scheme 3.78). This proved to be successful, 
giving the hydrogenated product 3.102 in 69% yield over the two steps. 
 
Scheme 3.78: Combined allylation and hydrogenation using Pd/C 
With the combined allylation/hydrogenation successfully carried out, it was attempted on the 
α-aryl ester MIDA boronate 3.95 (Scheme 3.79). In this case, no hydrogenated product was 
observed after 24 hours. Additional Pd/C was added, and the hydrogenation continued for a 
further 24 hours, however still only 70% conversion from alkene 3.101 to alkane 3.103 was 
achieved. 
104 
 
 
Scheme 3.79: Attempted allylation and hydrogenation of 3.98 
To determine where the problem with the hydrogenation of the α-aryl ester 3.101 was, a 
competition reaction was setup using naphthyl MIDA boronate 3.41 (Scheme 3.80). As the 
allylated naphthalene 3.51 had already been shown to be hydrogenated under these 
conditions, if the hydrogenated product 3.102 is not formed, then it suggests the presence of 
the α-aryl ester is inhibiting the hydrogenation. Analysis of the product mixture showed that 
both alkenes had been formed successfully, but neither hydrogenated product was present. 
 
Scheme 3.80: Competition reaction between 3.41 and 3.98 
If the α-aryl ester was indeed inhibiting the hydrogenation, this could be due to formation of a 
palladium enolate species. Addition of acid during the hydrogenation could help suppress this 
formation if it is occurring. To that end, the allylation/hydrogenation was carried out with 
various acid additives included during the hydrogenation step (Table 3.10). Addition of HCl, 
either 10 or 50 equivalents, saw no hydrogenation product formed, with a small amount of 
decomposition (entries 1 and 2). Acetic acid saw only the formation of the alkene 3.101, with 
no hydrogenation taking place (entry 3). Finally, p-toluenesulfonic acid also had no effect, 
with only the alkene 3.101 and a small amount of decomposition present (entry 4). 
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Table 3.10: Effect of acid on allylation and hydrogenation of 3.98 
 
Entry Additive Equiv. acid Result 
1 HCl 10 3.101 + some 
decomposition 
2 HCl 50 3.101 + some 
decomposition 
3 Acetic acid 50 3.101 
4 p-Toluenesulfonic acid 50 3.101 + some 
decomposition 
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3.2.7 Conclusions 
A new allylation reaction of MIDA boronates has been developed, allowing formation of a new 
bond to an sp3 carbon for the first time. While attempts at sp3–sp3 allylation proved 
unsuccessful, the allylation was successfully applied to a wide range of MIDA boronates and 
allyl halide coupling partners (Figure 3.3). 
 
Figure 3.3: Products of MIDA boronate allylation 
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A deuterium labelling study was carried out, revealing that the reaction proceeds via a π-allyl 
0–II cycle. This was able to help explain some of the selectivity observed during the allylation 
reaction. 
The utility of the allylation reaction was demonstrated in its application to a new synthesis of 
Ibuprofen 3.81. It was used as the key step in a three-step palladium-catalysed synthesis 
giving Ibuprofen in a 44% overall yield (Scheme 3.81). By making use of the “catch and 
release” purification on 3.98, the synthesis of Ibuprofen can be compatible with automated 
synthesis. 
 
Scheme 3.81: New palladium-catalysed synthesis of Ibuprofen 3.81 
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Summary 
In Chapter 1, the carboallylation reaction was further optimised and expanded to include 
formation of indolinones. It was shown that formation of the undesired direct coupling product 
could be supressed via substrates with restricted rotation. The isohypsic mechanism was 
demonstrated by a deuterium-labelling study, with the separate mechanism for direct coupling 
giving insight into additional routes for further optimisation. 
The second chapter detailed the expansion of the isohypsic-redox sequence to include the 
oxyallylation–Heck-coupling. The two-step procedure was applied to a range of functionally 
diverse aryl bromides, adding another point of functionalisation after the heteroallylation 
reaction. Further studies into the aminoallylation–Grubbs–Wacker oxidation were also 
undertaken, showing the vital role of the catalyst formation in avoiding unwanted 
isomerisation. 
Chapter 3 described the development of a new palladium-catalysed allylation of MIDA 
boronates. Allowing formation of a new bond to an sp3 carbon, this was applied to a range of 
MIDA boronate and allyl halide coupling partners. A deuterium-labelling study revealed he 
operative mechanism, helping explain the observed selectivity. Finally, the allylation was 
applied as a key step in the development of a new palladium-catalysed synthesis of 
Ibuprofen.  
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4 Experimental 
4.1 General Experimental Information 
Reactions involving air-sensitive reagents and dry solvents were performed in glassware that 
had been dried in an oven (150 °C) or flame-dried prior to use. These reactions were carried 
out with the exclusion of air using an argon atmosphere. All microwave reactions were carried 
out using a Biotage Initiator system. NMR spectra were recorded on a Bruker DPX-400 
spectrometer (1H NMR at 400 MHz and 13C NMR at 101 MHz) or a Bruker DPX-500 
spectrometer (1H NMR at 500 MHz and 13C NMR at 126 MHz). Chemical shifts are reported 
in ppm. 1H NMR spectra were recorded with CDCl3 as the solvent using residual CHCl3 (δ = 
7.26) as internal standard or DMSO-d6 as the solvent using residual DMSO (δ = 2.5) as 
internal standard. For 13C NMR spectra the chemical shifts are reported relative to the central 
resonance of CDCl3 (δ = 77.16) or DMSO (δ = 39.52). Signals in NMR spectra are described 
as singlet (s), doublet (d), triplet (t), quartet (q), multiplet (m) or combination of these, which 
refers to the spin−spin coupling pattern observed. Spin−spin coupling constants reported are 
uncorrected. Two-dimensional (COSY, HSQC, HMBC) NMR spectroscopy was used where 
appropriate to assist in the assignment of signals in the 1H and 13C NMR spectra. IR spectra 
were obtained employing a Shimadzu FTIR-8400 instrument with a Golden Gate™ 
attachment that uses a type IIa diamond as a single reflection element so that the IR 
spectrum of the compound (solid or liquid) could be detected directly (thin layer). High 
resolution mass spectra were recorded under ESI, EI and CI conditions by the analytical 
services at the University of Glasgow. Melting points were recorded with a Stuart Scientific 
SMP1 apparatus. Flash column chromatography was performed using forced flow of the 
indicated solvent system on EMD Geduran® Silica Gel 60 as solid support and HPLC graded 
solvents as eluant. Reactions were monitored by thin layer chromatography (TLC) on Merck 
Silica Gel 60 covered aluminium sheets. TLC plates were visualised under UV-light and/or 
developed with an acidic ethanolic anisaldehyde solution or a KMnO4 solution. Liquid 
reagents were distilled prior to use where stated. All reagents were purchased from 
commercial suppliers and used without further purification unless otherwise stated. 
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4.2 Experimental Details 
Potassium (2-(2-methylallyloxy)phenyl)trifluoroborate 
 
Following a literature procedure,25 to a stirred suspension of 2-iodophenol 1.79 (12 g, 52 
mmol) and potassium carbonate (14 g, 110 mmol) in DMF (260 mL) was added methallyl 
chloride (6.1 mL, 63 mmol). The reaction mixture was heated at 70 °C for 16 h then cooled to 
room temperature, diluted with EtOAc (250 mL) and the phases were separated. The organic 
phase was washed with water (100 mL) and brine (3 x 100 mL), dried (MgSO4), filtered and 
concentrated in vacuo to give 1-(2-methylallyloxy)-2-iodobenzene 1.80 as a yellow oil (14 g, 
quant.). Analytical data were in accordance with literature values.95 
1H NMR (500 MHz, CDCl3) δ (ppm): 7.78 (1H, dd, J = 7.7, 1.6 Hz, Ar-H), 7.28 (1H, ddd, J = 
8.3, 7.4, 1.6 Hz, Ar-H), 6.80 (1H, dd, J = 8.3, 1.3 Hz, Ar-H), 6.71 (1H, td, J = 7.6, 1.3 Hz, Ar-
H), 5.20–5.19 (1H, m, C=CHa), 5.02–5.01 (1H, m, C=CHb), 4.48 (2H, s, OCH2), 1.86 (3H, d, 
J = 0.5 Hz, CH3). 
Following a literature procedure,96 to a stirred solution of 1-(2-methylallyloxy)-2-iodobenzene 
1.80 (12 g, 43 mmol) and triisopropyl borate (12 mL, 52 mmol) in toluene:THF (4:1) (160 mL) 
at –78 °C was added nBuLi (26 mL, 52 mmol). The reaction mixture was stirred at –78 °C for 
1 h then allowed to warm to –20 °C and quenched with 2M aq. HCl (100 mL). The mixture 
was allowed to warm to room temperature then extracted with Et2O (2 x 50 mL). The 
combined organic extracts were washed with brine, dried (MgSO4), filtered and concentrated 
in vacuo. Purification by flash chromatography (petroleum ether:EtOAc, 9:1 to 4:1) gave a 
pale yellow solid which was boiled in water for 2 hours. After cooling, the mixture was filtered 
to give 2-(2-methylallyloxy)phenylboronic acid 1.74 as a pale yellow crystalline solid (4.2 g, 
51%). Analytical data were in accordance with literature values.96 
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1H NMR (500 MHz, CDCl3) δ (ppm): 7.86 (1H, dd, J = 7.3, 1.7 Hz, Ar-H), 7.42 (1H, ddd, J = 
8.3, 7.3, 1.7 Hz, Ar-H), 7.04 (1H, t, J = 7.3 Hz, Ar-H), 6.90 (1H, d, J = 8.3 Hz, Ar-H), 6.17 (2H, 
s, B(OH)2), 5.08 (2H, d, J = 23.8 Hz, C=CH2), 4.55 (2H, s, OCH2), 1.86 (3H, s, CH3). 
Following a literature procedure,50 to a stirred solution of 2-(2-methylallyloxy)phenylboronic 
acid 1.74 (0.50 g, 2.6 mmol) in acetonitrile (11 mL) was added a solution of KF (0.60 g, 10 
mmol) in water (1.2 mL). A solution of (L)-tartaric acid (0.80 g, 5.3 mmol) in THF (4.0 mL) was 
then added to the rapidly stirring solution and a white precipitate was observed immediately. 
The reaction mixture was stirred rapidly for 30 min then the precipitate was removed by 
filtration, and washed with acetonitrile. The filtrate was concentrated in vacuo to give the title 
compound 1.78 as a fluffy white solid (0.63 g, 95%). 
1H NMR (400 MHz, d6-DMSO) δ (ppm): 7.29 (1H, dd, J = 7.1, 1.9 Hz, Ar-H), 6.96 (1H, ddd, J 
= 8.0, 7.2, 2.0 Hz, Ar-H), 6.66 (1H, t, J = 7.2 Hz, Ar-H), 6.62 (1H, d, J = 8.1 Hz, Ar-H), 5.16–
5.14 (1H, m, C=CHa), 4.85–4.84 (1H, m, C=CHb), 4.27 (2H, s, OCH2), 1.76 (3H, s, CH3); 13C 
NMR (125 MHz, DMSO) δ (ppm): 161.6 (C), 142.1 (C), 138.7 (C)*, 133.4 (q, 3J(C–F) = 3.1 
Hz, CH), 126.3 (CH), 119.1 (CH), 110.99 (CH), 110.97 (CH2), 70.5 (CH2), 19.3 (CH3); IR 
(solid) 1597, 1437, 1209, 1188, 922 cm-1; HRMS (ESI) exact mass calculated for C10H11F3OB 
[M-K]- m/z 214.0897, found m/z 214.0858. *detected by HMBC 
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Potassium (2-(allyloxy)phenyl)trifluoroborate 
 
Following a literature procedure,25 to a stirred suspension of 2-iodophenol 1.79 (10 g, 46 
mmol) and potassium carbonate (13 g, 91 mmol) in DMF (250 mL) was added allyl chloride 
(4.2 mL, 55 mmol). The reaction mixture was heated at 70 °C for 16 h then cooled to room 
temperature, diluted with EtOAc (250 mL) and separated. The organic phase was washed 
with water (100 mL) and brine (3 x 100 mL), dried (MgSO4), filtered and concentrated in 
vacuo to give 1-allyloxy-2-iodobenzene 1.83 as a yellow oil (12 g, quant.). Analytical data 
were in accordance with literature values.97 
1H NMR (500 MHz, CDCl3) δ (ppm): 7.78 (1H, dd, J = 7.8, 1.6 Hz, Ar-H), 7.30–7.26 (1H, m, 
Ar-H), 6.81 (1H, dt, J = 8.2, 1.3 Hz, Ar-H), 6.73–6.69 (1H, m, Ar-H), 6.11–6.02 (1H, m, 
CH=CH2), 5.53 (1H, dq, J = 17.2, 1.8 Hz, C=CHa), 5.32 (1H, dq, J = 10.6, 1.6 Hz, C=CHb), 
4.61–4.59 (2H, m, OCH2). 
Following a literature procedure,96 to a stirred solution of 1-allyloxy-2-iodobenzene 1.83 (11 g, 
43 mmol) and triisopropyl borate (12 mL, 52 mmol) in toluene:THF (4:1) (160 mL) at –78 °C 
was added nBuLi (26 mL, 52 mmol). The reaction mixture was stirred at –78 °C for 1 h then 
allowed to warm to –20 °C and quenched with 2M aq. HCl (100 mL). The mixture was 
allowed to warm to room temperature then extracted with Et2O (2 x 50 mL). The combined 
organic extracts were washed with brine, dried (MgSO4), filtered and concentrated in vacuo. 
Purification by flash chromatography (petroleum ether:EtOAc, 4:1) gave a pale yellow solid 
which was boiled in water for 2 hours. After cooling, the mixture was filtered to give 2-
allyloxyphenylboronic acid 1.84 as a pale yellow crystalline solid (3.5 g, 46%). Analytical data 
were in accordance with literature values.98 
1H NMR (500 MHz, CDCl3) δ (ppm): 7.85 (1H, dd, J = 7.3, 1.7 Hz, Ar-H), 7.44–7.40 (1H, m, 
Ar-H), 7.03 (1H, dt, J = 7.3, 0.8 Hz, Ar-H), 6.90 (1H, d, J = 8.3 Hz, Ar-H), 6.14–6.04 (1H, m, 
CH=CH2), 5.88 (2H, s, B(OH)2), 5.43 (1H, dq, J = 17.2, 1.4 Hz, C=CHa), 5.36 (1H, dd, J = 
10.5, 1.2 Hz, C=CHb), 4.64 (2H, td, J = 5.6, 1.3 Hz, OCH2). 
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Following a literature procedure,50 to a stirred solution of 2-allyloxyphenylboronic acid 1.84 
(3.5 g, 20 mmol) in acetonitrile (79 mL) was added a solution of KF (4.6 g, 79 mmol) in water 
(7.9 mL). A solution of (L)-tartaric acid (6.1 g, 40 mmol) in THF (30 mL) was then added to 
the rapidly stirring solution and a white precipitate was observed immediately. The reaction 
mixture was stirred rapidly for 30 min then the precipitate was removed by filtration, and 
washed with acetonitrile. The filtrate was concentrated in vacuo to give the title compound 
1.85 as a fluffy white solid (3.4 g, 71%). Analytical data were in accordance with literature 
values.96 
1H NMR (500 MHz, DMSO) δ (ppm): 7.30 (1H, dd, J = 7.1, 1.7 Hz, Ar-H), 6.98 (1H, td, J = 
7.9, 1.9 Hz, Ar-H), 6.69 (1H, t, J = 7.1 Hz, Ar-H), 6.65 (1H, d, J = 8.0 Hz, Ar-H), 6.00 (1H, ddt, 
J = 17.3, 10.6, 4.7 Hz, CH=CH2), 5.46 (1H, dq, J = 17.3, 2.0 Hz, C=CHa), 5.15 (1H, dq, J = 
10.6, 2.0 Hz, C=CHb), 4.41 (2H, dt, J = 4.6, 1.8 Hz, OCH2). 
Potassium (2-(2-methylallyloxy)-3-methylphenyl)trifluoroborate 
 
Following a literature procedure,25 to a stirred suspension of 6-bromo-o-cresol 1.91 (0.66 mL, 
5.4 mmol) and potassium carbonate (1.5 g, 11 mmol) in DMF (30 mL) was added methallyl 
chloride (0.62 mL, 6.4 mmol). The reaction mixture was heated at 70 °C for 16 h then cooled 
to room temperature, diluted with EtOAc (30 mL) and separated. The organic phase was 
washed with water (20 mL) and brine (3 x 20 mL), dried (MgSO4), filtered and concentrated in 
vacuo to give 2-(2-methylallyl)-3-bromotoluene 1.92 as a yellow oil (1.3 g, quant.). 
1H NMR (500 MHz, CDCl3) δ (ppm): 7.38 (1H, dd, J = 8.0, 1.5 Hz, Ar-H), 7.12 (1H, dq, J = 
7.6, 0.7 Hz, Ar-H), 6.89 (1H, t, J = 7.8 Hz, Ar-H), 5.19–5.18 (1H, m, C=CHa), 5.02–5.01 (1H, 
m, C=CHb), 4.31 (2H, s, OCH2), 2.33 (3H, s, CH3), 1.93 (3H, d, J = 0.4 Hz, CH3); 13C NMR 
(125 MHz, CDCl3) δ (ppm): 154.4 (C), 141.4 (C), 133.6 (CH), 131.2 (CH), 130.5 (C), 125.3 
(CH), 117.7 (C), 113.1 (CH2), 76.2 (CH2), 19.9 (CH3), 16.8 (CH3); IR (thin film) 2920, 1653, 
1464, 1452, 1260, 1220 cm-1; HRMS (EI) exact mass calculated for C11H13OBr [M]+ m/z 
240.0150, found m/z 240.0153. 
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Following a literature procedure,96 to a stirred solution of 2-(2-methylallyl)-3-bromotoluene 
1.92 (0.79 g, 3.3 mmol) and triisopropyl borate (0.90 mL, 3.9 mmol) in toluene:THF (4:1) (14 
mL) at –78 °C was added nBuLi (1.8 mL, 3.9 mmol). The reaction mixture was stirred at –
78 °C for 1 h then allowed to warm to –20 °C and quenched with 2M aq. HCl (10 mL). The 
mixture was allowed to warm to room temperature then extracted with Et2O (2 x 5 mL). The 
combined organic extracts were washed with brine, dried (MgSO4), filtered and concentrated 
in vacuo. Purification by flash chromatography (petroleum ether:ethyl acetate, 9:1) gave a 
pale yellow solid which was boiled in water for 2 hours. After cooling, the mixture was filtered 
to give 2-(2-methylallyloxy)-3-methyl-phenylboronic acid 1.93 as a pale yellow crystalline solid 
(0.44 g, 66%). 
1H NMR (400 MHz, CDCl3) δ (ppm): 7.68 (1H, dd, J = 7.2, 1.6 Hz, Ar-H), 7.31 (1H, ddt, J = 
7.5, 1.9, 0.7 Hz, Ar-H), 7.11 (1H, t, J = 7.4 Hz, Ar-H), 6.04 (2H, s, B(OH)2), 5.23 (1H, s, 
C=CHa), 5.05 (1H, s, C=CHb), 4.23 (2H, s, OCH2), 2.31 (3H, s, CH3), 1.89 (3H, s, CH3); 13C 
NMR (125 MHz, CDCl3) δ (ppm): 163.1 (C), 140.9 (C), 135.1 (CH), 134.3 (CH), 130.3 (C), 
124.8 (CH), 123.0 (C)*, 113.3 (CH2), 78.0 (CH2), 19.8 (CH3), 16.1 (CH3); IR (thin film) 3412, 
2910, 1464, 1435, 1383, 1344, 1084 cm-1; HRMS (CI) exact mass calculated for C11H15O3B 
[M]+ m/z 206.1229, found m/z 206.1232. *detected by HMBC 
Following a literature procedure,50 to a stirred solution of 2-(2-methylallyloxy)-3-methyl-
phenylboronic acid 1.93 (0.072 g, 0.35 mmol) in acetonitrile (1.4 mL) was added a solution of 
KF (0.081 g, 1.4 mmol) in water (0.15 mL). A solution of (L)-tartaric acid (0.11 g, 0.72 mmol) 
in THF (0.53 mL) was then added to the rapidly stirring solution and a white precipitate was 
observed immediately. The reaction mixture was stirred rapidly for 30 min then the precipitate 
was removed by filtration, and washed with acetonitrile. The filtrate was concentrated in 
vacuo to give the title compound 1.94 as a fluffy white solid (0.084 g, 89%). 
1H NMR (400 MHz, DMSO) δ (ppm): 7.20 (1H, dd, J = 7.2, 1.9 Hz, Ar-H), 6.87 (1H, ddd, J = 
7.2, 2.0, 0.8 Hz, Ar-H), 6.73 (1H, t, J = 7.2 Hz, Ar-H), 5.05 (1H, dq, J = 2.4, 1.0 Hz, C=CHa), 
4.83 (1H, dq, J = 2.7, 1.3 Hz, C=CHb), 4.23 (2H, s, OCH2), 2.12 (3H, s, CH3), 1.78 (3H, dd, J 
= 1.5, 0.8 Hz, CH3); 13C NMR (125 MHz, DMSO) δ (ppm): 160.6 (C), 143.3 (C), 142.0 (C)*, 
132.0 (q, 3J(C–F) = 3.0 Hz, CH), 128.3 (CH), 128.2 (C), 121.8 (CH), 110.2 (CH2), 75.5 (CH2), 
19.6 (CH3), 16.5 (CH3); IR (solid) 1448, 1192, 993 cm-1; HRMS (ESI) exact mass calculated 
for C11H13F3OB [M-K]- m/z 228.1053, found m/z 228.1034. *detected by HMBC 
  
115 
 
Cesium (2-(2-methylallyloxy)phenyl)trifluoroborate 
 
Following a literature procedure,50 to a stirred solution of 2-(2-methylallyloxy)phenylboronic 
acid 1.74 (0.20 g, 1.1 mmol) in acetonitrile (4.2 mL) was added a solution of CsF (0.64 g, 4.2 
mmol) in water (0.42 mL). A solution of (L)-tartaric acid (0.33 g, 2.2 mmol) in THF (1.7 mL) 
was then added to the rapidly stirring solution and a white precipitate was observed 
immediately. The reaction mixture was stirred rapidly for 30 min then the precipitate was 
removed by filtration, and washed with acetonitrile. The filtrate was concentrated in vacuo to 
give the title compound 1.82 as a fluffy white solid (0.34 g, 90%). 
1H NMR (400 MHz, DMSO) δ (ppm): 7.29 (1H, dd, J = 7.1, 1.9 Hz, Ar-H), 6.97 (1H, ddd, J = 
8.0, 7.2, 2.0 Hz, Ar-H), 6.67 (1H, tt, J = 7.2, 0.8 Hz, Ar-H), 6.63 (1H, d, J = 8.1 Hz, Ar-H), 5.15 
(1H, dq, J = 2.6, 0.8 Hz, C=CHa), 4.85 (1H, dq, J = 2.6, 1.4 Hz, C=CHb), 4.28 (2H, d, J = 1.5 
Hz, OCH2), 1.77–1.76 (3H, m, CH3); 13C NMR (100 MHz, DMSO) δ (ppm): 161.6 (C), 142.1 
(C), 138.4 (C)*, 133.4 (q, 3J(C–F) = 2.8 Hz, CH), 126.3 (CH), 119.1 (CH), 111.02 (CH), 
111.98 (CH2), 70.5 (CH2), 19.3 (CH3); IR (solid) 1597, 1438, 1186, 949 cm-1; HRMS (ESI) 
exact mass calculated for C10H11BCsF3NaO [M+Na]+ m/z 370.9802, found m/z 370.9762. 
*detected by HMBC 
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N,2-Dimethyl-N-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-2-
propenamide 
 
Following a modification of a literature procedure99, a mixture of bromoaniline 1.115 (0.11 mL, 
1.0 mmol) and bis(pinacolato)diboron (0.38 g, 1.5 mmol) in dioxane (4 mL) was sparged with 
argon for 20 min. Potassium acetate (0.20 g, 2.0 mmol) and Pd(dppf)Cl2 (0.041 g, 0.050 
mmol) were added and the reaction mixture was stirred at 80 °C. After 24 h, 
bis(pinacolato)diboron (0.38 g, 1.5 mmol) was added, and the reaction mixture stirred at 
80 °C for a further 24 h. After cooling to room temperature, water (10 mL) was added and the 
mixture extracted with EtOAc (3 x 10 mL). The combined organic extracts were washed with 
brine, dried (MgSO4), filtered and concentrated in vacuo. Purification by flash chromatography 
(petroleum ether:ethyl acetate, 96:4) afforded 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)aniline 1.110 as an orange crystalline solid (0.15 g, 67%). Analytical data were in 
accordance with literature values.100 
1H NMR (500 MHz, CDCl3) δ (ppm): 7.61 (1H, dd, J = 7.4, 1.5 Hz, Ar-H), 7.21 (1H, m, Ar-H), 
6.67 (1H, td, J = 7.4, 1.0 Hz, Ar-H), 6.60 (1H, d, J = 8.1 Hz, Ar-H), 4.74 (2H, s, NH2), 1.34 
(12H, s, 4xCH3). 
Following a literature procedure,100 to a stirred solution of 2-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)aniline 1.110 (0.1 g, 0.46 mmol) in toluene (15 mL) at 0 °C was added 
triethylamine (0.50 mL, 0.46 mmol, 0.90 M) in toluene. A solution of methacryloyl chloride 
(0.50 mL, 0.46 mmol, 0.9 M) in toluene was added slowly (0.2 mL/min). The reaction mixture 
was stirred at 0 °C for 20 min then allowed to warm to room temperature. The reaction 
mixture was washed with water (2 x 20 mL), dried (MgSO4), filtered and concentrated in 
vacuo. Purification by flash chromatography (petroleum ether:ethyl acetate, 85:15) afforded 
2-methyl-N-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-2-propenamide 1.112 as a 
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light brown crystalline solid (90 mg, 69%). Analytical data were in accordance with literature 
values.100 
1H NMR (500 MHz, CDCl3) δ (ppm): 9.82 (1H, s, N-H), 8.62 (1H, d, J = 8.4, Ar-H), 7.78 (1H, 
dd, J = 7.5, 1.6 Hz, Ar-H), 7.47 (1H, td, J = 7.9, 1.7 Hz, Ar-H), 7.07 (1H, td, J = 7.4, 0.8 Hz, 
Ar-H), 5.97 (1H, s, C=CHa), 5.47 (1H, s, C=CHb), 2.10 (3H, s, CH3), 1.37 (12H, s, 4xCH3). 
Following a literature procedure, to a stirred suspension of 2-methyl-N-[2-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)phenyl]-2-propenamide 1.112 (0.73 g, 2.5 mmol) and potassium 
carbonate (0.40 g, 2.9 mmol) in DMF (41 mL) was added methyl iodide (0.22 mL, 3.6 mmol). 
The reaction mixture was stirred at room temperature overnight, diluted with EtOAc (100 mL), 
water (100 mL) and extracted. The organic phase was washed with water (2 x 100 mL) and 
brine (3 x 100 mL), dried (MgSO4), filtered and concentrated in vacuo. Purification by flash 
chromatography (petroleum ether:ethyl acetate, 4:1) afforded the title compound 1.106 as an 
orange crystalline solid (0.47 g, 62%). 
1H NMR (500 MHz, d6-DMSO, 80 °C) δ (ppm): 7.69 (1H, dd, J = 7.4, 1.7 Hz, Ar-H), 7.48 (1H, 
td, J = 7.7, 1.7 Hz, Ar-H), 7.31 (1H, td, J = 7.4, 1.1 Hz, Ar-H), 7.19 (1H, dd, J = 8.0, 1.1 Hz, 
Ar-H), 4.99 (2H, s, C=CH2), 3.20 (3H, s, NCH3), 1.73 (3H, s, CCH3), 1.29 (12H, s, 4 x CCH3); 
13C NMR (125 MHz, d6-DMSO, 80 °C) δ (ppm): 169.7 (C), 140.3 (C), 136.0 (C), 135.3 (CH), 
132.5 (CH), 131.3 (C), 128.6 (CH), 126.2 (CH), 116.8 (CH2), 82.9 (C), 37.7 (CH3), 24.2 (CH3), 
19.5 (CH3); IR (thin film) 2978, 1653, 1352, 1145 cm-1; HRMS (ESI) exact mass calculated for 
C17H24BNNaO3 [M+Na]+ m/z 324.1741, found m/z 324.1740.  
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Potassium 2-methyl-N-methyl-N-(phenyltrifluoroborate)-2-propenamide 
 
Following a literature procedure,50 to a stirred solution of N,2-dimethyl-N-[2-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-2-propenamide 1.106 (0.10 g, 0.33 mmol) in 
acetonitrile/methanol (0.67 mL/0.67 mL) was added a solution of potassium fluoride (0.077 g, 
1.3 mmol) in water (0.13 mL). A solution of (L)-tartaric acid (0.10 g, 0.68 mmol) in THF (0.50 
mL) was then added to the rapidly stirring solution and a white precipitate was observed 
immediately. The reaction mixture was stirred rapidly for 1 h then the precipitate was 
removed by filtration, and washed with acetonitrile. The filtrate was concentrated in vacuo to 
give a yellow oil. This oil was washed with CH2Cl2 to give the title compound 1.117 as a 
brown solid (0.036 g, 39%). 
1H NMR (500 MHz, DMSO) δ (ppm): 7.44–7.42 (1H, m, Ar-H), 7.04–7.00 (2H, m, Ar-H), 6.75–
6.73 (1H, m, Ar-H), 4.94 (1H, s, C=CHH), 7.74–7.73 (1H, m, C=CHH), 3.10 (3H, s, NCH3), 
1.64 (3H, s, CH3); 13C NMR (125 MHz, DMSO) δ (ppm): 170.2 (C), 147.3 (C), 140.8 (C), 
134.0 (q, 3J(C-F) = 2.8 Hz, CH), 126.9 (CH), 126.0 (CH), 125.4 (CH), 117.2 (CH2), 37.1 (CH3), 
20.5 (CH3). 
2-Methyl-N-methyl-N-(phenyldifluoroborane)-2-propenamide 
 
Following a modification of a literature procedure,50 to a stirred solution of N,2-dimethyl-N-[2-
(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-2-propenamide 1.106 (0.10 g, 0.33 
mmol) in acetonitrile/methanol (0.67 mL/0.67 mL) was added a solution of potassium fluoride 
(0.077 g, 1.3 mmol) in water (0.13 mL). A solution of (L)-tartaric acid (0.10 g, 0.68 mmol) in 
THF (0.50 mL) was then added to the rapidly stirring solution and a white precipitate was 
observed immediately. The reaction mixture was stirred rapidly for 2 h, at which point TLC 
analysis showed the presence of starting material. A solution of potassium fluoride (0.077 g, 
1.3 mmol) in water (0.13 mL) was added, followed by a solution of (L)-tartaric acid (0.10 g, 
119 
 
0.68 mmol) in THF (0.50 mL). The reaction mixture was stirred rapidly for a further 1 h then 
the precipitate was removed by filtration, and washed with acetonitrile. The filtrate was 
concentrated in vacuo at 50 °C for 1 h to give the title compound 1.118 as a light brown solid 
(0.075 g, quant.). 
1H NMR (500 MHz, CDCl3) δ (ppm): 7.78–7.76 (1H, m, Ar-H), 7.44–7.40 (2H, m, Ar-H), 7.20–
7.19 (1H, m, Ar-H), 5.73 (1H, d, J = 1.6 Hz, C=CHH), 5.55 (1H, d, J = 0.9 Hz, C=CHH), 3.74 
(3H, s, NCH3), 2.17 (3H, s, CH3); 13C NMR (125 MHz, CDCl3) δ (ppm): 170.9 (C), 139.6 (t, 
2J(C-F) = 3.0 Hz, C), 136.7 (C), 132.0 (CH), 128.8 (CH), 128.5 (CH), 123.8 (CH2), 115.0 (CH), 
38.4 (CH3), 20.0 (CH3); LRMS (EI) mass calculated for C11H12BF2NO [M]+ m/z 222.1, found 
m/z 222.1. 
3-(But-3-en-1-yl)-3-methyl-2,3-dihydrobenzofuran 
 
A 4 mL screw-top glass vial was charged with potassium (2-(2-
methylallyloxy)phenyl)trifluoroborate 1.78 (76 mg, 0.30 mmol), Pd(hfacac)2 (16 mg, 0.030 
mmol), Na2CO3 (64 mg, 0.60 mmol), dimethoxyethane (1.2 mL) and allyl chloride (49 μL, 0.60 
mmol) and the vial was sealed under ambient atmosphere. The resulting mixture was heated 
to 50 °C by immersion of the entire vial into a preheated aluminium block for 16 hours. 
Purification by flash chromatography (petroleum ether:dichloromethane, 9:1) afforded the title 
compound 1.75 as a colourless oil (27 mg, 48%). 
1H NMR (400 MHz, CDCl3) δ (ppm): 7.15–7.07 (2H, m, Ar-H), 6.88 (1H, td, J = 7.4, 1.0 Hz, 
Ar-H), 6.79 (1H, dt, J = 8.0, 0.5 Hz, Ar-H), 5.76 (1H, ddt, J = 16.7, 10.2, 6.4 Hz, CH=CH2), 
4.98 (1H, dq, J = 17.1, 1.7 Hz, CH=CHH), 4.94–4.90 (1H, m, CH=CHH), 4.37 (1H, d, J = 8.7 
Hz, O-CHH), 4.16 (1H, d, J = 8.6 Hz, O-CHH), 2.15–2.05 (1H, m, CH2CHHCH=CH2), 1.92–
1.82 (1H, m, CH2CHHCH=CH2), 1.73–1.68 (2H, m, CH2CH2CH=CH2), 1.36 (3H, s, CH3); 13C 
NMR (125 MHz, CDCl3) δ (ppm): 159.9 (C), 138.5 (CH), 135.0 (C), 128.2 (CH), 123.0 (CH), 
120.6 (CH), 114.7 (CH2), 109.7 (CH), 82.6 (CH2), 45.3 (C), 40.2 (CH2), 29.2 (CH2), 25.7 
(CH3); IR (thin film) 2934, 1365, 1196 cm-1; HRMS (EI) exact mass calculated for C13H16O 
[M]+ m/z 188.1201, found m/z 188.1203. 
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3-(But-3-en-1-yl)-3-methyl-7-methyl-2,3-dihydrobenzofuran 
 
A 4 mL screw-top glass vial was charged with potassium (2-(2-methylallyloxy)-3-
methylphenyl)trifluoroborate 1.94 (220 mg, 0.80 mmol), Pd(hfacac)2 (42 mg, 0.080 mmol), 
Na2CO3 (170 mg, 1.6 mmol), dimethoxyethane (3.2 mL) and allyl chloride (0.13 mL, 1.6 
mmol) and the vial was sealed under ambient atmosphere. The resulting mixture was heated 
to 50 °C by immersion of the entire vial into a preheated aluminium block for 16 hours. 
Purification by flash chromatography (petroleum ether:dichloromethane, 9:1) afforded the title 
compound 1.95 as a colourless oil (74 mg, 46%). 
1H NMR (500 MHz, CDCl3) δ (ppm): 6.96 (1H, dq, J = 7.4, 0.7 Hz, Ar-H), 6.92 (1H, dd, J = 
7.4, 0.7 Hz, Ar-H), 6.80 (1H, t, J = 7.4 Hz, Ar-H), 5.75 (1H, ddt, J = 16.8, 10.2, 6.5 Hz, 
CH=CH2), 4.99 (1H, dq, J = 17.1, 1.7 Hz, CH=CHH), 4.93–4.91 (1H, m, CH=CHH), 4.38 (1H, 
d, J = 8.7 Hz, O-CHH), 4.17 (1H, d, J = 8.7 Hz, O-CHH), 2.22 (3H, s, CH3), 2.14–2.06 (1H, m, 
CH2CHHCH=CH2), 1.91–1.84 (1H, m, CH2CHHCH=CH2), 1.75–1.65 (2H, m, 
CH2CH2CH=CH2), 1.35 (3H, s, CH3); 13C NMR (125 MHz, CDCl3) δ (ppm): 158.0 (C), 138.6 
(CH), 134.3 (C), 129.4 (CH), 120.5 (CH), 120.4 (CH), 119.9 (C), 114.6 (CH2), 82.4 (CH2), 45.6 
(C), 40.2 (CH2), 29.2 (CH2), 25.7 (CH3), 15.2 (CH3); IR (thin film) 2965, 2922, 1456, 1188 cm-
1; HRMS (EI) exact mass calculated for C14H18O [M]+ m/z 202.1358, found m/z 202.1357. 
3-(But-3-en-1-yl)-3-methyl-7-methyl-2,3-dihydrobenzofuran 
 
A 4 mL screw-top glass vial was charged with N,2-dimethyl-N-[2-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)phenyl]-2-propenamide 1.106 (22 mg, 0.080 mmol), Pd(hfacac)2 (4.2 mg, 
0.0080 mmol), Na2CO3 (17 mg, 0.16 mmol), dimethoxyethane (0.32 mL) and allyl chloride (13 
µL, 0.16 mmol) and the vial was sealed under ambient atmosphere. The resulting mixture 
was heated to 50 °C by immersion of the entire vial into a preheated aluminium block for 16 
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hours. Purification by flash chromatography (petroleum ether:ethyl acetate, 95:5) afforded the 
title compound 1.107 as a colourless oil (7.5 mg, 47%). 
1H NMR (500 MHz, CDCl3) δ (ppm): 7.27 (1H, td, J = 7.7, 1.2 Hz, Ar-H), 7.17 (1H, dd, J = 7.3, 
0.7 Hz, Ar-H), 7.07 (1H, td, J = 7.5, 0.8 Hz, Ar-H), 6.84 (1H, d, J = 7.8 Hz, Ar-H), 5.68–5.60 
(1H, m, CH=CH2), 4.843–4.841 (1H, m, CH=CHH), 4.82–4.81 (1H, m, CH=CHH), 3.20 (3H, s, 
N-CH3), 2.05–2.00 (1H, m, CH2CHHCH=CH2), 1.85–1.79 (1H, m, CH2CHHCH=CH2), 1.77–
1.69 (1H, m, CHHCH2CH=CH2), 1.66–1.59 (1H, m, CHHCH2CH=CH2), 1.36 (3H, s, CH3); 13C 
NMR (125 MHz, CDCl3) δ (ppm): 180.7 (C), 143.5 (C), 137.9 (CH), 134.0 (C), 127.9 (CH), 
122.7 (CH), 122.6 (CH), 114.7 (CH2), 108.0 (CH), 48.3 (CH3), 37.7 (CH2), 29.1 (CH2), 26.2 
(CH3); IR (thin film) 2974, 2929, 1705, 1614, 1379, 1352 cm-1; HRMS (EI) exact mass 
calculated for C14H17ON [M]+ m/z 215.1310, found m/z 215.1311. 
3-(4,4-Dideuteriobut-3-en-1-yl)-3-methyl-2,3-dihydrobenzofuran 
 
A 4 mL screw-top glass vial was charged with potassium (2-(2-
methylallyloxy)phenyl)trifluoroborate 1.78 (64 mg, 0.25 mmol), Pd(hfacac)2 (13 mg, 0.025 
mmol), Na2CO3 (53 mg, 0.50 mmol), dimethoxyethane (1.0 mL) and dideuteroallyl bromide58 
(0.37 mL, 1.3 M in Et2O, 0.50 mmol). and the vial was sealed under ambient atmosphere. The 
resulting mixture was heated to 50 °C by immersion of the entire vial into a preheated 
aluminium block for 16 hours. Purification by flash chromatography (petroleum 
ether:dichloromethane, 9:1) afforded the title compound 1.122 as a colourless oil (8.8 mg, 
19%). 
1H NMR (400 MHz, CDCl3) δ (ppm): 7.13 (1H, ddd, J = 8.0, 7.4, 1.5 Hz, Ar-H), 7.08 (1H, ddd, 
J = 7.4, 1.5, 0.6 Hz, Ar-H),  6.88 (1H, td, J = 7.4, 1.0 Hz, Ar-H), 6.79 (1H, ddd, J = 8.0, 1.0, 
0.5 Hz, Ar-H), 5.79–5.73 (1H, m, CH=CD2), 4.38 (1H, d, J = 8.7 Hz, O-CHH), 4.17 (1H, d, J = 
8.7 Hz, O-CHH), 2.15–2.06 (1H, m, CHHCH2CH=CD2), 1.92–1.83 (1H, m, CHHCH2CH=CD2), 
1.73–1.69 (2H, m, CH2CH2CH=CD2), 1.36 (3H, s, CH3); 13C NMR (100 MHz, CDCl3) δ (ppm): 
159.7 (C), 138.3 (CH), 135.0 (C), 128.2 (CH), 123.0 (CH), 120.6 (CH), 114.0 (t, 1J(C-D) = 
24.1 Hz, CD2), 109.7 (CH), 82.6 (CH2), 45.3 (C), 40.2 (CH2), 29.1 (CH2), 25.7 (CH3); IR (thin 
film) 2926, 2237, 1600, 1481 cm-1; HRMS (EI) exact mass calculated for C13H14D2O [M]+ m/z 
190.1321, found m/z 190.1315. 
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1-(Dideuterioallyl)-2-((2-methallyl)oxy)benzene 
 
A 4 mL screw-top glass vial was charged with potassium (2-(2-
methylallyloxy)phenyl)trifluoroborate 1.78 (64 mg, 0.25 mmol), Pd(hfacac)2 (13 mg, 0.025 
mmol), Na2CO3 (53 mg, 0.50 mmol), dimethoxyethane (1.0 mL) and dideuteroallyl bromide58 
(0.37 mL, 1.3 M in Et2O, 0.50 mmol). and the vial was sealed under ambient atmosphere. The 
resulting mixture was heated to 50 °C by immersion of the entire vial into a preheated 
aluminium block for 16 hours. Purification by flash chromatography (petroleum 
ether:dichloromethane, 9:1) afforded the title compounds in a 1:1 mixture as a colourless oil 
(1 mg, 1%). 
1H NMR (400 MHz, CDCl3) δ (ppm): 7.19–7.14 (2H, m, Ar-H), 6.90 (1H, t, J = 7.4, Ar-H), 6.83 
(1H, d, J = 8.1, Ar-H), 6.04–5.97 (1H, m, CH=CD2/CH=CH2), 5.11 (1H, s, OCH2C=CHa), 
5.09–5.02 (2H, m, CD2C=CH2), 4.98 (1H, s, OCH2C=CHb), 4.43 (2H, s, OCH2), 3.43 (2H, d, J 
= 6.6 Hz, CH2C=CD2), 1.84 (3H, s, CH3); 13C NMR (100 MHz, CDCl3) δ (ppm): 159.7 (C), 
138.3 (CH), 135.0 (C), 128.2 (CH), 123.0 (CH), 120.6 (CH), 114.0 (t, 1J(C-D) = 24.1 Hz, CD2), 
109.7 (CH), 82.6 (CH2), 45.3 (C), 40.2 (CH2), 29.1 (CH2), 25.7 (CH3); IR (thin film) 2926, 
2237, 1600, 1481 cm-1; HRMS (EI) exact mass calculated for C13H14D2O [M]+ m/z 190.1321, 
found m/z 190.1315. 
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2-(Prop-1-en-2-yl)benzoic acid 
 
To a stirred suspension of methyl triphenylphosphonium bromide (21 g, 60 mmol) in THF 
(150 mL) was added a solution of potassium tert-butoxide (6.7 g, 60 mmol) in THF (60 mL). 
The resulting yellow solution was stirred for 15 minutes then a solution of o-
bromoacetophenone 2.23 (6.7 mL, 50 mmol) in THF (100 mL) was added dropwise. The 
resulting suspension was stirred at room temperature for 3 h then quenched with sat. aq. 
NH4Cl (200 mL). The mixture was extracted with Et2O (3 x 100 mL) and the combined organic 
extracts were dried (Na2SO4), filtered and concentrated in vacuo. Purification by flash 
chromatography (petroleum ether) afforded 1-bromo-2-(prop-1-en-2-yl)-benzene 2.24 as a 
colourless oil (8.20 g, 87%). Analytical data were in accordance with literature values.101 
1H NMR (500 MHz, CDCl3) δ (ppm): 7.55 (1H, dd, J = 8.0, 1.1 Hz, Ar-H), 7.27 (1H, td, J = 7.5, 
1.2 Hz, Ar-H), 7.19 (1H, dd, J = 7.6, 1.8 Hz, Ar-H), 7.11 (1H, td, J = 7.7, 1.9 Hz, Ar-H), 5.24–
5.22 (1H, m, C=CHa), 4.943–4.938 (1H, m, C=CHb), 2.104–2.099 (3H, m, CH3). 
To a cooled (0 °C) solution of 1-bromo-2-(prop-1-en-2-yl)-benzene 2.24 (4.0 g, 22 mmol) in 
Et2O (42 mL) was added dropwise a solution of n-butyllithium (2.1 M in hexanes, 15 mL, 32 
mmol). The resulting yellow suspension was stirred for 15 minutes then CO2 bubbled through 
the mixture. The mixture was allowed to warm to room temperature over 2 h then quenched 
with sat. aq. NaHCO3 (100 mL). The mixture was extracted with Et2O (3 x 50 mL) and the 
aqueous phase adjusted to pH 1 with 1M aq. HCl. The aqueous phase was then extracted 
with Et2O (3 x 100 mL) and the combined organic extracts were dried (Na2SO4), filtered and 
concentrated in vacuo to afford the title compound 2.20 as a light yellow solid (2.3 g, 65%). 
Analytical data were in accordance with literature values.102 
Melting point: 76–79 °C; 1H NMR (400 MHz, CDCl3) δ (ppm): 7.95 (1H, dd, J = 7.8, 1.1 Hz, 
Ar-H), 7.50 (1H, td, J = 7.5, 1.4 Hz, Ar-H), 7.35 (1H, td, J = 7.7, 1.3 Hz, Ar-H), 7.26 (1H, dd, J 
= 7.5, 1.0 Hz, Ar-H), 5.14–5.12 (1H, m, C=CHa), 4.90–4.89 (1H, m, C=CHb), 2.12 (3H, dd, J 
= 1.4, 0.9 Hz, CH3). 
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3-(But-3-enyl)-3-methylisobenzofuran-1(3H)-one 
 
A 4 mL screw-top glass vial was charged with 2-(prop-1-en-2-yl)benzoic acid 2.20 (54 mg, 
0.33 mmol), toluene (1.3 mL), allyl bromide (0.14 mL, 1.7 mmol), NaHCO3 (49 mg, 0.66 
mmol) and Pd(hfacac)2 (8.8 mg, 0.017 mmol) and the vial was sealed under ambient 
atmosphere. The resulting mixture was heated to 50 °C by immersion of the entire vial into a 
preheated aluminium block for 16 hours. The reaction mixture was cooled to room 
temperature and diluted with H2O (10 mL) and extracted with Et2O (3 x 10 mL). The combined 
organic extracts were dried (Na2SO4), filtered and concentrated in vacuo. Purification by flash 
chromatography (petroleum ether:ethyl acetate, 9:1) afforded the title compound 2.21 as a 
colourless oil (46 mg, 69%). Analytical data were in accordance with literature values.48 
1H NMR (400 MHz, CDCl3) δ (ppm): 7.84 (1H, dt, J = 7.7, 1.0 Hz, Ar-H), 7.65 (1H, td, J = 7.5, 
1.1 Hz, Ar-H), 7.49 (1H, td, J = 7.5, 1.0 Hz, Ar-H), 7.36 (1H, dd, J = 7.7, 0.9 Hz, Ar-H), 5.67 
(1H, ddt, J = 16.8, 10.2, 6.3 Hz, CH=CH2), 4.92–4.88 (1H, m, C=CHa), 4.87–4.85 (1H, m, 
C=CHb), 2.13 (1H, ddd, J = 13.3, 11.2, 4.1 Hz, CH2CHHCH=CH2), 2.07–1.98 (1H, m, 
CH2CHHCH=CH2), 1.94 (1H, ddd, J = 13.4, 11.0, 4.0 Hz, CHHCH2CH=CH2), 1.77–1.67 (1H, 
m, CHHCH2CH=CH2), 1.63 (3H, s, CH3). 
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(E)-3-Methyl-3-(4-(4-nitrophenyl)but-3-en-1-yl)isobenzofuran-1(3H)-one 
 
A 4 mL screw-top glass vial was charged with 2-(prop-1-en-2-yl)benzoic acid 2.20 (32 mg, 
0.20 mmol), toluene (0.80 mL), allyl bromide (90 μL, 1.0 mmol), NaHCO3 (30 mg, 0.40 mmol) 
and Pd(hfacac)2 (5.0 mg, 0.010 mmol) and the vial was sealed under ambient atmosphere. 
The resulting mixture was heated to 50 °C by immersion of the entire vial into a preheated 
aluminium block for 16 hours. The reaction mixture was cooled to room temperature and the 
volatile components were evaporated in vacuo. To the vial was added acetonitrile (2.0 mL), 
P(o-tol)3 (6.0 mg, 0.020 mmol), 4-bromonitrobenzene (81 mg, 0.40 mmol) and triethylamine 
(60 µL, 0.40 mmol) and the vial was sealed under ambient atmosphere. The mixture was then 
heated at 80 °C for 16 hours. The reaction mixture was cooled to room temperature and 
quenched with H2O (10 mL) then extracted with EtOAc (3 x 10 mL). The combined organic 
extracts were dried over NaSO4, filtered and concentrated in vacuo to give a colourless oil. 
This oil was then purified by flash chromatography on silica gel (toluene/EtOAc; 98:2) to give 
the title compound 2.26 as a colourless oil (32 mg, 40% from 2.20 along with minor isomers 
2.27 and 2.28). 
1H NMR (400 MHz, CDCl3) δ 8.12 (2H, dt, J = 9.2, 2.0 Hz, Ar-H), 7.87 (1H, dt, J = 7.6, 0.8 Hz, 
Ar-H), 7.68 (1H, td, J = 7.6, 1.2 Hz, Ar-H), 7.51 (1H, td, J = 7.6, 0.8 Hz, Ar-H), 7.40 (1H, dt, J 
= 7.6, 0.8 Hz, Ar-H), 7.35 (2H, dt, 8.8, 2.0 Hz, Ar-H), 6.30 (1H, d, J = 16.0 Hz, HC=CH), 6.23 
(1H, dt, J = 16.0, 6.0 Hz, HC=CH), 2.33–2.20 (2H, m, C=CHCHHCHH), 2.11–1.94 (2H, m, 
C=CHCHHCHH), 1.69 (3H, s, CH3); 13C NMR (100 MHz, CDCl3) δ 169.2 (C), 153.4 (C), 146.7 
(C), 143.9 (C), 134.4 (CH), 134.3 (CH), 129.3 (CH), 128.9 (CH), 126.5 (CH), 126.2 (C), 126.0 
(CH), 124.0 (CH), 121.0 (CH), 87.2 (C), 39.0 (CH2), 27.6 (CH2), 26.5 (CH3); IR (thin film) 
2930, 1755, 1512, 1341, 1031; HRMS (EI) exact mass calculated for C19H17NO4 [M]+ m/z 
323.1158, found m/z 323.1142. 
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(E)-3-(4-(3-Fluoro-4-(hydroxymethyl)phenyl)but-3-en-1-yl)-3-
methylisobenzofuran-1(3H)-one 
 
A 4 mL screw-top glass vial was charged with 2-(prop-1-en-2-yl)benzoic acid 2.20 (32 mg, 
0.20 mmol), toluene (0.80 mL), allyl bromide (90 μL, 1.0 mmol), NaHCO3 (30 mg, 0.40 mmol) 
and Pd(hfacac)2 (5.0 mg, 0.010 mmol) and the vial was sealed under ambient atmosphere. 
The resulting mixture was heated to 50 °C by immersion of the entire vial into a preheated 
aluminium block for 16 hours. The reaction mixture was cooled to room temperature and the 
volatile components were evaporated in vacuo. To the vial was added acetonitrile (2.0 mL), 
P(o-tol)3 (6.0 mg, 0.020 mmol), 4-bromo-2-fluorobenzyl alcohol (82 mg, 0.40 mmol) and 
triethylamine
 
(60 µL, 0.40 mmol) and the vial was sealed under ambient atmosphere. The 
mixture was then heated at 80 °C for 16 hours. The reaction mixture was cooled to room 
temperature and quenched with H2O (10 mL) then extracted with EtOAc (3 x 10 mL). The 
combined organic extracts were dried over NaSO4, filtered and concentrated in vacuo to give 
a colourless oil. This oil was then purified by flash chromatography on silica gel 
(toluene/EtOAc; 4:1) to give the title compound 2.33 as a colourless oil (30 mg, 33% from 
2.20 along with minor isomers 4.1 and 4.2). 
1H NMR (400 MHz, CDCl3) δ 7.87 (1H, dt, J = 7.6, 1.0 Hz, Ar-H), 7.67 (1H, td, J = 7.6, 1.2 Hz, 
Ar-H), 7.51 (1H, td, J = 7.6, 0.8 Hz, Ar-H), 7.39 (1H, dt, J = 7.6, 1.0 Hz, Ar-H), 7.29 (1H, t, 7.8 
Hz, Ar-H), 7.00 (1H, dd, J = 8.0, 1.6 Hz, Ar-H), 6.93 (1H, dd, J = 11.4, 1.6 Hz, Ar-H), 6.20 
(1H, d, J = 16.0 Hz, HC=CH), 6.03 (1H, dt, J = 16.0, 6.6 Hz, HC=CH), 4.70 (2H, d, J = 6.0 Hz, 
CH2OH), 2.28–2.16 (2H, m, C=CHCHHCHH), 2.07–1.99 (1H, m, C=CHCHHCHH), 1.92–1.85 
(1H, m, C=CHCHHCHH), 1.68, (3H, s, CH3); 13C NMR (100 MHz, CDCl3) δ 170.1 (C), 160.9 
(d, 1J(C-F) = 245.7 Hz, C), 153.6 (C), 139.4 (C), 134.3 (CH), 130.5 (CH), 129.5 (d, 3J(C-F) = 
5.2 Hz, CH), 129.4 (d, 4J(C-F) = 2.5 Hz, CH), 129.3 (CH), 126.5 (d, 2J(C-F) = 15.3 Hz, C), 
127 
 
126.2 (C), 126.0 (CH), 122.1 (d, 4J(C-F) = 3.0 Hz, CH), 121.0 (CH), 112.4 (d, 2J(C-F) = 21.9 
Hz, CH), 87.3 (C), 59.4 (d, 3J(C-F) = 4.0 Hz, CH2), 39.3 (CH2), 27.3 (CH2), 26.4 (CH3); IR (thin 
film) 3410, 2925, 1740, 1287, 1034; HRMS (EI) exact mass calculated for C20H19FO3 [M]+ m/z 
326.1318, found m/z 326.1333. 
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(E)-4-(4-(1-Methyl-3-oxo-1,3-dihydroisobenzofuran-1-yl)but-1-en-1-
yl)benzenesulfonamide 
 
A 4 mL screw-top glass vial was charged with 2-(prop-1-en-2-yl)benzoic acid 2.20 (32 mg, 
0.20 mmol), toluene (0.80 mL), allyl bromide (90 μL, 1.0 mmol), NaHCO3 (30 mg, 0.40 mmol) 
and Pd(hfacac)2 (5.0 mg, 0.010 mmol) and the vial was sealed under ambient atmosphere. 
The resulting mixture was heated to 50 °C by immersion of the entire vial into a preheated 
aluminium block for 16 hours. The reaction mixture was cooled to room temperature and the 
volatile components were evaporated in vacuo. To the vial was added acetonitrile (2.0 mL), 
P(o-tol)3 (6.0 mg, 0.020 mmol), 4-bromobenzenesulfonamide (94 mg, 0.40 mmol) and 
triethylamine
 
(60 µL, 0.40 mmol) and the vial was sealed under ambient atmosphere. The 
mixture was then heated at 80 °C for 16 hours. The reaction mixture was cooled to room 
temperature and quenched with H2O (10 mL) then extracted with EtOAc (3 x 10 mL). The 
combined organic extracts were dried over NaSO4, filtered and concentrated in vacuo to give 
a colourless oil. This oil was then purified by flash chromatography on silica gel 
(toluene/EtOAc; 3:2) to give the title compound 2.29 as a colourless oil (40 mg, 44% from 
2.20 along with minor isomers 4.3 and 4.4).  
1H NMR (400 MHz, CDCl3) δ 7.86 (1H, d, J = 7.6 Hz, Ar-H), 7.79 (2H, d, J = 8.4 Hz, Ar-H), 
7.67 (1H, td, J = 7.6, 1.2 Hz, Ar-H), 7.51 (1H, td, J = 7.6, 1.2 Hz, Ar-H), 7.40 (1H, d, J = 7.6 
Hz, Ar-H), 7.32 (2H, d, J = 8.8 Hz, Ar-H), 6.24 (1H, d, J = 16.0 Hz, HC=CH), 6.15 (1H, dt, J = 
16.0, 6.4 Hz, HC=CH), 5.15 (2H, s, NH2), 2.30–2.16 (2H, m, C=CHCHHCHH), 2.08–1.89 (2H, 
m, C=CHCHHCHH), 1.67 (3H, s, CH3); 13C NMR (100 MHz, CDCl3) δ 170.1 (C), 153.4 (C), 
141.9 (C), 140.2 (C), 134.4 (CH), 132.9 (CH), 129.3 (CH), 129.2 (CH), 126.8 (2xCH), 126.5 
(2xCH), 126.1 (C), 125.9 (CH), 121.0 (CH), 87.4 (C), 39.0 (CH2), 27.5 (CH2), 26.4 (CH3); IR 
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(thin film) 3248, 2925, 1740, 137, 1159, 1036; HRMS (EI) exact mass calculated for 
C19H19NO4S [M]+ m/z 357.1035, found m/z 357.1017. 
(E)-1,3-Dimethyl-5-(4-(1-methyl-3-oxo-1,3-dihydroisobenzofuran-1-yl)but-1-en-1-
yl)pyrimidine-2,4(1H,3H)-dione 
 
A 4 mL screw-top glass vial was charged with 2-(prop-1-en-2-yl)benzoic acid 2.20 (32 mg, 
0.20 mmol), toluene (0.80 mL), allyl bromide (90 μL, 1.0 mmol), NaHCO3 (30.0 mg, 0.400 
mmol) and Pd(hfacac)2 (5.0 mg, 0.010 mmol) and the vial was sealed under ambient 
atmosphere. The resulting mixture was heated to 50 °C by immersion of the entire vial into a 
preheated aluminium block for 16 hours. The reaction mixture was cooled to room 
temperature and the volatile components were evaporated in vacuo. To the vial was added 
acetonitrile (2.0 mL), P(o-tol)3 (6.0 mg, 0.020 mmol), 5-bromo-1,3-dimethyluracil (88 mg, 0.40 
mmol) and triethylamine
 
(60 µL, 0.40 mmol) and the vial was sealed under ambient 
atmosphere. The mixture was then heated at 80 °C for 16 hours. The reaction mixture was 
cooled to room temperature and quenched with H2O (10 mL) then extracted with EtOAc (3 x 
10 mL). The combined organic extracts were dried over NaSO4, filtered and concentrated in 
vacuo to give a colourless oil. This oil was then purified by flash chromatography on silica gel 
(toluene/EtOAc; 3:1) to give the title compound 2.31 as a colourless oil (39 mg, 36% from 
2.20 along with minor isomers 4.5 and 4.6).  
1H NMR (400 MHz, CDCl3) δ 7.85 (1H, dt, J = 7.6, 1.0 Hz, Ar-H), 7.67 (1H, td, J = 7.6, 1.0 Hz, 
Ar-H), 7.50 (1H, td, J = 7.6, 0.8 Hz, Ar-H), 7.37 (1H, dt, J = 7.6, 1.0 Hz, Ar-H), 7.10 (1H, s, 
C=CH), 6.21 (1H, dt, J = 15.6, 6.6 Hz, HC=CH), 5.96 (1H, d, J = 15.6 Hz, HC=CH), 3.40 (3H, 
s, NCH3), 3.33 (3H, s, NCH3), 2.24–2.15 (1H, m, C=CHCHHCH2), 2.13–2.04 (1H, m, 
C=CHCH2CHH), 2.03–1.95 (1H, m, C=CHCH2CHH), 1.91–1.83 (1H, m, C=CHCHHCH2), 1.65 
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(3H, s, CH3); 13C NMR (100 MHz, CDCl3) δ 170.1 (C), 162.5 (C), 153.52 (C), 153.50 (C), 
138.7 (CH), 134.3 (CH), 130.4 (CH), 129.2 (CH), 126.2 (C), 125.8 (CH), 121.2 (CH), 121.0 
(CH), 111.5 (C), 87.5 (C), 39.2 (CH2), 37.2 (CH3), 28.1 (CH3), 27.8 (CH2), 26.4 (CH3); IR (thin 
film) 2928, 1755, 1697, 1647, 1034; HRMS (EI) exact mass calculated for C19H20N2O4 [M]+ 
m/z 340.1423, found m/z 340.1419. 
1-Allyl-N-tosyl-pyrrole-2-carboxamide 
 
Following a modified literature procedure,79 to a cooled (0 °C) suspension of NaH (60% 
dispersion in mineral oil, 0.72 g, 16 mmol) in DMF (15 mL) was added a solution of methyl 2-
pyrrole-carboxylate 2.49 (1.5 g, 12 mmol) in DMF (3 mL). The resulting mixture was stirred for 
20 minutes at 0 °C, then allyl bromide (1.8 mL, 21 mmol) was added dropwise. The mixture 
was allowed to warm to room temperature, and stirred for 2 h, then quenched by pouring onto 
ice (45 g). The mixture was extracted with Et2O (3 x 25 mL). The combined organic extracts 
were washed with H2O (4 x 25 mL) and brine (2 x 25 mL), dried (Na2SO4), filtered and 
concentrated in vacuo to give a brown oil (2.0 g, quant.) which was used without further 
purification. 
To a solution to methyl 1-allyl-pyrrole-2-carboxylate 2.50 (2.0 g, 12 mmol) in EtOH (28 mL) 
was added 1 M aq. NaOH (33 mL). The mixture was refluxed for 2h, then EtOH was removed 
in vacuo. The residue was washed with EtOAc (3 x 40 mL) then adjusted to pH 2 with 2 M aq. 
HCl and extracted with EtOAc (3 x 40 mL). The combined organic extracts were dried 
(Na2SO4), filtered and concentrated in vacuo to give a brown solid (1.4 g, 79%) which was 
used without further purification. 
To a solution of 1-allyl-pyrrole-2-carboxylic acid 2.51 (0.25 g, 1.7 mmol) in THF (5 mL) was 
added p-tosyl isocyanate (0.51 mL, 3.3 mmol). The resulting solution was stirred for 10 
minutes then triethylamine (0.25 mL, 1.8 mmol) was added dropwise. Gas evolution was 
observed on addition. After 1 h, the mixture was diluted with EtOAc (25 mL) and washed with 
2 M aq. HCl (25 mL) and brine (25 mL). The organic extracts were dried (Na2SO4), filtered 
131 
 
and concentrated in vacuo. Purification by flash chromatography (dichloromethane) afforded 
the title compound 2.45 as a white solid (0.41 g, 81%). Analytical data were in accordance 
with literature values.79 
1H NMR (400 MHz, CDCl3) δ 8.13 (1H, s, NH), 8.00 (2H, d, J = 8.3 Hz, Ar-H), 7.34 (2H, d, J = 
8.1 Hz, Ar-H), 6.88 (1H, t, J = 2.1 Hz, Ar-H), 6.72 (1H, dd, J = 4.1, 1.6 Hz, Ar-H), 6.16 (1H, 
dd, J = 4.1, 2.6 Hz, Ar-H), 5.90 (1H, ddt, J = 16.2, 10.8, 5.8 Hz, CH=CH2), 5.09 (1H, dd, J = 
10.2, 1.4 Hz, CH=CHa), 4.96 (1H, dd, J = 17.0, 1.6 Hz, CH=CHb), 4.85 (2H, d, J = 5.8 Hz, 
CH2), 2.44 (3H, s, CH3). 
4-(1-Oxo-2-tosyl-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-3-yl)butanal 
  
A 4 mL screw-top glass vial was charged with 1-allyl-N-tosyl-pyrrole-2-carboxamide (61 mg, 
0.20 mmol), toluene (0.32 mL), H2O (0.32 mL), allyl chloride (80 μL, 1.0 mmol) and 
Pd(hfacac)2 (13 mg, 0.024 mmol) and the vial was sealed under ambient atmosphere. The 
resulting mixture was heated to 80 °C by immersion of the entire vial into a preheated 
aluminium block overnight. The reaction mixture was cooled to room temperature and the 
volatile components were evaporated in vacuo. To the vial was added benzonitrile (50 µL, 
0.48 mmol), CuCl2•2H2O (4.1 mg, 0.024 mmol) and silver nitrite (3.7 mg, 0.024 mmol). The 
vial was sparged for 2 minutes with O2. tBuOH (3.0 mL) and MeNO2 (0.20 mL) were added 
and the vial sparged for 2 minutes with O2. The reaction mixture was then stirred at room 
temperature under an O2 atmosphere overnight. The reaction mixture was quenched with 
water (20 mL) then extracted with Et2O (3 x 20 mL). The combined organic extracts were 
dried (Na2SO4), filtered and concentrated in vacuo. 
132 
 
Dodecanal 
 
Following a literature procedure,103 to a 4 mL vial was added dodecene 2.52 (50 µL, 0.20 
mmol), PdCl2(PhCN)2 (9.2 mg, 0.024 mmol), CuCl2•2H2O (4.1 mg, 0.024 mmol) and silver 
nitrite (3.7 mg, 0.024 mmol). The vial was sparged for 45 seconds with O2. tBuOH (3.0 mL) 
and MeNO2 (0.20 mL) were added and the vial sparged for a further 45 seconds with O2. The 
reaction mixture was then stirred at room temperature under an O2 atmosphere overnight. 
The reaction mixture was quenched with water (20 mL) then extracted with Et2O (3 x 20 mL). 
The combined organic extracts were dried (Na2SO4), filtered and concentrated in vacuo. The 
crude material was then analysed by 1H NMR. Analytical data were in accordance with 
literature values.103 
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2-Naphthyl boronic acid MIDA ester 
 
Following a literature procedure, naphthyl boronic acid (0.86 g, 5.0 mmol) and MIDA (0.74 g, 
5.0 mmol) were stirred in DMF (15 mL) at 85 °C for 16 h then allowed to cool to room 
temperature. The reaction mixture was diluted with EtOAc (100 mL) and H2O (100 mL) then 
separated. The organic phase was washed with H2O (50 mL) and brine (3 x 50 mL) then 
dried (Na2SO4), filtered and concentrated in vacuo. Purification by flash chromatography 
(diethyl ether:methanol, 98.5:1.5 then THF) gave a yellow oil. Addition of Et2O formed a white 
precipitate which was collected by vacuum filtration affording the title compound as a white 
solid (1.3 g, 93%). Analytical data were in accordance with literature values.104 
1H NMR (400 MHz, DMSO) δ (ppm): 7.99 (1H, s, Ar-H), 7.94–7.88 (3H, m, Ar-H), 7.57–7.50 
(3H, m, Ar-H), 4.38 (2H, d, J = 17.2 Hz, 2 x NCHH), 4.17 (2H, d, J = 17.1 Hz, 2 x NCHH), 
2.52 (3H, s, NCH3). 
General procedure for allylation of MIDA boronates 
A 4 mL screw-top glass vial was charged with boronic acid MIDA ester (0.10 mmol), dioxane 
(1.25 mL), allyl bromide (0.020 mL, 0.20 mmol) and Pd2dba3 (5.2 mg, 0.0050 mmol). A 3 M 
aq. solution of K3PO4 (0.25 mL, 0.75 mmol) was added and the vial sealed under ambient 
atmosphere. The resulting mixture was heated to 60 °C by immersion of the entire vial into a 
preheated aluminium block until the substrate had been consumed, as judged by TLC 
analysis. The reaction mixture was cooled to room temperature, quenched with 1 M aq. 
NaOH (5 mL) then extracted with Et2O (3 x 5 mL). The combined organic extracts were dried 
(Na2SO4), filtered and concentrated in vacuo. Addition of 1,3,5-trimethoxybenzene (17 mg, 
0.10 mmol) allowed determination of the yield by 1H NMR. 
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2-Allylnaphthalene 
 
The general procedure was employed for the allylation of 2-naphthylboronic acid MIDA ester 
(28 mg, 0.10 mmol). Yield determined by 1H NMR: 91%. Analytical data were in accordance 
with literature values.105 
1H NMR (400 MHz, CDCl3) δ 7.86–7.81 (3H, m, Ar-H), 7.67 (1H, s, Ar-H), 7.51–7.44 (2H, m, 
Ar-H), 7.37 (1H, dd, J = 8.4, 1.8 Hz, Ar-H), 6.10 (1H, ddt, J = 16.8, 10.1, 6.7 Hz, CH=CH2), 
5.19 (1H, dq, J = 10.5, 1.7 Hz, C=CHa), 5.17–5.15 (1H, m, C=CHb), 3.59 (2H, d, J = 6.6 Hz, 
CH2). 
2-(2-Buten-1-yl)-naphthalene/2-(1-methyl-2-propen-1-yl)-naphthalene 
 
The general procedure was employed for the allylation of 2-naphthylboronic acid MIDA ester 
(32 mg, 0.10 mmol) using 3-chlorobut-1-ene (0.020 mL, 0.20 mmol). Purification by flash 
chromatography (petroleum ether) afforded the title compounds as a colourless oil (12.4 mg, 
68%, 1.6:1). Analytical data were in accordance with literature values.106 
1H NMR (400 MHz, CDCl3) δ 7.82–7.77 (3H, m, Ar-H), 7.66 (1H, s, Ar-H), 7.62 (1H, s, Ar-H), 
7.48–7.40 (2H, m, Ar-H), 7.39–7.32 (1H, m, Ar-H), 6.10 (1H, ddd, J = 16.9, 10.3, 6.4 Hz, 
CH=CH2), 5.72–5.54 (2H, m, CH=CH), 5.14–5.08 (2H, m, CH=CH2), 3.67–3.57 (1H, m, 
CHCH3), 3.49 (2H, dd, J = 6.5, 1.2 Hz, CH2), 1.73 (3H, dq, J = 6.1, 1.4 Hz, CHCH3), 1.47 (3H, 
d, J = 7.0 Hz, CH=CHCH3). 
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2-(3-Methyl-2-buten-1-yl)-naphthalene/2-(2-methyl-3-buten-2-yl)-naphthalene 
 
The general procedure was employed for the allylation of 2-naphthylboronic acid MIDA ester 
(32 mg, 0.10 mmol) using prenyl chloride (0.020 mL, 0.20 mmol). Purification by flash 
chromatography (petroleum ether) afforded the title compounds as a colourless oil (15.1 mg, 
77%, 3:1). Analytical data were in accordance with literature values.107 
1H NMR (400 MHz, CDCl3) δ .82 (3H, m, Ar-H), 7.62 (1H, s, Ar-H), 7.52–7.40 (2H, m, Ar-H), 
7.34 (1H, dd, J = 8.5, 1.8 Hz, Ar-H), 6.12 (1H, dd, J = 17.3, 10.7 Hz, CH=CH2), 5.43 (1H, 
tseptet, J = 7.3, 1.4 Hz, CH=C(CH3)2), 5.15–5.10 (2H, m, CH=CH2), 3.52 (2H, d, J = 7.3 Hz, 
CH2), 1.79 (6H, dd, J = 4.4, 1.4 Hz, CH=C(CH3)2), 1.52 (6H, s, 2 x CH3). 
2-(3-Phenyl-2-propen-1-yl)-naphthalene 
 
The general procedure was employed for the allylation of 2-naphthylboronic acid MIDA ester 
(32 mg, 0.10 mmol) using cinnamyl chloride (0.030 mL, 0.20 mmol). Purification by flash 
chromatography (petroleum ether) afforded the title compound as a colourless oil (20.2 mg, 
83%). Analytical data were in accordance with literature values.108 
1H NMR (400 MHz, CDCl3) δ 7.85–7.80 (3H, m, Ar-H), 7.70 (1H, s, Ar-H), 7.50–7.43 (2H, m, 
Ar-H), 7.41–7.38 (3H, m, Ar-H), 7.34–7.29 (2H, m, Ar-H), 7.25–7.21 (1H, m, Ar-H), 6.53 (1H, 
d, J = 15.8 Hz, CH2CH=CH), 6.45 (1H, dt, J = 15.8, 6.3 Hz, CH2CH=CH), 3.73 (2H, d, J = 6.2 
Hz, CH2CH=CH). 
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2-(2-Methyl-2-propen-1-yl)-naphthalene 
 
The general procedure was employed for the allylation of 2-naphthylboronic acid MIDA ester 
(85 mg, 0.30 mmol) using 2-methylallyl bromide (0.030 mL, 0.30 mmol). Purification by flash 
chromatography (petroleum ether) afforded the title compound as a colourless oil (47.2 mg, 
86%). Analytical data were in accordance with literature values.106 
1H NMR (500 MHz, CDCl3) δ (ppm): 7.83–7.78 (3H, m, Ar-H), 7.65 (1H, s, Ar-H), 7.45 (2H, 
quintet d, J = 6.8, 1.5 Hz, Ar-H), 7.35 (1H, dd, J = 8.4, 1.7 Hz, Ar-H), 4.88–4.87 (1H, m, 
C=CHa), 4.81–4.80 (1H, m, C=CHb), 3.50 (2H, s, CH2), 1.72 (3H, s, CH3). 
2-(2-Propen-1-yl-3,3-d2)-naphthalene/2-(2-propen-1-yl-1,1-d2)-naphthalene 
 
The general procedure was employed for the allylation of 2-naphthylboronic acid MIDA ester 
(28 mg, 0.10 mmol) using dideuteroallyl bromide58 (0.23 mL, 0.89 M in Et2O, 0.20 mmol). 
Purification by flash chromatography (petroleum ether) afforded the title compounds as a 
colourless oil (14.1 mg, 83%, 1:1). Analytical data were in accordance with literature 
values.109 
1H NMR (400 MHz, CDCl3) δ 7.83–7.78 (3H, m, Ar-H), 7.64 (1H, dd, J = 1.8, 0.8 Hz, Ar-H), 
7.49–7.42 (2H, m, Ar-H), 7.35 (1H, dd, J = 8.4, 1.8 Hz, Ar-H), 6.09–6.02 (1H, m, 
CH=CH2/CH=CD2), 5.16 (0.5H, dd, J = 12.0, 2.0 Hz, CH=CHH), 5.13 (0.5H, dd, J = 5.2, 2.0 
Hz, CH=CHH), 3.57 (1H, dd, J = 6.6, 0.7 Hz, CH2CH=CD2); 13C NMR (100 MHz, CDCl3) δ 
137.7 (2 x C), 137.4 (CH), 137.2 (CH), 133.8 (2 x C), 132.3 (2 x C), 128.0 (2 x CH), 127.8 (2 x 
CH), 127.6 (2 x CH), 127.5 (2 x CH), 126.8 (2 x CH), 126.1 (2 x CH), 125.4 (2 x CH), 116.22 
(CH2), 115.7 (p, 1J(C-D) = 23.7 Hz, CD2), 40.4 (CH2), 39.8 (p, 1J(C-D) = 19.6 Hz, CD2); IR 
(thin film) 3053, 2923, 2113, 1689 cm-1; HRMS (EI) exact mass calculated for C13H10D2 [M]+ 
m/z 170.1059, found m/z 170.1080. 
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4-Allylbromobenzene 
 
The general procedure was employed for the allylation of 4-bromophenylboronic acid MIDA 
ester (31 mg, 0.10 mmol). Yield determined by 1H NMR: 90%. Analytical data were in 
accordance with literature values.110 
1H NMR (400 MHz, CDCl3) δ 7.45–7.39 (2H, m, Ar-H), 7.09–7.04 (2H, m, Ar-H), 5.93 (1H, 
ddt, J = 16.6, 10.4, 6.4 Hz, CH=CH2), 5.11–5.03 (2H, m, CH=CH2), 3.34 (2H, d, J = 6.6 Hz, 
CH2). 
4-Allylchlorobenzene 
 
The general procedure was employed for the allylation of 4-chlorophenylboronic acid MIDA 
ester (27 mg, 0.10 mmol). Yield determined by 1H NMR: 92%. Analytical data were in 
accordance with literature values.110 
1H NMR (400 MHz, CDCl3) δ 7.29–7.25 (2H, m, Ar-H), 7.14–7.11 (2H, m, Ar-H), 5.94 (1H, 
ddt, J = 17.2, 10.4, 6.8 Hz, CH=CH2), 5.11–5.10 (1H, m, CH=CHa), 5.09–5.05 (1H, m, 
CH=CHb), 3.36 (2H, d, J = 6.7 Hz, CH2). 
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4-Allylphenol 
 
The general procedure was employed for the allylation of 4-hydroxyphenylboronic acid MIDA 
ester (31 mg, 0.10 mmol). Yield determined by 1H NMR: 28%. Analytical data were in 
accordance with literature values.111 
1H NMR (400 MHz, CDCl3) δ 7.06 (2H, d, J = 8.4 Hz, Ar-H), 6.78 (2H, d, J = 8.5 Hz, Ar-H), 
5.95 (1H, ddt, J = 16.7, 10.4, 6.7 Hz, CH=CH2), 5.08–5.03 (2H, m, CH=CH2), 4.86 (1H, s, 
OH), 3.32 (2H, d, J = 6.7 Hz, CH2). 
2-Allylcyanobenzene 
 
The general procedure was employed for the allylation of 2-cyanophenylboronic acid MIDA 
ester (77 mg, 0.30 mmol). Yield determined by 1H NMR: 88%. Analytical data were in 
accordance with literature values.112 
1H NMR (400 MHz, CDCl3) δ 7.63 (1H, dd, J = 7.7, 1.1 Hz, Ar-H), 7.53 (1H, td, J = 3.9, 1.4 
Hz, Ar-H), 7.36–7.28 (2H, m, Ar-H), 5.95 (1H, ddt, J = 16.9, 10.2, 6.6 Hz, CH=CH2), 5.17–
5.08 (2H, m, CH=CH2), 3.61 (2H, d, J = 6.6 Hz, CH2). 
2-Allylfluorobenzene 
 
The general procedure was employed for the allylation of 2-fluorophenylboronic acid MIDA 
ester (25 mg, 0.10 mmol). Yield determined by 1H NMR: 83%. Analytical data were in 
accordance with literature values. 
1H NMR (400 MHz, CDCl3) δ 7.22–7.16 (2H, m, Ar-H), 7.09–6.98 (2H, m, Ar-H), 6.01–5.91 
(1H, m, CH=CH2), 5.10–5.05 (2H, m, CH=CH2), 3.41 (2H, dd, J = 6.6, 1.5 Hz, CH2). 
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3-Allylnitrobenzene 
 
The general procedure was employed for the allylation of 3-nitrophenylboronic acid MIDA 
ester (83 mg, 0.30 mmol). Yield determined by 1H NMR: 92%. Analytical data were in 
accordance with literature values.113 
1H NMR (400 MHz, CDCl3) δ 8.08–8.06 (2H, m, Ar-H), 7.54–7.51 (1H, m, Ar-H), 7.46 (1H, 
ddd, J = 7.6, 7.0, 1.6 Hz, Ar-H), 5.96 (1H, ddt, J = 16.8, 10.1, 6.7 Hz, CH=CH2), 5.17 (1H, dq, 
J = 10.3, 1.4 Hz, CH=CHa), 5.13 (1H, dq, J = 17.3, 1.6 Hz, CH=CHb), 3.50 (2H, d, J = 6.6 Hz, 
CH2). 
3-Allyliodobenzene 
 
The general procedure was employed for the allylation of 3-iodophenylboronic acid MIDA 
ester (36 mg, 0.10 mmol). Yield determined by 1H NMR: 91%. Analytical data were in 
accordance with literature values.114 
1H NMR (400 MHz, CDCl3) δ 7.57–7.53 (2H, m, Ar-H), 7.17–7.14 (1H, m, Ar-H), 7.06–7.00 
(1H, m, Ar-H), 5.92 (1H, ddt, J = 18.0, 10.7, 6.7 Hz, CH=CH2), 5.13–5.06 (2H, m, CH=CH2), 
3.33 (2H, d, J = 6.6 Hz, CH2). 
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2-Phenyl-1,4-pentadiene 
 
The general procedure was employed for the allylation of 1-phenylvinylboronic acid MIDA 
ester (78 mg, 0.30 mmol). Yield determined by 1H NMR: 89%. Analytical data were in 
accordance with literature values.115 
1H NMR (400 MHz, CDCl3) δ 7.47–7.42 (2H, m, Ar-H), 7.36–7.30 (2H, m, Ar-H), 7.30–7.25 
(1H, m, Ar-H), 5.91 (1H, ddt, J = 17.1, 10.1, 6.6 Hz, CH=CH2), 5.42–5.41 (1H, m, C=CHa), 
5.16–5.04 (3H, m, C=CHb, CH=CH2), 3.27–3.25 (2H, m, CH2). 
2-Allylfuran 
 
The general procedure was employed for the allylation of 2-furanylboronic acid MIDA ester 
(22 mg, 0.10 mmol). Yield determined by 1H NMR: 45%. Analytical data were in accordance 
with literature values.116 
1H NMR (400 MHz, CDCl3) δ 7.41 (1H, d, J = 2.4 Hz, Ar-H), 7.32 (1H, d, J = 2.8 Hz, Ar-H), 
6.29 (1H, d, J = 2.8 Hz, Ar-H), 6.02 (1H, d, J = 3.1 Hz, Ar-H), 5.97–5.88 (1H, m, CH=CH2), 
5.16–5.10 (2H, m, CH=CH2), 3.39 (2H, d, J = 6.5 Hz, CH2). 
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2-Allyl-N-Boc pyrrole 
 
The general procedure was employed for the allylation of N-Boc-pyrrole-2-boronic acid MIDA 
ester (32 mg, 0.10 mmol). Yield determined by 1H NMR: 67%. Analytical data were in 
accordance with literature values.117 
1H NMR (400 MHz, CDCl3) δ 7.22 (1H, dd, J = 1.8, 1.5 Hz, Ar-H), 6.09 (1H, t, J = 3.3 Hz, Ar-
H), 6.02 (1H, ddt, J = 16.7, 10.2, 6.4 Hz, CH=CH2), 5.98–5.96 (1H, m, Ar-H), 5.10–5.02 (2H, 
m, CH=CH2), 3.61 (2H, dd, J = 6.3, 1.2 Hz, CH2), 1.58 (9H, s, C(CH3)3). 
2-(2-Cyclohexen-1-yl)-naphthalene 
 
The general procedure was employed for the allylation of 2-naphthylboronic acid MIDA ester 
(28 mg, 0.10 mmol) using 3-bromocyclohex-1-ene (0.020 mL, 0.20 mmol). Purification by 
flash chromatography (petroleum ether) afforded the title compound as a colourless oil (5.3 
mg, 25%). Analytical data were in accordance with literature values.107 
1H NMR (400 MHz, CDCl3) δ 7.82–7.78 (3H, m, Ar-H), 7.65 (1H, s, Ar-H), 7.47–7.42 (2H, m, 
Ar-H), 7.38 (1H, dd, J = 8.4, 1.8 Hz, Ar-H), 5.97 (1H, dtd, J = 9.9, 3.6, 2.3 Hz, CH=CH), 5.84–
5.79 (1H, m, CH=CH), 3.61–3.55 (1H, m, ArCH), 2.17–2.06 (3H, m, CH2), 1.82–1.75 (1H, m, 
CH2), 1.71–1.64 (2H, m, CH2). 
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1,2-Diphenylethane 
 
Following a literature procedure,89 to a 4 mL vial was added phenethylboronic acid MIDA 
ester (29 mg, 0.11 mmol) and Pd(dppf)Cl2 (8.2 mg, 0.010 mmol). The vial was evacuated and 
backfilled with argon. THF (1.0 mL) and bromobenzene (11 µL, 0.10 mmol) were added, 
followed by degassed, distilled H2O (0.20 mL). The mixture was stirred at room temperature 
for 5 minutes followed by the addition of K2CO3 (83 mg, 0.60 mmol). The vial was sealed with 
a screw-cap and heated at 80 °C for 72 h by submerging the vial in a pre-heated aluminium 
block. The reaction mixture was then cooled to room temperature and H2O (2 mL) added. The 
aqueous mixture was extracted with Et2O (3 x 5 mL), then the combined organic extracts 
dried (Na2SO4), filtered and concentrated in vacuo. Purification by flash chromatography 
(petroleum ether) afforded the title compound as a colourless oil (12 mg, 66%). Analytical 
data were in accordance with literature values.89 
1H NMR (400 MHz, CDCl3) δ 7.32–7.27 (4H, m, Ar-H), 7.23–7.19 (6H, m, Ar-H), 2.94 (4H, s, 
CH2). 
Phenethylboronic acid 
 
Following a literature procedure,83 to a solution of phenethylboronic acid MIDA ester (0.13 g, 
0.50 mmol) in THF (2.5 mL) was added 1 M aq. NaOH (2.5 mL). The reaction was stirred at 
room temperature for 20 minutes. After removal of THF in vacuo, sat. aq. NH4Cl (10 mL) was 
added with vigorous stirring. The mixture was extracted with Et2O (3 x 5 mL), then the 
combined organic extracts were dried (Na2SO4), filtered and concentrated in vacuo to ~1 mL. 
This solution was then transferred to a 7 mL vial, rinsing with THF (1 mL). The vial was 
sealed with a septum cap and the solution concentrated to ~1 mL under a stream of argon. 
THF (2 mL) was added and the solution concentrated to ~1.25 mL under a stream of argon. 
This solution was used directly in the next reaction. Analytical data were in accordance with 
literature values.118  
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Benzyl propanoate 
 
Following a literature procedure,119 to a dry flask was added benzyl alcohol (1.6 mL, 15 mmol) 
and propionyl chloride (1.6 mL, 18 mmol). The neat mixture was stirred at room temperature 
until the alcohol was consumed, as determined by TLC analysis. The reaction mixture was 
then dissolved in Et2O (60 mL), then washed with sat. aq. NaHCO3 (60 mL) and brine (60 
mL). The organic phase was dried (Na2SO4), filtered and concentrated in vacuo. Purification 
by flash chromatography (petroleum ether:ethyl acetate, 95:5) afforded the title compound as 
a colourless oil (2.3 g, 93%). Analytical data were in accordance with literature values.120 
1H NMR (400 MHz, CDCl3) δ 7.38–7.32 (5H, m, Ar-H), 5.12 (2H, s, OCH2), 2.39 (2H, q, J = 
7.6 Hz, CH2CH3), 1.17 (3H, t, J = 7.6 Hz, CH2CH3). 
Benzyl 2-methyl-3-oxopentanoate 
 
Following a literature procedure,90 to an oven dried 7 mL vial fitted with a stir bar was added 
palladium acetate (5.4 mg, 0.024 mmol) and DavePhos (20 mg, 0.050 mmol). LiHMDS (1 M 
in THF, 2.0 mL, 2.0 mmol) and toluene (3.2 mL) were added and the mixture was stirred for 
10 minutes at room temperature. The mixture was cooled to –10 °C and benzyl propanoate 
(0.29 mL, 1.8 mmol) was added dropwise. The mixture was stirred for a further 10 minutes at 
–10 °C then benzyl bromide (90 µL, 0.80 mmol) was added. The reaction mixture was 
allowed to warm to room temperature, then was stirred at 80 °C for 3 h. After cooling to room 
temperature, the reaction mixture was concentrated in vacuo. Purification by flash 
chromatography (petroleum ether:ethyl acetate, 99:1) afforded an analytical sample of the 
title compound as a colourless oil. Analytical data were in accordance with literature 
values.121 
1H NMR (400 MHz, CDCl3) δ 7.36–7.28 (5H, m, Ar-H), 5.17 (2H, s, CH2O), 3.57 (1H, q, J = 
7.1 Hz, CHCH3), 2.62–2.42 (2H, m, CH2), 1.36 (3H, d, J = 7.2 Hz, CHCH3), 1.26 (3H, t, J = 
7.1 Hz, CH3).  
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tert-Butyl propanoate 
 
Following a modified literature procedure,122 to a flask fitted with a stir bar and condenser was 
added tert-butyl alcohol (4.3 mL, 45 mmol) and propionic anhydride (17 mL, 140 mmol). The 
reaction mixture was stirred at 105 °C overnight. After cooling to room temperature, the 
mixture was quenched with 1 M aq. NaOH, taking care to avoid a large exotherm by addition 
in small portions. The mixture was then separated, affording the title compound as a 
colourless oil (5.9 mL, 87%). Analytical data were in accordance with literature values. 
1H NMR (400 MHz, CDCl3) δ 2.23 (2H, q, J = 7.5 Hz, CH2), 1.44 (9H, s, C(CH3)3), 1.09, (3H, t, 
J = 7.6 Hz, CH3). 
tert-Butyl 2-methyl-3-oxopentanoate 
 
Following a literature procedure,90 to an oven dried flask fitted with a stir bar and condenser 
was added palladium acetate (5.4 mg, 0.024 mmol) and DavePhos (20 mg, 0.050 mmol). 
LiHMDS (1.5 M in hexanes, 1.3 mL, 2.0 mmol) and 1,4-dioxane (3.2 mL) were added and the 
was mixture stirred for 10 minutes at room temperature, then tert-butyl propanoate (0.16 mL, 
1.8 mmol) was added dropwise. The mixture was stirred for a further 10 minutes then 
bromobenzene (90 µL, 0.80 mmol) was added. The reaction mixture was stirred at 80 °C for 3 
h. After cooling to room temperature, the reaction mixture was concentrated in vacuo. 
Purification by flash chromatography (petroleum ether:ethyl acetate, 99:1) afforded an 
analytical sample of the title compound as a colourless oil. Analytical data were in 
accordance with literature values.123 
1H NMR (400 MHz, CDCl3) δ 3.43 (1H, q, J = 7.1 Hz, CHCH3), 2.66–2.45 (2H, m, CH2), 1.46 
(9H, s, C(CH3)3), 1.29 (3H, d, J = 7.1 Hz, CHCH3), 1.08 (3H, t, J = 7.3 Hz, CH3).  
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tert-Butyl 2-phenylpropionate 
 
Following a literature procedure,90 to an oven dried flask fitted with a stir bar and condenser 
was added palladium acetate (5.4 mg, 0.024 mmol) and DavePhos (20 mg, 0.050 mmol). 
LiHMDS (1 M in THF, 2.0 mL, 2.0 mmol) and toluene (3.2 mL) were added and the mixture 
was stirred for 10 minutes at room temperature. The mixture was cooled to –10 °C and 
benzyl propanoate (0.29 mL, 1.8 mmol) was added dropwise. The mixture was stirred for a 
further 10 minutes at –10 °C then bromobenzene (90 µL, 0.80 mmol) was added. The 
reaction mixture was allowed to warm to room temperature, then stirred at 80 °C for 3 h. After 
cooling to room temperature, the reaction mixture was concentrated in vacuo. Purification by 
flash chromatography (petroleum ether:ethyl acetate, 99:1) afforded the title compound as a 
colourless oil (83 mg, 21%). Analytical data were in accordance with literature values.124 
1H NMR (400 MHz, CDCl3) δ 7.30–7.18 (5H, m, Ar-H), 3.57 (1H, q, J = 7.2 Hz, CHCH3), 1.41 
(3H, d, J = 7.2 Hz, CHCH3), 1.36 (9H, s, C(CH3)3). 
2-(2-Methylpropyl)naphthalene 
 
A 4 mL screw-top glass vial was charged with naphthylboronic acid MIDA ester (28 mg, 0.10 
mmol), dioxane (1.25 mL), allyl bromide (0.020 mL, 0.20 mmol) and (10%) Pd/C (5.3 mg, 
0.0050 mmol). A 3 M aq. solution of K3PO4 (0.25 mL, 0.75 mmol) was added and the vial was 
sealed under ambient atmosphere. The resulting mixture was heated to 60 °C by immersion 
of the entire vial into a preheated aluminium block for 16 h. After cooling to room temperature, 
the vial was evacuated and backfilled with argon, then evacuated and backfilled with H2. The 
reaction mixture was stirred at room temperature under H2 atm. for 16 h. After removal of H2, 
the reaction mixture was filtered through celite, then diluted with H2O (10 mL) and extracted 
with Et2O (3 x 5 mL). The combined organic extracts were dried (Na2SO4), filtered and 
concentrated in vacuo. Yield determined by 1H NMR: 69%. Analytical data were in 
accordance with literature values.125 
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1H NMR (400 MHz, CDCl3) δ 7.81–7.75 (3H, m, Ar-H), 7.58 (1H, s, Ar-H), 7.46–7.39 (2H, m, 
Ar-H), 7.31 (1H, dd, J = 8.4, 1.7 Hz, Ar-H), 2.64 (2H, d, J = 7.2 Hz, CH2), 1.98 (1H, septet, J = 
6.8 Hz, CH(CH3)2), 0.94 (6H, d, J = 6.6 Hz, 2xCH3). 
1-Bromo-4-(2-methyl-2-propen-1-yl)-benzene 
 
The general procedure was employed for the allylation of 4-bromophenylboronic acid MIDA 
ester (0.94 g, 3.0 mmol) using 2-methylallyl bromide (0.60 mL, 6.0 mmol). Purification by 
flash chromatography (petroleum ether) afforded the title compound as a colourless oil (594 
mg, 94%). Analytical data were in accordance with literature values.126 
1H NMR (400 MHz, CDCl3) δ 7.42–7.40 (2H, m, Ar-H), 7.08–7.05 (2H, m, Ar-H), 4.82 (1H, t, J 
= 1.7 Hz, C=CHa), 4.72 (1H, dd, J = 2.3, 1.2 Hz, C=CHb), 3.27 (2H, s, CH2), 1.66 (3H, s, 
CH3). 
tert-Butyl 2-bromozincpropionate 
 
Following a literature procedure,91 to a dry 2-necked flask with a condenser was added zinc 
powder (1.2 g, 19 mmol), THF (7.5 mL) and trimethylsilyl chloride (0.080 mL, 0.63 mmol). The 
mixture was stirred for 15 minutes. A solution of tert-butyl 2-bromopropionate (2.10 mL, 12.5 
mmol) in THF (17.5 mL) was added over 2–3 minutes with an exotherm observed. Once the 
mixture returned to room temperature, stirring was discontinued. The solution was used 
directly in the next step (assumed concentration: 0.23M). 
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tert-Butyl 2-(4-phenyl boronic acid MIDA ester)propionate 
 
Following a modified literature procedure,91 to a dry flask charged with a stir bar was added 4-
bromophenylboronic acid MIDA ester (0.31 g, 1.0 mmol), Pd(dba)2 (5.8 mg, 0.010 mml), 
QPhos (7.1 mg, 0.010 mmol) and THF (3.0 mL). The mixture was stirred briefly, then a 
freshly prepared solution of tert-butyl 2-bromozincpropionate in THF (8.7 mL, 2.0 mmol) was 
added. The reaction mixture was stirred at 65 °C for 1.5 h. After cooling to room temperature, 
the reaction was quenched with sat. aq. NH4Cl (10 mL), followed by addition of brine (10 mL). 
The phases were separated and the organic phase was dried (Na2SO4), filtered and 
concentrated in vacuo. The residue was adsorbed onto silica gel then purification by flash 
chromatography (diethyl ether:methanol, 98.5:1.5 then THF) afforded the title compound as a 
light pink solid (0.32 g, 90%). 
1H NMR (400 MHz, d6-DMSO) δ 7.39 (2H, d, J = 8.1 Hz, Ar-H), 7.25 (2H, d, J = 8.1 Hz, Ar-H), 
4.32 (2H, d, J = 17.2 Hz, 2 x NCHH), 4.11 (2H, d, J = 17.2 Hz, 2 x NCHH), 3.64 (1H, q, J = 
7.1 Hz, CHCH3), 2.49 (3H, s, NCH3), 1.34 (9H, s, 3 x CCH3); 13C NMR (100 MHz, d6-DMSO) 
δ 174.3 (C), 173.0 (C), 169.3 (C), 141.6 (C), 132.5 (CH), 126.5 (CH), 79.9 (C), 61.8 (CH2), 
47.5 (CH3), 45.5 (CH), 27.6 (CH3), 18.5 (CH3); IR (solid) 2978, 1724, 1713, 1367, 1150 cm-1; 
HRMS (ESI) exact mass calculated for C18H24BNNaO6 [M+Na]+ m/z 384.1589, found m/z 
384.1575. 
tert-Butyl 2-(4-methallylphenyl)propionate 
 
The general procedure was employed for the allylation of tert-butyl MIDA (36 mg, 0.10 mmol) 
using 2-methylallyl bromide (0.020 mL, 0.20 mmol). Yield was determined by 1H NMR: 73%. 
1H NMR (400 MHz, CDCl3) δ 7.21 (2H, d, J = 8.1 Hz, Ar-H), 7.13 (2H, d, J = 8.1 Hz, Ar-H), 
4.81–4.79 (1H, m, C=CHH), 4.73–4.71 (1H, m, C=CHH), 3.59 (1H, q, J = 7.2 Hz, CHCH3), 
3.29 (2H, s, Ar-CH2C), 1.67 (3H, s, CCH3), 1.44 (3H, d, J = 7.2 Hz, CHCH3), 1.39 (9H, s, 3 x 
CCH3); 13C NMR (100 MHz, CDCl3) δ 173.9 (C), 145.2 (C), 139.0 (C), 138.3 (C), 128.9 (CH), 
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127.3 (CH), 111.6 (CH2), 80.3 (C), 46.0 (CH), 44.1 (CH2), 27.8 (CH3), 21.9 (CH3), 18.3 (CH3); 
IR (thin film) 2978, 2934, 1728, 1452, 1148, 739 cm-1; HRMS (ESI) exact mass calculated for 
C17H24NaO2 [M+Na]+ m/z 283.1669, found m/z 283.1666. 
Ibuprofen 
 
A stirred solution of ester (18 mg, 0.069 mmol), palladium acetate (1.1 mg, 0.0050 mmol) and 
DavePhos (3.9 mg, 0.010 mmol) in dioxane/H2O (1.25 mL/0.25 mL) under an argon 
atmosphere was evacuated and backfilled with H2. The reaction mixture was stirred at room 
temperature under a H2 atmosphere for 16 h. The flask was evacuated and backfilled with 
argon, then conc. HCl (0.60 mL) was added to give an overall concentration of 4 M HCl. The 
reaction mixture was stirred at room temperature for 16 h then quenched with 2 M aq. NaOH. 
The mixture was extracted with Et2O (2 x 10 mL) then the aqueous phase adjusted to pH 1 
with 2 M aq. HCl. The aqueous phase was extracted with Et2O (2 x 10 mL) then the combined 
organic extracts were dried (Na2SO4), filtered and concentrated in vacuo affording the title 
compound as a white solid (9.5 mg, 67%). Analytical data were in accordance with literature 
values.127 
1H NMR (400 MHz, CDCl3) δ 8.62 (1H, s, COOH), 7.22 (2H, d, J = 7.9 Hz, Ar-H), 7.10 (2H, d, 
J = 7.8 Hz, Ar-H), 3.71 (1H, q, J = 7.1 Hz, CHCH3), 2.44 (2H, d, J = 7.2 Hz, CH2), 1.84 (1H, 
septet, J = 6.6 Hz, CH(CH3)2), 1.50 (3H, d, J = 7.1 Hz, CHCH3), 0.90 (6H, d, J = 6.6 Hz, 
CH(CH3)2). 
Octyl boronic acid MIDA ester 
 
Following a literature procedure, octyl boronic acid (0.32 g, 2.0 mmol) and MIDA (0.29 g, 2.0 
mmol) were stirred in DMF (6.0 mL) at 85 °C for 16 h then allowed to cool to room 
temperature. The reaction mixture was diluted with EtOAc (50 mL) and H2O (50 mL) then 
separated. The organic phase was washed with H2O (2 x 25 mL) and brine (3 x 25 mL) then 
dried (Na2SO4), filtered and concentrated in vacuo. Et2O (50 mL) was added to the residue 
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and the resulting suspension was stirred at room temperature for 1 h. The precipitate was 
then collected by vacuum filtration affording the title compound as a white solid (0.38 g, 70%). 
Analytical data were in accordance with literature values.83 
1H NMR (400 MHz, d6-DMSO) δ 4.15 (2H, d, J = 17.0 Hz, 2 x NCHH), 3.96 (2H, d, J = 17.0 
Hz, 2 x NCHH), 2.82 (3H, s, NCH3), 1.32–1.24 (12H, m, CH2), 0.86 (3H, t, J = 6.8 Hz, 
CH2CH3), 0.51–0.48 (2H, m, CH2CH3) 
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